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The persistent threat of infection has contributed to variation in mortality and survival,
shaping mammalian genomes throughout history. Genetic variation that now exists con-
trols infection outcomes, although the specific genes and variants are not well known.
Common methods for genome-wide mapping often assume predominantly additive genetic
action, for reasons of power and simplicity. However, non-additive effects may arise from
mutations in critical pathways, such as those that regulate the host resistance to influenza
A virus. Notably, complex, non-additive genetic architecture is difficult to characterize in
human studies, and certain effects may remain elusive except in model organisms, such
as mice. Thus, the identification of novel non-additive genetic effects in host-pathogen
interactions is an area of open research, and this dissertation focuses specifically on under-
standing the role of dominance, parent-of-origin, and additive genetic variation the host
control of influenza infection. In this research, I use experimental crosses of inbred strains
of mice, both standard and recombinant inbreds, to introduce genetic diversity and in-
crease levels of heterozygosity. Using replicable, genetically diverse populations, I model
and characterize genetic variation that controls the host pathogenic response to influenza.
In Chapter 1, I provide a basic introduction for influenza virus, diallels, and reciprocal
cross breeding designs for genetic studies, and I review systems and statistical genetics
analysis with recombinant inbred strains known as the Collaborative Cross. In Chapter 2,
I describe the genetic architecture of the host response to influenza in a diallel, and the
dissection of subspecies-specific Mx1 dominance. In Chapter 3, I describe novel parent-
of-origin effects on pathology and on gene regulation in the response to influenza in F1
reciprocal cross mice. Chapter 4 covers the discovery of a novel genomic locus that con-
iii
trols pathology of influenza infection in the lung, via quantitative trait locus mapping in
Collaborative Cross F1 mice. I conclude in Chapter 5 with a recap and future directions.
In summary, this work provides a path forward for interrogating and understanding
the complex genetic architecture of genome-wide contributions to host pathology follow-
ing influenza infection, using quantitative, statistical, and systems approaches in inbred
and hybrid mice.
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To my son, Lucas.
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“We snatch in vain at Nature’s veil,
She is mysterious in broad daylight,
No screws or levers can compel her to reveal
The secrets she has hidden from our sight.”
— Goethe 1
“Nature uses only the longest threads to weave her patterns,
so each small piece of her fabric
reveals the organization of the entire tapestry.”
— R. Feynman 2
“Sit down before a fact as a little child,
be prepared to give up every preconceived notion.”
— T. H. Huxley 3
1Faust: Volume 1, von Goethe and Luke (1998)
2The Character of Physical Law, Feynman and Wilczek (2017)
3Letter to Charles Kingsley, Sept 23, 1860, Huxley and Huxley (1913)
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In the first section of the introduction (§1.1), I briefly introduce influenza and the
host genetics of infection. In the second section of the introduction (§1.2), I provide back-
ground introducing the concept of the diallel cross, which is relevant for the published
work presented in Chapter 2 of the dissertation. In the third section (§1.3), I describe
how quantitative phenotypes may be affected by heritable parent-of-origin effects (POE),
which are particularly relevant for the study described in Chapter 3. In the fourth section
(§1.4), I briefly describe the concept of Genetic Reference Populations (GRPs) and Multi-
parental Populations (MPPs), and focus on the design of the the Collaborative Cross, a
multiparental GRP derived from eight inbred founder strains of mice, and CC-F1 inter-
cross (CC-RIX) for generating QTL mapping populations, which are especially relevant
topics for Chapter 4 of this dissertation. In the fifth section of the introduction (§1.5), I
include a general protocol for the use of the CC for systems genetics analysis and quan-
titative trait loci mapping of a variety of infectious disease phenotypes. Finally, in the
last section of the introduction (§1.6), I lay out Dissertation Objectives for the research
chapters that follow.
1.1 Our Innate Capacity to Confront the Great Influenza
The ongoing threat of influenza virus. Influenza A virus (IAV) is an Orthomyx-
ovirus (family: Orthomyxoviridae), with a spherical or filamentous enveloped virion con-
taining an eight-segmented, negative-sense, single-stranded RNA genome encoding 11 pro-
teins, among which the HA and NA protein subtypes are used in combination to define
the viral subtypes (e.g. H1N1, H3N2, H5N1, etc.) (Shaw and Palese 2013; Wright et al.
2013; Szewczyk et al. 2014). Influenza virus was first identified as the causative agent
of human influenza disease in 1933 (Smith et al. 1933). In humans, IAV is a respiratory
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infection characterized by fever, congestion, cough, body aches and headaches, among
other symptoms (Wright et al. 2013), and severe pathology is often correlated with inflam-
mation in lower respiratory regions, elevated systemic cytokine responses, and adverse
contributions from secondary bacterial infections (Taubenberger and Morens 2008). The
Orthomyxoviridae family includes several genera of influenza viruses, including IAV, which
exhibits broad species-specific tropism (dogs, waterfowl, poultry, horses, pigs, and oth-
ers), influenza B virus (IBV; found in humans and seals), influenza C virus (ICV; humans,
dogs, and pigs), and the recently discovered influenza D virus (IDV; isolated from cattle)
(Hause et al. 2014; Ferguson et al. 2016; Wright et al. 2013); the focus of this dissertation
is on the host genetic effects on infection with influenza A (H1N1).
There are several molecular, epidemiological and ecological factors that contribute
to the perpetual public health burden of IAV. This virus exhibits rapid evolution (Ram-
baut et al. 2008; Nelson and Holmes 2007; Ghedin et al. 2005), a high global incidence of
common seasonal infections, zoonotic introductions (Olsen et al. 2006), and severe pan-
demic outbreaks (Zimmer and Burke 2009; Itoh et al. 2009; Monto and Webster 2013)
arising primarily from segmental reassortments which cause antigentic shifts and escape
pre-existing host influenza virus immunity (Vijaykrishna et al. 2010; Lowen 2017). In
addition, the fast mutation rate of IAV is a function of its low-fidelity polymerase, lack
of proof-reading, and virus replication speed, and predisposes IAV to have a propensity
for antiviral resistance and immune evasion, leading to recurrent emergence of new viral
strains and subtypes (Drake 1993; Duffy et al. 2008). It has been estimated that in recent
years seasonal influenza has caused approximately 1.2 − 5.6 × 104 deaths per year in the
US alone (Rolfes et al. 2016). In addition to the regular, continuous burden of influenza,
historic IAV pandemic outbreaks have caused some of the most devastating human infec-
tious disease outcomes in recent human history, of which the 1918 H1N1 pandemic gener-
ated the greatest mortality, likely causing at least 50 million human deaths, and given the
regularity of large-scale outbreaks, future severe pandemics are thought to be imminent
and inevitable (Taubenberger et al. 1997; Morens et al. 2010; Monto and Webster 2013;
Fong 2017; Paules and Subbarao 2017).
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Host genetics of infectious disease. Even as the general threat to human health
from IAV is evident, there are those within the human host population who are at much
greater risk due to known and unknown host factors. Host genetic variation is one com-
ponent of many that contribute to differences in influenza infection pathology (Arcanjo
et al. 2014; Kash and Taubenberger 2015; Bahadoran et al. 2016), and may arise from
single-gene inborn errors of immunity (Conley and Casanova 2014; Al-Herz et al. 2014;
Ciancanelli et al. 2016) and/or polygenic variation (Frodsham and Hill 2004). Although
human studies have uncovered important determinants of variation in the immune re-
sponse to infection (Casanova 2015), the genetic effect of the host remains murky in clin-
ical studies (Horby et al. 2012), partly due to issues regarding study design, selection of
matched controls for causal inference, confounding/covariates and restricted phenotyping.
Additional issues arise due to uncertainty regarding viral dose and strain, with genetic
diversity of the pathogen leading to imprecision in mapping phenotypes to genotypes, and
a substantial loss of power—indeed the relative dearth of genetic variation in the bacterial
pathogen Mycobacterium tuberculosis may have contributed to the relative ease and power
for mapping its host susceptibility variants (Hill 2012). By using replicable experimental
designs in mice, in which we control for virus strain, dose, and a range of covariates, we
improve our chances of finding genetic regions and specific variants that are responsible
for directing the host response to virus infection.
Genetic architecture of infectious disease. When a host is challenged with a
pathogen, a number of important heritable factors regulate the disease process, guiding
the host toward a spectrum of resistance, tolerance, or suceptibility (Iwasaki and Pillai
2014). In order to understand the complexity of the host response to infection, a number
of modeling approaches may be used to uncover important heritable variation underlying
severe disease, including advanced statistical genetics methods. Statistical genetics is, in
large part, concerned with the estimation of genome-wide genetic effects, and prediction
of phenotypic effects based on genotypes, in genetically diverse populations. Systems
genetics, in part, attempts to model system complexity by using a diversity of allelic vari-
ants, assorted in different configurations, with the intent of yielding more generalizable
interpretations of variant effects on phenotypes, across genetic backgrounds. In contrast,
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standard approaches in viral pathogenesis are directed toward understanding the contribu-
tion of a limited, often engineered, set of host genetic variants. By taking a statistical and
systems genetics approach to studying viral pathogenesis, examining many genome-wide
contributions simultaneously, and using natural variation rather than mutagenesis/trans-
genesis, we are not restricted to simply exploring host factors that are a priori known
to be related to the immune system, or only to viral restriction factors that have been
previously characterized. As well, we are more likely to discover host variation that is
meaningful across mouse subspecies and, in many cases, more translatable in the context
of human disease.
It has been hypothesized that the genetic architecture of host resistance to infection
may have a distinct character compared with the architecture of baseline phenotypes and
other types of disease traits (Hill 2012), perhaps because resistance to infection is a phe-
notype that is necessarily related to interactions between genes and their environment,
or between genotypes and pathogen “treatments.” Thus, using a causal inference frame-
work and matched treatment-control design, to explore the impact of genetic variation
on induced phenotypes such as infection or vaccination, we may gain insights that are
important both biomedically and also with respect to our overall understanding of the
many possible compositions of genetic architecture that exist for mammalian phenotypes
(Mackay 2001; Flint and Mackay 2009).
1.2 The Utility of Modeling Infection Phenotypes in a Diallel
The diallel. In this section, I briefly introduce the utility of the diallel cross, which is
an old genetic design whereby N inbred lines are crossed one to another, in both parental
directions, in order to generate a population of N inbred strains and N × (N − 1)/2 recip-
rocal F1 lines, providing genetic replicates for phenotyping, and useful for quantifying
heritability and replicability of phenotypes based on a number of genetic and non-genetic
effects classes. I then briefly summarize the effect classes that may contribute to the host
infection response, and describe the use of statistical modeling to deconvolute their action
on phenotypes in a diallel cross.
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A variety of effects underlie the genetic architecture of monogenic and complex phe-
notypes. The diallel cross is an old experimental design in genetics, whose method was
introduced into the literature almost a century ago (Schmidt 1919), which enables us
to experimentally and statistically address questions about additive, maternal, inbred,
epistatic, parent-of-origin, and sex-specific effects on phenotypes in a coordinated and
unified way. The analysis of diallel studies has historically been challenging. However,
an opportunity has arisen, due to the availability of several recent Bayesian statistical
models, such as (Greenberg et al. 2010), and, more relevant to our studies, BayesDial-
lel (Lenarcic et al. 2012; Crowley et al. 2014), to robustly characterize these genetic and
non-genetic effects in diallels, some of which are shown as toy examples in Figure 1.1.
Additive effects. Additive genetic effects, also considered dosage effects, contribute
to phenotypic traits based on the specific count of alleles or haplotypes (e.g., counts of 0,
1, or 2 for diploid organisms at a biallelic site), where one dose provides one additional
unit of a quantitative phenotype, and two doses provides twice as many units, in expec-
tation. This class of effects, and those that I describe below, can be modeled at the fine
level of a single variant site, such as a single nucleotide polymorphism (SNP), or they can
be considered at the broader level of inbred genomes, such as modeling effects of a single
or double dose of C57BL/6J (B6), depending on the count of B6 parents belonging to an
F1 mouse. Additive effects serve as a baseline from which a biparental average can be
estimated, which may provide an expectation for offspring phenotypes, and deviations
from these estimates can be attributed to the non-additive effects classes considered be-
low. There is some literature exploring the additivity, or genetic dose-dependent action,
of host antiviral factors, based on experiments in mice (Sun et al. 2006), however this con-
cept has not been well-studied in mice, or humans. In the influenza diallel study (Chapter
2), we discuss the general expectation for additivity versus dominance in the specific case
of the host antiviral factor Mx1 , and provide a quantitative analysis of additivity for a
specific Mx1 allele.
Dominance effects. Dominant genetic effects in diploid organisms, which are re-
lated to inbred or hybrid effects and can be reparameterized as such, are effects for which





























Figure 1.1 A simplified diagram illustrating phenotypic contributions of diallel effects
demonstrates the patterns of additive, maternal, inbred, and epistatic effects (strainpair,
and parent-of-origin) in a 3×3 cross of imaginary strains 1, 2, and 3. Darker shading
indicates increasing mean units of a given quantitative phenotype.
tive phenotype, and an additional dose contributes no additional amount—hence one
copy of a dominant allele may be sufficient to confer a “maximum” or “minimum” pheno-
type (Veitia 2006). Dominance, and in a related fashion recessivity, however, manifests
itself in natural populations along a continuous spectrum, rather than in categorical abso-
lutes. Earlier work in quantitative genetics by Wright (1934) and Comstock and Robinson
(1948), furthered by Kacser and Burns (1981) and Falconer and Mackay (1996), defined
dominance parametrically as a continuous, and quantifiable measure based on the phe-
notypes observed within a set of wild-type, mutant, and heterozygote (wild-type crossed
with mutant) genotypes. As stated above, in the influenza diallel chapter (Chapter 2), we
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use a diallel design to quantify the dominance of functional Mx1 haplotypes arising from
Mus musculus musculus (in combination with Mx1 null) in the Collaborative Cross in-
bred founder strains, in comparison with the additivity observed for functional Mx1 from
Mus musculus castaneus, with respect to post-infection weight loss. The extent to which
host antiviral factors tend to be dominant, and the effect of that dominance on the evo-
lution of host traits in the presence of ongoing pathogen challenge, is an area of ongoing
research, with implications for study design, resistance to disease in breeding populations,
and molecular evolution.
Inbred effects. Inbred effects are deviations of phenotypes in inbred animals com-
pared with those in hybrid animals, after accounting for additive effects and other effects
classes in a genetic cross. In a diallel, inbred effects are closely related to dominance as
well as overdominance effects (Hughes and Nei 1988), and connected with the concept of
inbreeding depression (Ayroles et al. 2009). In a similar way, heterosis (Shull 1908; Hay-
man 1957) or hybrid vigor (Bruce 1910) describes specific phenotypic outcomes, usually
implying improved phenotypic or fitness qualities, that arise in hybrids of inbred lines
due to differences in overall dominance and recessivity effects at loci spread across the
inbred genomes, when combined in F1 crosses (Han et al. 2008). Inbred effects, for the
purpose of our statistical genetic analysis, are simply parameters indicating deviations
of inbreds from expectation—a quantitative penalization—rather than effects specifically
attributable to the biological process of inbreeding. Whereas a number of studies in viral
pathogenesis have used inbred lines to understand strain-specific effects on infection, the
quantification of inbred effects, whether strain-specific or strain-independent, necessarily
requires contrasts with hybrid mice. If, conversely, the inbred state is taken as a baseline,
these effects can be translated into corresponding hybrid (heterozygote) effects, where
we model the deviation in hybrids compared with expected values based on inbreds. Het-
erozygote effects have been noted at MHC (Hedrick 2002), and likely play an important
and underappreciated role in infection and immune studies, and in the evolution of the
immune response, since heterozygote advantage may play a role in infection resistance
and thus fitness effects in a diverse population over a sustained period of time in the pres-
ence of selection pressure due to infection.
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Strainpair effects. In generating F1 hybrid animals from inbred lines, we can also
model effects that are attributed to the specific pairing of two strains—effects which may
be called epistatic or strain-by-strain (strainpair) interaction effects. These effects in-
dicate interactions between genes at the same locus, or at different loci across genomes
(Ehrenreich 2017). When these effects are present, they may either be identical in recip-
rocal F1 hybrids (symmetric), or they may differ depending on the direction of the F1
cross (e.g., A×B pairwise effect is much greater than B×A pairwise effect), suggesting a
strainpair-specific parent-of-origin effect which may be mediated by the epigenetic process
of imprinting. The importance of epistasis, or gene-by-gene interaction effects, has been
hard to detect, quantify, and interpret (Hall and Ebert 2013; Mackay 2014; Tyler et al.
2016). However, statistical detection of epistatic interactions can lead to important bio-
logical insights. A notable example of an epistatic interaction substantially influencing
resistance to viral infection was an interaction found between host cytomegalovirus resis-
tance factor Cmv3 and major histocompatibility complex H2K—an effect first detected
by linkage analysis in an F2 population of MA/My × BALB/c mouse strains (Desrosiers
et al. 2005), and subsequently validated in new F2 and F3 crosses (Fodil-Cornu et al.
2011). Notably, parent-of-origin effects (POE) are dependent on offspring genotypes them-
selves, but are distinguished from those that are specifically mediated by maternal or
paternal genotypes alone. POE are discussed in the next section of the introduction (§1.3)
in more detail, and have been largely unexplored in the context of viral infection.
Maternal effects. We define maternal genetic effects as those which are mediated
by maternal genotype, both prenatal and postnatal, and comprise a sort of indirect ge-
netic effect on offspring phenotypes. Absent any genetic interactions, these effects are not
directly dependent on offspring genotypes. In this way, we differentiate maternal effects
from POE. It is known that mammalian maternal fostering effects may contribute toward
infection resistance in offspring through mechanisms such as diet, nutrition, and passive
transfer of neutralizing antibodies (Lemke et al. 2004), although the full extent of mater-
nal genetic effects on disease resistance is likely an underappreciated and understudied
area of research in genetic studies of viral infection.
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Sex-specific effects. Sex-specific differences in genetic architecture can arise from
social, hormonal, or sex-chromosome-specific sources, among others (Gilks et al. 2014). In
generating a diallel cross, we can model phenotypes in both sexes across all possible geno-
typic combinations, thereby detecting sex-specific effects and sex-specific interactions with
other diallel effects. Notably, sex-specific effects have been described for host response
to influenza infection and vaccination, and are thought to have a meaningful impact on
influenza public health strategies and outcomes (Larcombe et al. 2011; Klein et al. 2012;
Klein and Pekosz 2014; Hall et al. 2016; Krementsov et al. 2017). Although we conduct
genome-wide mapping in females only in Chapter 4, we model infections in both male and
female mice, and consider sex-specific effects on infection outcomes, in Chapters 2 and 3.
Bayesian statistical analysis of diallel effects. Whereas the targeted examination
of any single one of these classes of effects in a diallel might require its own statistical
formulation, we use a hierarchical statistical model that is able to accommodate, and si-
multaneously estimate, a very large number (n > 100) of strain- and strainpair-specific
parameters due to partial pooling of estimates based on class—i.e. statistical shrinkage
toward the overall class mean using linear mixed models in a generalized Bayesian frame-
work (Wilson et al. 2010; Gelman et al. 2013). Our ability to carry out unified estimation
of a diverse variety of effects helps make the factorial design of the diallel a powerful tool
for understanding the overall genetic architecture of a quantitative phenotype, including
specific estimates for each effect, and also the overall percent variance contribution of
these effects using measures of heritability and/or variance projection (VarP; an ideal-
ized percent variance calculation). We are furthermore able to incorporate causal effect
analysis in the diallel framework, using treatment-response designs and matching to calcu-
late difference scores between treatment groups, in order to model the genetic effect on a
treatment response, i.e. quantifying gene-by-treatment (G×T) effects.
In summary, the statistical approach we use for diallel modeling allows us to dissect
quantitative traits, such as infection response, in such a way that we can characterize
multiple classes of effects, such as additive, dominant, and parent-of-origin effects, among
others, through a detailed exploration of a single, large-scale, diallel study.
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1.3 Parent-of-Origin Effects on Disease Phenotypes
In this section, I briefly introduce a class of epigenetic inheritance effects that man-
ifest as parent-of-origin effects (POE) on quantitative phenotypes. POE are a class of
dominance effects of alleles at specific loci, contingent on parental origin of the expressed
alleles, and are generally detected by phenotypic asymmetry, or specifically gene expres-
sion asymmetry, indicating the effect of molecular imprinting on gene regulation. In or-
der to illustrate the relationship between POE and genetic dominance, suppose we cross
Strain A (high response phenotype) with Strain B (low response phenotype) in a two-way
cross, in both directions. In the following diagram (Figure 1.2), I have shown some pos-
sible mean phenotypic outcomes in inbred (AA, BB) and F1 reciprocal hybrids (AB, BA,






































Figure 1.2 Dominance and parent-of-origin effects in two-way crosses. This diagram
draws from and simplifies the framework for understanding genomic imprinting patterns,


















Figure 1.3.2 Schematic toy diagram of parent-of-origin e ects on infection-induced dis-
ease.
7 In the context of influenza virus infection in a two-way inbred line cross, one might
imagine a scenario where Strain A confers some amount of protection from weight loss
post-infection, but only when inherited maternally. Strain B provides no such protection,
whether inherited from the maternal or paternal lineage. In this case, we might observe the
following distribution of phenotypes in the cross, as shown in Figure 1.3.2. The phenotypes
of AB and BA mice di er in a parent-of-origin-dependent manner. We could also examine
other pathogenesis-related phenotypes, such as percent lymphocyte composition or viral
titer, and observe similar e ects.
Importantly, the mode of inheritance 8 of these host factors that exhibit POE can
have an impact on natural selection in the host, leading to shifts in population-level allele
frequencies for infectious dissease susceptibility and resistance genes, some of which we have
7MTH: I would call this disease (or pathogenesis), rather than pathology. For these figures (this and the ones
above) you should indicate that they are toy diagrams. Are these your own original figures (I ask because
you indicate that the figures in the next section are new)? If so, I think that the are very nice and useful for
illustrating these concepts, and I want to borrow them from you for my talks. If derived from another source,
be sure to reference the source material.
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Figure 1.3 Schematic toy diagram of parent-of-origin effects on infection-induced disease.
We see that the deviation in phenotypes between AB and BA mice, in the bottom row
of Figure 1.2 appears to point to a parent-of-origin effect, rather than simple dominance
or recessivity of strain A or B. In regions that are (paternally or maternally) imprinted
via molecular silencing due to DNA methylation, epigenetic marks are written on specific
bases and cause biased allelic expression, whereby, in maternal imprinting for instance,
alleles inherited from the maternal strain are preferentially expressed compared with alle-
les from the paternal strain. Although not much is known about parent-of-origin effects
on viral infection, some literature exists describing parent-of-origin effects thought to in-
fluence autoimmune disease in mice and humans (Ebers et al. 2004; Stridh et al. 2014),
suggesti g a relationship betw en parent-of-origin effects on gene expr ssion and clinically-
relevant mmune-related disease phenotypes.
In the context of influenza virus infection in a two-way inbred strain cross, one could
imagine a scenario where Strain A confers some amount of protection from weight loss
post-infection, but only when inherited maternally. In this case, Strain B provides no
such protection, whether inherited from the maternal or paternal lineage. We might in
this situation observe the following distribution of phenotypes in the cross, as shown in
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Figure 1.4 Parent-of-origin effects on total expression, in a toy example. In the absence
of imprinting (top row), strain-specific variants, shown at red and blue vertical lines,
present in regulatory noncoding regions, modify total expression such that strain A has
higher expression at this locus than strain B, for both a coding and non-coding gene, re-
gardless of the directon of the cross. Strain-specific effects on total expression are present,
but not observed, between reciprocal F1 cross mice, in the absence of imprinting. Imprint-
ing (second row) causes asymmetric effects in reciprocal crosses (reciprocal effects), in this
case, where total expression at this locus is from the paternal chromosome only. These
total expression effects can be observed for protein-coding and non-coding genes.
Figure 1.3. The phenotypes of AB and BA mice differ in a parent-of-origin-dependent
manner. We could also examine other pathogenesis-related phenotypes, such as percent
lymphocyte composition or viral titer, and observe similar effects.
The following diagrams illustrate the observable effect of imprinting on differential
total expression (Figure 1.4), and on differential allelic expression (Figure 1.5), in F1
reciprocal cross mice.
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Figure 1.5 Parent-of-origin effects on allelic expression, in a toy example. In the ab-
sence of imprinting (top row), transcripts with strain-specific variants, shown at red and
blue vertical lines, are present at equivalent levels (equal parts blue-containing and red-
containing) in expressed transcripts, regardless of the directon of the cross. Imprinting
(second row) causes asymmetric effects, in this case where only transcripts with the pa-
ternal allele are expressed, in reciprocal crosses (reciprocal effects). These allelic expres-
sion effects can be observed for protein-coding and non-coding genes. The key from Fig-
ure 1.4 applies here as well.
Studies exploring POE on infection-related phenotypes are warranted both for clini-
cal diagnostics and for broader evolutionary understanding of the mode and mechanisms
of inheritance of infection resistance and susceptibility genes. Experimental approaches
using reciprocal F1 crosses of mice can thus identify imprinted genes based on expression
differences measured using next-generation RNA sequencing platforms, and help to iden-
tify potential causal links between imprinted gene expression patterns and differences in
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Figure 1.6 Comparison of reciprocal F1 cross phenotypes in the influenza POE study.
As outlined above, this is the general approach we take in Chapter 3, where we exam-
ine the effect of reciprocal cross and parent-of-origin on differential pathology and gene
expression in reciprocal C57BL/6J × 129S1/SvImJ F1 cross mice, comparing phenotypes
from reciprocals as schematically outlined in Figure 1.6. There is a notable absence of
studies exploring POE on the host response to viral infection, making this a potentially
fruitful avenue of research in the years to come.
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1.4 Genetic Reference Populations
Having established some of the immunological complexity of the host response to
pathogens, the genetic complexity (e.g., polygenicity, non-additivity, etc.) of infection-
related phenotypes, and barriers that exist in identifying these complexities in natural
populations, it is increasingly apparent that experimental populations that are genetically
diverse and replicable are critical for dissecting the immune response and identifying key
host factors contributing to differential disease outcomes.
In order to map quantitative trait loci, however, F1 populations such as the diallel are
not suitable given their lack of distinct recombination sites across the genome. Straight-
forward approaches to introducing recombination between genomes from two parents
include the F2 intercross, which uses sibling mating after an initial F1, and the backcross
(BC), where F1 animals are mated with parental strains, or alternatively outcrossed to
a standardized heterologous strain. Building on the F2 method of introducing recombi-
nation, and expanding on the types of genetic analysis that can be done in simple bi- or
multi-parental populations (MPPs), such as the diallel cross, panels of genetically diverse
recombinant inbred strains, making up genetic reference populations (GRPs), are useful
for dissecting diverse complex traits, including those related to infection and immunity.
There are a variety of GRPs that have been developed in mammalian systems, as well as
in plants and invertebrates, which harbor a large degree of polymorphism and are stably
maintained, enabling replicable phenotyping in multiple individuals from the same strain.
The relative stability of the recombinant inbred genomes over time means that genotyping
does not have to be performed in every study, as in F2 study designs.
One murine GRP is the Hybrid Mouse Diversity Panel (HMDP) which consists of 100
inbred strains of mice, including 29 classical inbred strains and three sets of RI panels
(BXD, AXB/BXA, and BXH) (Bennett et al. 2010; Ghazalpour et al. 2012). Chromo-
some substitution (consomic) strains (CSS) are GRPs that are generated through marker-
assisted breeding and many generations of backcrossing so that a single chromosome from
strain A replaces the native chromosome in strain B, and this is repeated until CSS are
reciprocally generated for all chromosomes, in both directions (Nadeau et al. 2000). CSSs
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can thus be used to quickly isolate chromosomes that contain significant QTL controlling
differences in phenotypes based on allelic variation between founder strains.
The Collaborative Cross. The Collaborative Cross GRP is generated from an ini-
tial set of eight inbred founders, with inbred progenitor strains from the three major Mus
musculus subspecies: musculus, domesticus and castaneus, where genetic diversity is intro-
duced by three rounds of directed outbreeding, and recombination sites are subsequently
fixed by numerous rounds of inbreeding (Figure 1.7). GRPs that are derived in a man-
ner similar to that of the CC are generally termed Multiparent Advanced Generation
Inter-Cross (MAGIC) populations, and have been constructed for a number of crops (rice,
wheat, maize, etc.) using various numbers of inbred founder lines as starting material for
breeding funnels that proceed with initial outbreeding followed by inbreeding (reviewed in
Huang et al. (2015)). In flies, the Drosophila synthetic resource population (DSPR) (King
et al. 2012), a MAGIC population containing >1600 RI lines, and the Drosophila genetic
reference panel (DGRP) (Mackay et al. 2012), containing 192 RI lines, are GRPs that can
be used for QTL mapping and quantifying genetic architecture of complex traits in flies.
The CC-RIX. The recombinant inbred intercross (RIX) was introduced as a pop-
ulation for mapping that is generated using a sparse diallel cross of recombinant inbred
strains, to combine the benefits of RI lines with the increased recombination and het-
erozygosity found in F2 populations (Zou et al. 2005). An toy example CC-RIX line is
shown for a set of CC strains in Figure 1.8. Due to the resemblance of their recombi-
nation patterns with those of F2 crosses, and their ease of genetic replicability, CC-RIX
lines have been termed “immortalized F2” (IF2) lines by some investigators (Hua et al.
2002; Ku et al. 2012).
Related Genetically Diverse Populations. In addition to the GRPs, there are
related multiparental populations which are genetically diverse and non-replicable, such
that each individual in the population is genetically distinct. These populations may be
constructed to exhibit a high level of outbreeding, and increased levels of recombination
that allow for fine-mapping of causal loci. Advanced intercross lines (AILs) can be used
for QTL mapping (Darvasi and Soller 1995), and are generated from biparental crosses
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Figure 1.7 Collaborative Cross breeding funnel design. Adapted and modified from
(Morgan and Welsh 2015). Matings are ordered dam × sire on every level, with G0
through G2 indicating outbreeding, and G2:F1 through G2:F20(+) indicating inbreed-
ing via sibling mating to generate mosaic autosomes that are roughly equally sourced
from the eight inbred founder strains. Haplotypes on representative autosome pairs (col-
ored rectangles) use the standard colors of the eight inbred founder strains of the CC,
and are kept consistent throughout this dissertation. They include the strain abbrevia-
tions A through H, which correspond to the following strains, respectively: A/J (yellow),
C57BL/6J (grey), 129S1/SvImJ (pink), NOD/ShiLtJ (blue), NZO/HlLtJ (light-blue),
CAST/EiJ (green), PWK/PhJ (red), and WSB/EiJ (purple). Colored bars within the
dotted grey box indicate the Y chromosome (left, males only) and mitochondrial genome
(right), which are inherited from the rightmost and leftmost parental srains in level G0,
respectively.
introduce additional recombination sites for fine mapping. AILs have been used to map
resistance to infection in various species, such dengue virus (DENV) resistance in the ar-
boviral vector mosquito, Aedes aegypti (Gomez-Machorro et al. 2004), parasitic resistance
in the mouse (Iraqi et al. 2000; Behnke et al. 2006), and bacterial resistance in chickens
(Hasenstein and Lamont 2007), among others. Thus, they represent a first step toward
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Figure 1.8 Collaborative Cross RIX (intercross) mating. CC-RIX lines are generated by
F1 crossing one CC strain to another.
MPPs for infection studies, but present some modeling challenges due to population struc-
ture, genotyping costs, and other factors (Cheng et al. 2010).
Heterogeneous stock (HS) populations, in the laboratory mouse (Valdar et al. 2006)
(Mus musculus) and laboratory rat (Johannesson et al. 2009) (Rattus norvegicus), are
constructed using pseudorandom breeding of inbred progenitor strains. The diversity
outcross (DO; or diversity outbred), similarly, is an HS constructed using the same eight
inbred founders of the CC, whereby partially inbred CC lines were outcrossed and are
maintained by randomized mating, introducing novel combinations of polymorphisms
and high levels of recombination and heterozygosity (Churchill et al. 2012; Svenson et al.
2012). These populations may suffer from loss or imabalance of founder alleles at certain
loci, and have a lack of replicability of genotypes. Their advantage is that they are a
multiparental resource of genomes with smaller haplotype blocks, useful for fine mapping.
The HS, DO, and related populations can thus serve as a promising, and complementary,
resource for mapping complex traits in infection and immunity in combination with the
CC and CC-RIX.
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1.5 Introduction to Systems Genetics of Infection with the CC
A version of this section was previously published as a chapter in the book Systems Ge-
netics. The text has been modified to fit the context of the dissertation, and new figures
have been added. 1
1.5.1 Introduction
Motivation. In this section, I provide a general protocol, i.e. a set of recommenda-
tions, outlining the design process behind a genetic mapping study using a GRP such as
the Collaborative Cross. The decision to conduct a larger genetic screen, for mapping or
identification of novel disease models, often begins with preliminary data collected using
the founder strains of a given GRP. Decisions about phenotypes and genotypes to use are
guided by successive analysis of experimental outcomes along the way.
It has been recognized that host genetic effects on infection are important in deter-
mining the disease outcomes (Chapman and Hill 2012; Bellamy 2003), motivating the use
of genetically variable experimental model systems to identify causal loci. These systems
allow for the identification, characterization, and mechanistic dissection of genetic vari-
ants that cause differential disease responses. Specifically, the focus of this section is the
application of the Collaborative Cross (CC) panel of recombinant inbred strains, and the
CC-RIX, to study viral pathogenesis, focusing on practical considerations for experimen-
tal design, assessment and analysis of disease responses within the CC and CC-RIX, as
well as listing some of the resources developed for these populations.
Small animal model systems have been and continue to be essential for the assess-
ment of host genes that drive differences in infection susceptibility and outcomes (Sri-
vastava et al. 2009; Boon et al. 2009; Bouvier and Lowen 2010; Boivin et al. 2012; Boon
et al. 2011). Studies in these systems have identified that differential immune regulation
before and after infection is often modulated by complex genetic effects, such as gene-
1Reprinted by permission from Springer Nature: Systems Genetics, “The Collaborative Cross Resource for
Systems Genetics Research of Infectious Diseases” by Paul L. Maurizio, Martin T. Ferris © 2017. Citation:
Maurizio PL & Ferris MT. (2017). The Collaborative Cross resource for systems genetics research of
infectious diseases. Systems Genetics – Methods and Protocols. Methods in Molecular Biology (Clifton,
N.J.), 1488(Chapter 28):579-596. https://doi.org/10.1007/978-1-4939-6427-7_28
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by-gene/gene-by-environment interactions, and allelic variation at individual genes (e.g.
hypomorphs, deletions) (Wei et al. 2014; Lenz et al. 2015; Wang et al. 2015; Shin et al.
2015). Complex effects such as these are best uncovered in the context of genetically di-
verse and multi-allelic systems. Therefore, in order to dissect the role of genetic variation
on host interactions with viruses and other pathogens, it is critical that novel frameworks
are developed for the analysis of these complex traits within these genetically diverse
systems.
Genetic reference populations (GRPs) have long proven to be powerful for studying
complex traits and their underlying causal genetic variants. Many of the classical GRPs
(e.g., the BxH (Turcotte 2004; Marquis et al. 2009; Berghout et al. 2013), A×B (Hassan
et al. 2015) and B×D panels (Nedelko et al. 2012)), as well as classical back- and inter-
crosses, have been critical in identifying polymorphic host genome regions that influence
disease susceptibility and pathology. Building upon the utility of the classical systems,
the CC GRP and the DO heterogeneous stock populations were created. These popu-
lations advanced the progress of complex trait studies in mice, while also modeling the
genetic and allelic complexity present in naturally occurring populations (Churchill et al.
2004, 2012; Svenson et al. 2012). As a result of their breeding designs, both populations
have high levels of genetic diversity (∼ 45 million SNPs, and ∼ 4 million indels) spread
roughly evenly across the genome. Furthermore, in these GRPs, up to eight unique alleles
may exist at any gene/locus, and novel epistatic (gene-by-gene) interactions have been
introduced that are not present in any of the classical inbred laboratory mouse strains.
Concurrently with advances in the development and genetic characterization of GRPs,
a variety of statistical and computational advances have been made. These have improved
our ability to identify and characterize unique genetic variants driving differential traits.
Improved power and precision for detecting QTL and causative underlying haplotypes,
as evinced in (Aylor et al. 2011), have resulted specifically from: our enhanced ability to
identify founder strain haplotypes (Mott et al. 2000); the publication of annotated whole-
genome sequences for the eight founder strains (Keane et al. 2011; Adams et al. 2015);
and the development of powerful software packages for genetic mapping (Arends et al.
2010; Zhang et al. 2014; Gatti et al. 2014). These advances have also enabled the narrow-
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Figure 1.9 Circular breeding design (a.k.a. “Ferris wheel”) for generating recombinant
inbred cross mice for mapping. In this display, arrows indicate the ordering of dam-to-
sire pairings, and each strain (blue node) serves twice as dam (outgoing arrows) and
twice as sire (incoming arrows). For simplicity, and visibility, only eight CC strains are
represented, by the letters a through h, generating a total of 16 CC-RIX lines (each RIX
indicated by an arrow), however many more RIX lines are required for mapping with
any degree of precision. Crossing strains in an ordered fashion is one way to balance
representation of each parental CC within the RIX population, and also balance maternal
vs. paternal contributions of each genome to the RIX population.
ing of QTL regions down directly to candidate causative polymorphisms. Concurrently,
RNA-seq and a variety of computational pipelines (Crowley et al. 2015; Zou et al. 2014;
Munger et al. 2014) allow for precise and accurate quantification of transcripts, allele-
specific expression, and isoform expression within genetically heterogeneous populations.
Together, these methods provide powerful new tools in the systems genetics arsenal.
To understand the contribution of host genetic effects on differential infectious disease
responses, the CC recombinant inbred (CC-RI) lines and a variety of related populations,
including the eight CC founder strains, the partially-inbred incipient CC (pre-CC), the
DO, and CC-F1 (recombinant inbred intercrosses, or CC-RIX), have been used in a num-
ber of recent studies. The circular breeding scheme, for a theoretical sparse diallel cross



























Figure 1.10 A comparison of diallel, targeted F1 reciprocal cross, and recombinant in-
bred cross breeding designs, using the CC founder strains (A through H) [left, middle], or
CC recombinant inbred strains (a through h, with additional CC matings indicated by
the ellipses) [right].
a number of mapping populations for the CC-RIX is shown in Figure 1.9. Each node
(marked with the lower case letters ‘a’ through ‘h’) represents a CC strain genotype, and
each arrow represents a dam×sire combination, with the origin being the dam, and the
destination being the sire. Although the breeding design is circular (double round-robin),
the design can be represented as a matrix, demonstrating its relationship to the diallel
cross (where capital ‘A’ through ‘H’ indicate the eight inbred founders strains of the Col-
laborative Cross), used in Chapter 1, and targeted F1 reciprocal cross studies such as
with C57BL/6J×129S1/SvImJ (Chapter 3), and shown in Figure 1.10.
Resources describing uses of the CC and related populations are available in the book
Schughart and Williams (2017), and are also referenced in the following reviews: Morgan
and Welsh (2015), which covers informatics resources for the Collaborative Cross; Mulli-
gan and Williams (2015) which discusses behavioral studies in complex genetic popula-
tions; Schäfer et al. (2014) which specifically deals with systems genetics of coronaviruses;
and Civelek and Lusis (2014) which reviews systems genetics and the utility of network
modeling for inference. In addition, there have been several studies examining baseline
immune status, autoimmunity, allergy and inflammation in the CC (Kelada et al. 2012,
2014; Phillippi et al. 2014; Rutledge et al. 2014).
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1.5.2 Experimental Designs
Here, I provide some suggestions for experimental design of infectious disease studies
in the CC. A general and useful basic guideline, as adapted from a chapter by (Kirk 2009)
is as follows: (1) formulate statistical and biological hypotheses; (2) determine treatment
variables, phenotypes of interest, and nuissance variables; (3) determine the population,
selecting and/or excluding mouse lines, and simulate and estimate the number of mice
that will be required; (4) decide on a randomization protocol; and (5) decide on tools for
computational and statistical analysis; and we expand on these points below. We note
that there are a large number of different approaches and goals for studying pathogens
within the CC. These include, but are not limited to: identifying novel models of patho-
genesis (Rasmussen et al. 2014); determining the effects, across genetic backgrounds, of
variants at previously characterized genes of major effect (e.g. Mx1 from Ferris et al.
(2013) or Oas1b from Graham et al. (2015)); and mapping genetic variants driving differ-
ential disease responses (Ferris et al. 2013; Gralinski et al. 2015). We focus the method-
ology within in this section as if a researcher were interested in genetic mapping. The
general principles and basic protocol are enumerated below:
1) Determine the range of phenotypes to be collected within the study.
Whereas a number of phenotypes are classically considered to be linked during viral in-
fection in traditional inbred lines, such as weight loss, histopathology and viral titer, it is
likely that: (a) these phenotypes will become unlinked due to segregating variants within
the CC; and (b) phenotypes causing severe pathology may be differentiated from those
simply correlated with disease. Thus, collecting a variety of related phenotypes will allow
for better inferences about the pathways involved in disease pathogenesis. Additionally, in
order to avoid confounding effects, potentially important baseline measures, prior to in-
fection, should be considered and recorded. Genetically diverse mice also have phenotyp-
ically diverse baseline measures, such as body mass, coat color, litter size, susceptibility
to spontaneous disease during aging, etc. Some of these measures may be important for
causal inference of the effect of infection, or for clarifying misallocated sample identities,
when the data is analyzed.
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2) Consider the impact of genes of major effect in order to determine ex-
perimental design and/or select a subset of lines. For many pathogens, host genes
or loci, e.g. MHC (Blackwell et al. 2009; Sellers et al. 2012), that exert major effects
on control of viral disease have already been identified, e.g. Cmv1 for cytomegalovirus,
Oas1b for flaviviruses, Mx1 for influenza, and CCR5 for HIV. Furthermore, for Oas1b
(Graham et al. 2015) and Mx1 (Ferris et al. 2013), there are both functional and non-
functional variants segregating within the CC. Using the genetic sequence information
available for CC-RIs, experimenters may wish to exclude specific lines from their exper-
imental population. For example, a researcher interested in identifying genetic variants
that enhance lung damage during influenza A virus infection might wish to exclude lines
with a functional Mx1 from their study. This topic is covered more in the following re-
search chapter, as we explore the level of resistance in heterozygous Mx1 crosses (i.e.
functional Mx1vs.. null Mx1 ), and consider study designs for CC-RIX mapping based on
our assessment of dominance of specific Mx1 alleles.
An analogous approach deals with those cases where reagents required to properly
assess disease responses are genotype-sensitive or genotype-specific. One example includes
a specific viral peptide or tetramer with a major histocompatibility complex (MHC)
haplotype restriction. In this case, although CC lines with (e.g.) a C57BL/6J MHC
haplotype should generate robust disease response data, CC lines with other founder
haplotypes at the MHC locus might not be compatible with the reagent, and therefore
accurate assessments of the antiviral states of these lines will not be possible. Thus, ex-
clusion of specific lines, stratified analysis of all lines, or alternative experimental de-
signs may be needed to address these issues. Carefully considering founder-strain hap-
lotypes at the genes/loci of interest can aid in the rational design of a mapping popu-
lation that is amenable to specific phenotyping requirements. The CC status website
(http://csbio.unc.edu/CCstatus/index.py) contains a variety of tools, reviewed in
(Morgan and Welsh 2015), with which researchers can identify and visualize the hap-
lotypes present in all available CC lines at given loci, and the Inbred Strain Variant
Database (ISVdb) (Oreper et al. 2017) can be used to obtain probabalistic sequence and
haplotype information for CC, CC-RIX, and CC founders. In this way, specific lines can
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be identified, and subsequently included or excluded, based the desired and required hap-
lotypes. We note that while the DO might provide a greater number of genetically unique
individuals for a study, the outbred nature of the DO and not being able to pre-select ani-
mals with given haplotypes from the DO before purchase might strongly affect the ability
to assess phenotypic variation if these haplotype-specific reagents and/or genes of major
effect are present.
3) Assess a range of phenotypes in a preliminary subset of lines or strains.
Host responses to viral infections can differ in a variety of ways, including disease mag-
nitude, kinetics, duration and infection dose responses. Depending on the question of
interest, any number of study designs may be optimal for analysis. However, in all cases
it is useful to understand the potential range of phenotypic variation being driven by
host genetic variants in the CC. This can be achieved by assessing a preliminary sub-
set of inbred mouse lines. A common and useful approach is to screen the eight founder
strains of the CC and DO, using a standard, well-characterized dose of virus and across
a substantial experimental timecourse. In this way, estimates of the range of variation
in kinetics, magnitude, onset, and duration of disease can be obtained. It is likely, due
to transgressive segregation and allele shuffling, that some CC lines will express more ex-
treme viral resistance or susceptibility phenotypes than the eight founder strains, however
the founders provide a basis for estimating phenotypic diversity in related populations.
Within the eight founder strains, one can collect data on the full range of viral pathogene-
sis phenotypes of interest (e.g. clinical disease, viral replication/dissemination and tissue
damage), following step (1), and determine the phenotypes which vary the most due to
host genetic differences.
In some cases, assessment of the founder strains will be insufficient for estimating
phenotypic ranges within the CC. An initial screen may be performed using a subset of
CC strains rather than, or in addition to, a screen in the eight founder lines.
4) Determine the batching/blocking and covariates to be used in the study.
After an initial screen using the subset of lines in step (3), it will be useful to revisit and
modify, as necessary, the experimental design for the larger CC study, including experi-
mental block designs and specific covariate data collection. In addition, it may be prefer-
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able to consider the the statistical model to be used in the analysis, and conduct a power
calculation or simulation to determine how to allocate resources. A few general guidelines
for deciding on batching/blocking may be helpful.
One type of idealized experimental design might include an assessment of every treat-
ment group, timepoint, and sex across multiple replicate animals in a single infection
batch, with several full batches studied to confirm and generalize these results. However,
we note that even for those examining a single timepoint post-infection, a screen of repli-
cate animals from the entire library of available CC lines might be logistically difficult.
In such cases, some form of well-reasoned batching (or “blocking”) is required to improve
experimental feasibly, while still maintaining an ability to assess statistical significance.
The investigator may also want to ensure that the characteristics of the various blocks are
well-balanced with respect to the sample size and factors of interest.
In order to ensure exchangeability, an attempt should be made to randomize the treat-
ment allocations, where possible, such that if there is a choice to be made, mice of a given
line and sex should be randomly selected from among those available, and balance of co-
variates should be sought between treatment groups. To preserve mapping power, it may
be preferable to assess and perform QTL mapping in a single sex, with follow-up studies
of single lines or timepoints expanded into both sexes to broaden conclusions and to ex-
amine sex-specific differences. The inclusion of specific timepoints or subsets of lines will
likely depend on the resources available and the phenotypes of interest, such as discovery
of new models of previously restricted pathogens, genetic mapping of host variants af-
fecting specific pathologic outcomes, or analysis of differentially expressed transcriptional
pathways.
For example, if genetic mapping at a single specific timepoint is critical, then ensur-
ing that some lines are repeated across multiple batches, and that each batch contains
lines that are repeated in other batches, can be useful for normalizing data across batches.
In contrast, if examining the kinetics of differential transcriptional networks is the goal,
batches should include all animals of each line in the experiment, with a subset of the
total lines to be used. Most importantly, when mock samples are to be paired with sam-
ples from a specific timepoint post-infection (e.g. to study transcriptional differences at
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2 DPI or to contrast immune cell infiltration into specific tissues), the mock animals and
infected animals from each line should be assayed on the same day to explicitly control
for any batch effects. To generalize, for a given contrast or factor of interest (sex, treat-
ment/condition, dose, etc.), including all the levels of interest within each given batch (or
even each cage), is preferable when feasible, so that the effect of confounding variables is
reduced.
5) Collect phenotype data. Once an appropriate experimental blocking is deter-
mined, the study should proceed following the investigator’s appropriate infection pro-
tocols and design. We note that it is critical to carefully observe and record potentially
important, yet previously undescribed disease responses. Such phenotypes might be use-
ful for characterizing novel disease phenotypes in follow-up studies and/or for improving
disease classifications for transcriptional analysis. Be aware of and carefully annotate
aberrant or unexpected phenotypes that might be useful as covariates in further analyses
(e.g. tumors within tissues of importance that could impact immune phenotypes in those
tissues).
6a) Examine the distribution of and correlation between phenotypes. Follow-
ing data collection, quantify and visualize the within-strain means and variances, as well
as the aggregate mean and variance for each phenotype. The use of a Box-Cox transfor-
mation on the raw pathogenesis phenotype data will ensure that the residuals follow a
more normal phenotypic distribution, enabling a more robust array of statistical analy-
ses. Once data are appropriately transformed, one may estimate the genetic contribution
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where σ2P is the total phenotypic variance, σ2G is the total variance attributable to
genetics, and σ2E is the remaining variance, attributable to environment and residual
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ponents. Broad-sense heritability (H2) is calculated as the ratio of the genetic variance
(σ2G), to the total phenotypic variance. Narrow-sense heritability (h
2), which is a subset
of H2, is calculated as the ratio of the additive (σ2G) to the total phenotypic variance.
The “coefficient of genetic determination” (g2), which is used for estimating broad-sense
heritability in inbred lines (Festing 1979; Rutledge et al. 2014), is a function of the num-
ber of animals tested per strain (n), and the between- and within-strain mean-squared
errors (MSB, MSW ).
Furthermore, a reexamination of the correlation structure of the disease phenotypes
(both stratified by strain, and in aggregate) can help to clarify relationships between
different aspects of viral pathogenesis, and can strengthen decision making regarding
the phenotypes to be used for mapping causal loci. Simple packages such as corrplot
(https://cran.r-project.org/web/packages/corrplot/index.html) and corrgram
(https://cran.r-project.org/web/packages/corrgram/index.html) in R can be used
to visualize the correlation and covariance structure of a phenotype matrix.
6b) Identify/select samples for transcriptional analysis. In some cases, re-
searchers may wish to add comprehensive transcriptional analysis to further clarify the
genes and pathways that are differentially expressed in concordance with specific phe-
notypes (see methods and rationale for transcriptomic analysis in Chapter 3). In many
cases, it will be cost-prohibitive to run transcriptional analyses on all samples, however
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RNA expression can be used for expression QTL (eQTL) analysis, or response eQTL
(reQTL) analysis, where the treatment response on gene expression between mock and
infected samples is measured and mapped for each transcript. Transcriptional analyses
that are focused on extreme phenotypic outcomes (e.g. contrast individuals with high
vs. undetectable titers), such as is used in bulk segregant analysis, may provide increased
power to identify transcripts associated with differential disease. This approach has been
illustrated in (Bottomly et al. 2012), where a combination of titer and weight loss ex-
tremes were used to identify reactive transcriptional networks differentiating the extreme
phenotypic groups. Archiving specific immune-related tissues (bone marrow, lymph nodes,
CNS, spleen), as well as “unrelated” control tissues may be helpful in follow-up studies,
following transcriptional analysis or mapping. CC-related in vitro resources (cell-culture,
such as mouse embryonic fibroblasts from CC-related mice) are being developed that may
be useful for validation and in-depth follow-up.
7) Conduct genetic mapping. Once phenotypes with high heritability and suffi-
ciently large variation have been identified (see phenotypic distributions of histology in
Chapter 4), genetic mapping can be carried out. A number of software packages exist for
multiparent mapping, including Bagpipe (http://valdarlab.unc.edu/software.html),
HAPPY (http://www.well.ox.ac.uk/happy/) (Mott et al. 2000), and DOQTL, a pack-
age for the R statistical computing environment (Gatti et al. 2014), which also works for
mapping in the CC. The DOQTL package is stably supported on Bioconductor (https:
//www.bioconductor.org/packages/release/bioc/html/DOQTL.html), and also has
features to integrate SNP and gene variant features based on the Sanger Institute’s rese-
quencing of the eight founder strains of the CC, as described in (Svenson et al. 2012) and
(Gatti et al. 2014).
More recently, a multiple-imputation approach implemented in the R package miQTL,
based on the interval mapping of HAPPY, has been developed and is being used for QTL
mapping studies in CC, heterogenous stock (HS) (Valdar et al. 2006; Keele et al. 2017;
Woods and Mott 2017), and CC-RIX (see Chapter 4). For mapping in the CC or the DO,
one uses a file(s) to describe the founder haplotype probabilities in the mapping popula-
tion. This is used both for fully inbred lines, where probabilities should be 1.0 or 0.0 for
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any given founder haplotype at each locus, as well as for heterozygous populations, with
fractional probabilities and haplotype uncertainties due to recombination and genotyp-
ing/HMM uncertainty. A separate file is used, containing the (transformed) phenotypes
and important covariates (e.g. batch, sex, starting weight). The software uses a linear
regression approach, asking whether there is a significant association between pheno-
types and haplotype probabilities at each haplotype block along the genome. Significance
thresholds are determined using permutation or false discovery rate approaches, both
of which take into account the distribution of genotypes and phenotypes within the test
population.
8) Identify causative polymorphisms. Once QTL are identified, a number of ap-
proaches may be utilized to determine specific causative genetic variants. Toward this
end, most multiparent mapping tools will generate allele effect plots. These plots display
the estimated scaled effects of each founder allele on a trait of interest within a given ge-
nomic locus. In this way, one can distinguish groups of haplotypes that enhance, suppress,
or have no effect on disease. By identifying SNPs and other genetic variants within the
QTL that follow the allele effects patterns, one can narrowly focus on subsets of candi-
date genes or features that are likely to be causative for the phenotype of interest. For ex-
ample, at a given SNP, if both “high” and “low” phenotype groups share a founder allele,
it is unlikely to be causative, whereas SNPs that contain alleles that segregate between
the high- and low-responder strains are much more likely to be causative. Further inte-
gration of already available whole-genome expression data, or post-hoc gene expression
analysis (e.g. qPCR) can help to narrow and refine candidates. For example, genes un-
derneath a QTL locus which are differentially expressed between high and low groups, in
a relevant tissue or compartment and at a relevant timepoint, will help lead to potential
candidate genes and/or pathways impacting disease outcomes. Fine mapping approaches
in separate populations, and association-based methods (see Yalcin et al. (2005)) can
be used to identify quantitative trait nucleotides (QTNs) under significant loci, that are
causative for the trait under analysis.
9) Consider alternative studies and experimental approaches. In the preced-
ing text, we highlighted a case where follow-up studies might be useful in identifying
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genetic variants, i.e., where initial QTL scans suggested a locus, but the effect of that lo-
cus was confounded by a covariate such as experimental batch. Following the collection of
initial data, there are a variety of other experiments which can help clarify and enhance
the initial studies. One possibility is that only one or two CC lines show a desired or ex-
treme disease response (Rogala et al. 2014; Rasmussen et al. 2014). Such outcomes may
indicate either complex gene-gene interactions (epistasis) or de novo mutations arising
in lines. In both cases, one should consider either a tailored follow-up genetic cross, such
as an F2, as in Rogala et al. (2014), or follow-up intensive expression analysis, as in Ras-
mussen et al. (2014), to focus on likely causative loci or networks driving these unique
disease responses. Another possible outcome is that a gene of major effect has been dis-
covered. This would be a case where a QTL explains a large fraction (e.g. 50 percent) of
trait variation for one or more of the pathology traits of interest. In these cases, it may
be useful to either (as recommended above) re-do analysis with the QTL of major effect
as a covariate in the main QTL scans OR to subset your set of lines into those with the
high versus low haplotypes at the QTL. These sub-population style analyses can help
in identifying further genetic variants that affect disease only in the context of a gene of
major effect. For example, if a variant impacts viral dissemination from a primary tissue,
its’ effect can be masked if there is an additional polymorphism that abrogates the viral
receptor within the CC. Only by mapping with the receptor positive population will it be
possible to identify the dissemination variant.
1.5.3 Expected Outcomes
Given that there are a variety of possible genetic architectures underlying host re-
sponses to multiple aspects of viral infection, it is difficult to precisely predict outcomes
for any given study type. However, based on the breadth of work conducted so far within
the CC, the DO, and related populations, one can expect that there are genetic variants
segregating within the CC system that will have impact on pathogenesis for any given
virus. Indeed, for at least four viral pathogens, as well as for a variety of other bacterial
and fungal pathogens, QTL have been identified that contribute to differential disease
responses and pathogenesis. Taken as a whole, these QTL typically have shown mod-
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est effects on pathogenic traits (e.g. a summary of the results of Ferris et al. (2013) and
Gralinski et al. (2015) show most QTL explaining 25% of phenotypic variance for each
trait). Furthermore, it is likely that transgressive segregation operates within the recom-
bined genomes of the CC. That is, alleles driving extreme responses may come from a
founder strain(s) that exhibits a mild or suppressed phenotype. Thus, only when the ge-
netic structure of the founder strains has been rearranged will the true effects of alleles
be identifiable. Lastly, it is likely that once QTL are identified, it will be possible to iden-
tify a set of high priority SNPs, based on the founder strain sequences, which act as the
causative variants. Additional pathological and molecular phenotyping will be required
for validation, but the integration of multiple allele effects, as well as sequence data, is a
substantial improvement over classical positional cloning for identifying causal variants.
1.5.4 Lessons Learned
There are several important considerations, gleaned from the studies to date, that can
specifically inform future studies and analysis of determinants of infectious disease suscep-
tibility. One clear lesson learned from virus infection studies in the CC and pre-CC so far
is that phenotypic correlations present within any any set of characterized founder strains
or knockouts are likely to be broken apart within the CC, unless there are strong causal
relationships between the correlated phenotypes. For example, a complete disassociation
was seen between different aspects of SARS-coronavirus (SARS-CoV) induced pathol-
ogy and disease within the pre-CC population (Gralinski et al. 2015). Furthermore, QTL
mapping will often show that distinct loci affect individual, distinct pathologic traits,
as seen in both the influenza pre-CC and SARS-CoV pre-CC studies (Ferris et al. 2013;
Gralinski et al. 2015). These results highlight one main impetus for utilizing GRPs such
as the CC (i.e. the discovery of novel phenotypic relationships and distinct genetic mark-
ers), but they also point to a critical consideration in the design and analysis of studies in
these systems. Namely, the assessment of a wide variety of phenotypes, even those classi-
cally thought to be redundant, will be highly useful and enable a better understanding of
disease pathogenesis.
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It is well known that susceptibility and resistance genes of major effect are predom-
inant within host-pathogen systems. These genes of major effect include, for example:
Cmv1 for murine cytomegalovirus (Scalzo et al. 1990; Scalzo and Yokoyama 2008); Oas1b
for flaviviruses (Scherbik et al. 2007); and Mx1 for influenza (Arnheiter et al. 1990; Stae-
heli et al. 1988). Indeed, both functional and defective Oas1b and Mx1 alleles circulate
within the CC/DO (Ferris et al. 2013; Graham et al. 2015). Given the genetic diversity
present within the CC and DO, it is likely that other genes of major effect for specific
pathogens will be found segregating within these populations. Although the presence of
genes and alleles of major effect may appear to be an obstacle for discovery of novel reg-
ulators of disease, obscuring the contribution of genes or alleles of lesser effect size, new
biological insight can still be obtained in the presence of these large effect alleles. For ex-
ample, given the potential for up to eight alleles segregating within the CC at any locus,
there may be several alleles, isoforms and/or transcriptional variants at a given causal
locus. This was observed clearly in the influenza challenge of the pre-CC, where the anti-
viral and clinically protective effects of Mx1 were disassociated via the presence of three
unique alleles at the Mx1 locus (Ferris et al. 2013).
Furthermore, epistasis and transgressive segregation are at work within the CC popu-
lation. Such segregation can most commonly reveal previously ‘hidden’ genetic variation.
For example, in the pre-CC study of SARS, the wild-derived founder strains (CAST,
PWK, and WSB) all die of SARS-CoV infection at low doses (Gralinski et al. 2015). In
contrast, for the pre-CC lines that survived SARS-CoV infection, causative alleles at a
variety of QTL are driven by wild derived parental alleles, and were therefore hidden in
the context of super-susceptible parent founders. Thus, the allelic variants that affect
immunopathology, viral replication and immune infiltration were identified only in the
context of disruption of founder haplotypes through recombination. Alternately, recom-
bination driving reassortment of alleles may cause emergent phenotypes by introducing
evolutionarily distinct allelic combinations. For example, it is only via this genetic reas-
sortment across the CC that a severe Ebola virus (EBOV)-induced hemorrhagic fever was
identified in mice, as this phenotype was not present in any of the CC founder strains
(Rasmussen et al. 2014).
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There are several reasons for emphasizing the thoughtful use of mock controls in in-
fectious disease studies in the CC. Firstly, given the novelty of the genetic backgrounds
generated in the CC, the response to mock treatment in some lines may differ substan-
tially from that of common inbred lines. Additionally, genetic loci that regulate baseline
immune phenotypes may be quite distinct from those that regulate immune phenotypes
after infection-induced pathways are up- or downregulated, hence QTL may be mapped
for untreated or mock-treated animals as a complement to QTL mapped for infection
response.
Finally, it should be noted that characterizing the variability or variance in a disease
phenotype, both within-strain and between-strain, is worthwhile and may be critical for
identifying genetic causes of differential disease. Identifying a strain or set of strains with
increased variance may lead you to identifying a novel genetic factor or latent environ-
mental variable that causes a substantial change in the phenotype of interest (Rönnegård
and Valdar 2011). During the characterization of within-strain variation, you may be able
to identify experimental issues that ought to be modeled or corrected (e.g. batch effects),
or rare de novo genetic variants that substantially modulate your phenotype, which can
be identified with additional genotyping or sequencing. In one recent study, using a dial-
lel of the wild-derived CC founder mice and their F1 reciprocal crosses, gene expression
was substantially altered in two mice, including one which was found to have a de novo
duplication (Crowley et al. 2015). Thus, having well-characterized within- and between-
strain variance estimates are critical for identifying novel genetic variants, for estimating
statistical power, and for successful experimental design and analysis in the CC.
1.5.5 Further Considerations and Limitations
Although systems genetics approaches and genetically diverse study populations pro-
vide a powerful combination of tools to identify host genetic variants driving infectious
disease, there are several caveats that ought to be considered in optimizing study design
and analysis approaches. Namely: appropriate molecular phenotyping, disentangling com-
plex phenotypic networks, and mechanistic insight into variant loci.
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Omics analysis (transcriptomics, proteomics, metabolomics, etc.) is a cornerstone of
the systems biology approach to research. One strong caveat for omics analysis is the
dependence of these approaches on accurate assessment of genome sequences for utilized
strains. The C57BL/6J genome has formed the backbone of mouse sequence analysis
and annotation, however we know that the other CC founder strains, and therefore the
CC themselves contain large numbers of polymorphisms, and more importantly struc-
tural variants and large insertion/deletions (Yalcin et al. 2011) (http://www.sanger.ac.
uk/science/data/mouse-genomes-project). Integration of imputed genome sequences
(pseudogenomes) for CC lines or DO animals (Munger et al. 2014) will substantially im-
prove integration of these omics data within these GRPs.
A variety of factors, such as prior immune history, opportunistic co-infection, and mi-
crobiome influences on the immune system (Ichinohe et al. 2011; Zhang et al. 2015) can
influence host responses to viral infections. Furthermore, there is evidence for genetic vari-
ants within the CC affecting basal variation in immune populations (Phillippi et al. 2014).
Given the potential for host genetic variation to impact a variety of immune phenotype
and the microbiome, it is likely that there will be complex causal networks underlying
variation in the direct viral pathogen traits of interest of a researcher. While dissection
of these networks may provide many years of fruitful study, they may present daunting
obstacles to study within the CC. Careful design of experiments (e.g. cohousing animals
from different CC lines; antibiotic pre-treatment to limit bacterial coinfection) can help
to ameliorate and control some of these effects and improve the ability to identify genetic
variants directly affecting host responses to viral pathogens of interest.
Finally, we note that identification of genetic variants with a GRP affecting host
responses to viral infection do little to identify the mechanisms and processes through
which these variants act. While integration of a variety of phenotypes (e.g. pathological,
immunological and molecular responses) can help to highlight mechanisms and path-
ways of activity, it is only through classical (and phenotype-specific) manipulation and
experimentation that a true understanding of these variants can be elucidated. Such ap-
proaches, often deemed ‘reductionist’, are critically useful in transitioning broad systems-
based responses with clear and actionable mechanistic processes.
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1.5.6 Outlook
Small animal models for the host response to infectious disease pathogens are critical
tools for the study of human susceptibility to disease, as well as for the development of
novel prophylactics and therapeutics. Indeed, the utility of these systems for studying
host-pathogen interactions appears to be persistent and critical. Notably, by varying the
host genetic background in the study of infectious disease, we enable the detection of ge-
netic variants that are important for disease across a population of genetically diverse
individuals, improving our chances that variants are reproducible across experiments and,
it is hoped, across species. Importantly, not only can these systems be used for identify-
ing genetic susceptibility loci, but they can also be used to identify and develop of novel
infectious disease models, using specific strains of CC mice as new resources for under-
standing severe disease, such as has been done in the recent development of CC mouse
models of Ebola virus pathogenesis (Rasmussen et al. 2014).
The CC is also useful for better understanding the genetic architecture of the host
response to infection. It has been recognized that non-additive genetic effects, such as
dominance, epistasis, and parent-of-origin effects, may contribute substantially to quan-
titative traits, including the host immune system and infectious disease responses. In
order to estimate, quantify and explore such complex genetic interactions, and to quan-
tify broad and narrow-sense heritability, future directions include characterizing infection
phenotypes in F1 reciprocal crosses of the eight founder lines and of the CC lines (using
CC-F1’s). Such experiments will add to our knowledge about how disease susceptibility
and resistance may be expressed and transmitted from parents to offspring, and this work
may reveal important genetic complexities, hard to uncover in human studies. These com-
plex genetic effects may be responsible for inhibiting our ability, at present, to identify
candidate genes through GWAS and linkage mapping studies, which less often include
rigorous screens for non-additive effects. Finally, the experimental designs and phenotypic
data sets that are being generated for systems genetics in the Collaborative Cross lend
themselves to innovative statistical and quantitative genetics models. These new models
and quantitative tools advance our understanding of human disease, and complement
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the variety of experimental tools being developed for the CC. Thus, infectious disease
research in CC promises to advance our knowledge about complex host-pathogen interac-
tions, and to enhance our ability to unravel and interpret increasingly complex biological
networks in order to improve human health.
1.6 Dissertation Objectives
The main objective guiding this dissertation work is to better understand the host
genetic determinants of influenza virus disease, using systematic and carefully designed in-
terbred mouse populations, along with richly-parameterized and rigorous statistical mod-
eling. In summary, in this work, I hope to demonstrate: (1) the utility of experimental
approaches that employ populations of multiple inbred parental lines of mice and simple
or advanced crosses between inbreds in order to generate heterozygous populations for
viral pathogenesis; (2) the thoughtful use of linear mixed models to model phenotypic and
genotypic variation in the context of infection response phenotypes; and (3) the combined
power of these approaches to characterize heritability, understand genetic architecture,
and identify novel genome regions, genes, and pathways responsible for host susceptibility
to severe disease.
Although a number of genetic determinants contributing to severe influenza A virus
infection have been identified, in particular in murine and human studies, the overall
genetic architecture of the host response to virus infection has been notably difficult to
characterize in human clinical and epidemiological studies due to difficulty obtaining
biopsies, genotypes, infection and vaccination histories, among many other covariates.
Therefore, precision estimates of quantitative genetic measures, such as the degree of
dominance of resistance genes, or the influence of parentally-dependent genetic imprinting,
are not easy to estimate, and many of these higher-order genetic effects may contribute
to the phenomenon of missing heritability (Manolio et al. 2009). These genetic effects,
may contribute as little as a few percent to over 40% of phenotypic variation in virus-
induced disease, yet even if the percent variation explained is small for any particular
type of effect (or single significant locus), in aggregate, these factors are nevertheless
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important to understand if we are to have a complete picture of the host factors that lead
to enhanced disease following exposure to an emerging contagion, and better prepare us
for targeted interventions based on host genetics.
Finally, the work described in these chapters presents: (1) the extent of Mx1 -independent
contributions to variation in influenza-induced pathogenesis, comprising over half of the
variation explained (34% Mx1 -independent, of 57% explained overall) in the diallel study
through day 4 post-infection; (2) quantitative estimates of the difference in genetic domi-
nance of Mx1 functional alleles when combined with Mx1 null alleles, depending on Mx1
subspecies origin; (3) a number of new candidate genes influencing viral pathogenesis on
day 4 post-infection that were possibly undetected in prior studies due to mode of inher-
itance (imprinted expression, dependent on parent-of-origin of alleles); and (4) a novel
signficiant QTL on chromosome 2 which explains over 14% of phenotypic variation in
lung histopathology at D10 post-infection. Through this work, we have used quantita-
tive genetic models and multiparental populations to add to the field’s understanding
of effects on the host response to influenza arising from a well-characterized host deter-
minant, Mx1 , as well as uncovering novel genes and loci that contribute significantly to
influenza-induced disease. In the Chapter 5 of this dissertation, I briefly summarize and
discuss results from Chapters 2, 3, and 4, and outline future directions. Appendices A, B,
C, and D contain, respectively, supplemental materials from the influenza diallel publica-
tion, extensions of the diallel model for other applications (exploring dominance in carrot
breeding from Turner et al. (2017); and binomial- and Poisson-distributed data in mouse
litter size), links to software/data resources, and a list of publications.
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CHAPTER 2
Diallel Analysis of Influenza Virus Pathogenesis 1
2.1 Introduction
Pathogenic response to viral infection varies dramatically between individuals in-
fected with the same viral strain and dose, and much of this variation is heritable. The
impact of host genetics is evident both on the primary exposure to a virus during early
life (Strunk et al. 2013) and upon infection with newly emerging viral strains — the lat-
ter, where prior immune exposure to a variant viral strain is not cross-protective, being
especially common for quickly evolving RNA viruses such as influenza A (IAV) (Morens
et al. 2010). Pathogenesis induced by IAV, whether contracted during early childhood or
later in life, is thus likely to have a significant heritable component. A greater understand-
ing of this heritability should improve our ability not only to identify populations at risk
of enhanced morbidity and mortality during an emerging pandemic but also to identify
successful options for treatment.
The past several years have seen significant progress identifying and characterizing
host genes that modulate susceptibility to IAV infection, via knockout mouse studies,
in vitro screens, and studies of primary immunodeficiencies and allelic variants in hu-
mans (To et al. 2015). In humans, screening for inborn errors identified a major role for
interferon regulatory factor 7 (Irf7 ) in modulating the the severity of primary IAV in-
fection (Ciancanelli et al. 2015), and allelic variation in Ifitm3, which was identified in a
high-throughput siRNA screen, was associated with differential severity of IAV infection
outcomes during the 2009 H1N1 pandemic (Everitt et al. 2012).
1A version of this chapter has been previously published. The original citation is as follows: Maurizio
PL, Ferris MT, Keele GR, Miller DR, Shaw GD, Whitmore AC, West A, Morrison CR, Noll KE, Plante
KS, Cockrell AS, Threadgill DW, Pardo-Manuel de Villena F, Baric RS, Heise MT & Valdar W. (2018).
Bayesian diallel analysis reveals Mx1 -dependent and Mx1 -independent effects on response to influenza
A virus in mice. G3: Genes, Genomes, Genetics, 8(2): 427-445. https://dx.doi.org/10.1534/g3.117.
300438. PMID:29187420.
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Most of our insights into genes modulating host IAV resistance, however, have come
from studies on mice. These include studies using knockout mice, which have identified
host genetic factors critical to antiviral responses, including Tlr3 (Hidaka et al. 2006) and
Isg15 (Lenschow et al. 2007), and studies that examine differences between laboratory
inbred strains. Inbred strain studies were the first to identify the Myxovirus resistance
(Mx) family of proteins as important for host antiviral response (Staeheli et al. 1988),
and inbred studies have continued to demonstrate the relevance of genetic background
to multiple aspects of IAV pathogenesis (Srivastava et al. 2009; Alberts et al. 2010; Leist
et al. 2016; Samet and Tompkins 2017).
Yet despite the identification of clear phenotypic differences between inbred strains,
there have been relatively few attempts to dissect the genetic basis of those differences
using traditional quantitative trait locus (QTL) mapping approaches such as the use of
F2s or backcrosses (although see Boivin et al. 2012). This may be in part because tradi-
tional QTL mapping approaches tend to rely on outbred animals — and when it comes to
studying viral pathogenesis, outbreds are in many respects problematic. One important
limitation is phenotyping. Studying the response to an infection is equivalent to study-
ing the causal effect of an applied treatment: its strict definition relies on a comparison
between otherwise identical individuals subject to infection vs. control. But such like-
for-like comparisons are biologically and technically challenging to make in an outbred
population, where every individual is genetically distinct, and this has undesirable conse-
quences for downstream interpretation: namely, that when genetic determinants of severe
IAV pathogenesis are confounded with those influencing baseline phenotypes, the roles of
any detected QTL are ambiguous. A related disadvantage of outbreds from the perspec-
tive of genetics is the inability to obtain biological replicates, which makes it harder to
distinguish which aspects of pathology are stable consequences of genetics versus prod-
ucts of stochastic variability. This is particularly important, since it also makes it almost
impossible to follow-up on genuinely extreme responders for additional mechanistic and
genetic analysis. Translating strain differences in IAV pathogenesis to meaningful QTL
studies ideally requires an experimental paradigm that combines population-level genetic
diversity with individual-level replicability.
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An exciting opportunity is therefore presented by replicable genetic reference popu-
lations, in particular, those based on panels of recombinant inbred (RI) strains. Across
a panel of RIs, genetic background varies, providing a basis for QTL mapping; within a
RI strain, individuals are genetically identical, providing a basis for replication. The com-
bination allows infection response to be rigorously defined and genomic regions affecting
that response to be mapped. It also permits the creation of sophisticated experiments
that target a wider range of heritable mechanisms: crossing RIs with each other to form
RI intercrosses (RIXs), or crossing them with outside strains, produces replicable systems
capable of distinguishing, for example additive, dominance, and parent-of-origin effects,
among others (e.g., Xiao et al. 1995; Hua et al. 2002; Kollipara et al. 2002; Threadgill
et al. 2002; Hua et al. 2003; Mei et al. 2005; Gonzalo et al. 2007; Swanson-Wagner et al.
2009; Shang et al. 2016; Liu et al. 2012; Zhou et al. 2012; Hallin et al. 2016; Williams and
Williams 2017).
Recombinant inbred (RI) genetic reference panels range from inbred lines derived from
crosses between two mouse strains to more complex multi-parental crosses. The BxD RI
panel, derived from two founder strains, has been used to study the impact of genetic
variation on susceptibility to IAV infection and map QTL associated with these effects.
Boon et al. (2009) studied H5N1 infection in females from 66 BXD strains, and Nedelko
et al. (2012) studied H1N1 infection in 53 BXD strains, with both studies identifying
QTL associated with susceptibility to infection. The Collaborative Cross (CC) RI panel is
a multiparental population (MPP) descended from eight inbred founder strains (Thread-
gill et al. 2002; Churchill et al. 2004), with these founders including representatives from
the three major domesticated house mouse subspecies (Yang et al. 2011). As such, the
CC captures considerably more genetic diversity, and thanks to its breeding structure
this diversity is also more uniformly distributed across the genome, with as many as eight
distinct haplotypes segregating at any given locus within the population (Collaborative
Cross Consortium 2012; Srivastava et al. 2017). The eight CC founder strains have dis-
tinct pathogenesis profiles in response to influenza virus (Leist et al. 2016), suggesting
that the CC RI panel is capable of a broader phenotypic range than would be observed
in less complex populations. Indeed, studies using an incompletely inbred, ancestor pop-
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ulation of the CC (the pre-CC), demonstrated high levels of phenotypic variation across
the population and successfully mapped several QTL associated with variation in sus-
ceptibility to IAV infection (Ferris et al. 2013; Bottomly et al. 2012). The CC therefore
represents a promising resource for studying how genetically diverse populations respond
to IAV infection.
Determining an optimal strategy for how the CC should be used to study the genetic
architecture of IAV pathogenesis is nonetheless complicated because (1) the space of
possible experimental designs is vast, and (2) information about what types of heritable
effects are likely to be present is extremely limited. Regarding (1), with more than 70 CC
strains currently available, including all reciprocal F1 hybrids (so called CC-RIXs), there
are more than 4900 potential replicable configurations; since only a subset of these config-
urations can be explored within any realistic experiment, any chosen experimental design
necessarily targets some types of heritable effects to the exclusion of others. Regarding
(2), to date, most in vivo studies of IAV pathogenesis have been confined to candidate
genes or additive interactions at single loci; studies investigating the broader question of
what types of heritability are at play during IAV infection are largely absent.
In order to rationally design studies of heritable effects in complex populations such
as the CC it is therefore helpful to have advance knowledge of which types of heritable
effects might be present. One source of such information is phenotype data collected
on the multiparental founders and their F1 hybrid offspring, a combination that can be
more formally described as an (inbred) diallel. Diallels have long history in quantitative
genetics, having been used originally in plant breeding studies to judge the relative merits
of different strain combinations and subsequently for gaining insight into the heritable
architecture of a broad range of phenotypes (e.g., refs in Christie and Shattuck 1992;
Lenarcic et al. 2012; Okoro and Mbajiorgu 2017), including host-pathogen interactions in,
e.g., crickets (Rantala and Roff 2006), flies (Wayne et al. 2011), and insects (Pereira et al.
2015) (see Methods and Discussion for connections to other diallel literature).
Here we use a diallel of the CC founders and their reciprocal F1 hybrids (hereafter,
a CC founder diallel) to give an overall predictive picture of the range and relative in-
fluence of different types heritable effects on IAV pathogenesis likely to be present in
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CC founder-derived MPPs, a group that includes not only replicable MPPs such as the
CC and the CC-RIX but also irreplicable ones such as the Diversity Outbred population
(Churchill et al. 2012). We take advantage of the diallel design’s replicability to mea-
sure IAV-induced pathogenesis in a precise way, as the response to an applied treatment
defined in terms of post-infection weight-loss differences (deltas) between matched sets
of mock and infected individuals. Adapting a recently developed statistical framework
for analyzing treatment-response diallels (Crowley et al. 2014), we use those deltas to
model how pathogenic response to IAV is modulated by parentage, sex and their inter-
action, framed in terms of additive genetics, dominance, epistasis, parent-of-origin, and
sex-specific versions thereof.
After observing that, following IAV infection, diallel individuals show a broad, contin-
uous distribution of day 4 post-infection weight loss, we find, through statistical model-
ing, that the IAV-induced weight loss includes substantial contributions of host additive,
epistatic, and sex-specific effects, with much of the heritable variation closely tracking the
genotype state implied by the three distinct functional alleles of the previously identified
resistance locus Mx1. Confirming previous findings, the functional CAST/EiJ Mx1 allele,
in contrast with functional NZO/HlLtJ and PWK/PhJ Mx1 alleles, provides interme-
diate levels of protection against H1N1 influenza strains. Unexpectedly, and confirmed
through additional modeling, we found that different classes of functional Mx1 alleles
exhibit distinct functional patterns, additive or dominant, when combined with null Mx1
alleles. Further, illustrating our general rationale, we show that the major strain-specific
Mx1 effect patterns are consistent across two CC founder-derived MPPs: the pre-CC, as
determined from reanalysis of a previously published dataset (Ferris et al. 2013), and a
previously unpublished 117-line CC-RIX, in which we conduct a limited analysis focused
on the Mx1 locus.
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D0 Population D1 D2 D3 D4
weight all mock pct pct pct pct
flu pct pct pct pct
matched
quartets delta delta delta delta
Diallel	- Analysis	Classes
Figure 2.1 Phenotype and treatment response classes for analysis of influenza A virus
infection in the diallel. Each filled square represents a weight or weight change phenotype
that is modeled independently. The gray square represents the starting body weight in all
animals, prior to treatment, at day 0 (D0) (analyzed with Model 1 in Table 2.2). Light
blue squares represent animals that were mock-treated and red squares represent animals
infected with IAV, with daily weights for each taken from D1 through D4 post-infection
(and these analyzed with Model 2 in Table 2.2). Purple squares represent infection re-
sponse, the primary quantity of interest, estimated using match quartets of 1 mock to 3
infected mice (analyzed with Models 3 and 4 in Table 2.2). Labels within each square
indicate phenotypes analyzed, where weight = pre-infection body weight, pct = post-
infection percent change in starting D0 weight (post), and delta = infection response,
as described in the Statistical Methods section. The coloring increases in saturation
from D1 through D4 for the influenza and matched quartet groups to indicate an overall
increasing amount of post-infection weight loss over time.
2.2 Experimental Materials and Methods
2.2.1 CC founder diallel mice
The inbred and F1 mice used within this study were bred in-house at the University
of North Carolina at Chapel Hill (UNC-CH). This colony was directly descended from
the subset of animals used to generate the initial CC funnels (Collaborative Cross Con-
sortium 2012), and included mice from the following eight strains at the Jackson Labora-
tory: A/J (“AJ”, #000646); C57BL/6J (“B6”, #000664); 129S1/SvImJ (“129”, #002448)
NOD/ShiLtJ (“NOD”, #001976); NZO/HlLtJ (“NZO”, #002105); CAST/EiJ (“CAST”,
#000928); PWK/PhJ (“PWK”, #003715); and WSB/EiJ (“WSB”, #001145). Mice from
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the UNC-CH colony were then used to generate all 62 possible inbred and (reciprocal) F1
combinations between these 8 strains, excluding NZO×CAST and NZO×PWK matings
which are non-productive (Chesler et al. 2008) (Figure 2.3A). This yielded a total of 124
distinct combinations of sex and parentage (hereafter, described as “diallel categories”).
Lung tissues were collected from a subset of each of the founder inbred strains in this
study, at D2 and D4 post-infection, and were used for a separate comparative RNA-seq
analysis by Xiong et al. (2014).
2.2.2 Mouse infections in the diallel
Mice were weaned at approximately 21 days old and housed 4 per cage, within each
diallel category, under standard conditions (12 h light/dark; food and water ad libitum.
Of the 4 mice in a cage, 1 was randomly assigned to mock and 3 to influenza infection, as
there is no evidence that mice can transmit influenza virus. Each cage was then assigned
to a harvest timepoint – Day 2 post-infection (D2 p.i., n = 533 mice), or D4 p.i. (n = 510
mice).
At 8-12 weeks of age, based on their assignments, mice were anesthetized with isoflu-
rane and inoculated intranasally with 500 plaque-forming units (PFU) of mouse-adapted
influenza A virus (H1N1 A/Puerto Rico/8/1934; short name PR8) or with the diluent,
phosphobuffered saline (PBS) alone as a mock control (Figure 2.2).
I. Modelling Heritability & Dominance Heritable factors
Influenza infections in the diallel
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Figure 2.2 Diallel experimental infection protocol. The yellow-orange arrow indicates
mock treatment with PBS or with 500 PFU of IAV PR8. Mice were weighed on days 0
through day 4 p.i.
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For each inbred line and F1 cross, about 6 mice (range: 5-9) of each sex were infected
with IAV PR8, and about two mice (range: 2-3) of each sex were mock-infected. This
gave a total of 1,043 mice across 54 experimental batches. Treatment assignment was
random: same-sex siblings from the same cage (and therefore batch) were randomly as-
signed at weaning to mock or infected groups prior to being moved to new cages. The
1,043 mice were housed in approximately 260 cages (about 4 mice per cage), with 775
infected mice and 268 mock-infected mice. Body mass was recorded daily. All animal
experiments were carried out in compliance with the Guide for the Care and Use of Lab-
oratory Animals (Institute of Laboratory Animal Resources, National Research Council,
1996, https://www.ncbi.nlm.nih.gov/books/NBK232589/). Animal protocols were ap-


















































































































































































































































Figure 2.3 Diagram of breeding strategy for diallel, pre-CC, and CC-RIX. (A) The di-
allel cross produces inbred (n = 8) and F1 (n = 54 lines) genotypes from an 8×8 cross of
inbred strains. (B) The pre-CC is comprised of incompletely inbred (n = 155 lines) geno-
types from 155 inbreeding funnels. (C) The CC-RIX produces F1 hybrid lines (n = 105
lines) from a sparse, round robin-like cross of 65 inbred CC strains.
2.2.3 Mouse infections in the pre-CC and CC-RIX
In order to verify strain-specific haplotype effects measured in the diallel for host
resistance locus, Mx1, we sought out CC-related IAV infection data sets for which we
could isolate Mx1 locus-specific effects.
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Existing data from pre-CC study
In the QTL mapping study of host response to IAV infection of Ferris et al. (2013),
155 female pre-CC mice from as many pre-CC lines were infected with IAV (PR8) at 8-12
weeks of age and assayed for post-infection weight loss via daily weights, with phenotypes
collected including starting weight (D0) and weight at D4 p.i. (Figure 2.3B). This study
did not include mock-infected mice.
CC-RIX study
In total 1,402 female mice were bred from 105 F1 crosses of CC strains (i.e., 105 CC-
RIX lines) as described in Supplemental Material (Figure 2.3C, Figure A2), as part
of an ongoing QTL mapping study. These mice were infected at 8-12 weeks of age with
5,000 PFU IAV (A/California/04/2009; short name CA04), a human 2009 pandemic
H1N1 isolate (Itoh et al. 2009), and phenotypes were collected, including starting weight
(D0) and weight at D7 p.i. CC-RIX were bred under similar conditions to diallel mice.
This experiment, whose broader analysis is still ongoing, included both flu-infected and
mock-treated mice. However, since the design did not match these to the same exact-
ing degree as the diallel, with mock controls missing entirely for some batch/line com-
binations, in the current study we consider data from the infected mice only. CC ani-
mals used to generate CC-RIX lines were purchased from the Systems Genetics Core at
UNC-Chapel Hill; information about CC strains available for distribution is found at
http://csbio.unc.edu/CCstatus/index.py?run=AvailableLines (Morgan and Welsh
2015).
2.3 Statistical Models and Methods
Our statistical analysis of heritable effects in the diallel (hereafter, diallel effects) relies
heavily on the BayesDiallel model and approach described by Lenarcic et al. (2012) and
Crowley et al. (2014). BayesDiallel was originally proposed in Lenarcic et al. (2012) for
diallel analysis of routine, single-outcome phenotypes, describing how the mean value of
those phenotypes was shifted by changes in parentage and sex. Although in some ways
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the method was built upon a canon of existing diallel literature (e.g., refs in Christie
and Shattuck 1992), including more recent work that used random effects (Zhu and Weir
1996; Tsaih et al. 2005) and Bayesian hierarchical modeling (Greenberg et al. 2010), in
other ways it represents a new parameterization, and a generalization of many earlier
methods (see Lenarcic et al. 2012 for explicit connections to those methods). In Crowley
et al. (2014), we extended BayesDiallel to treatment response phenotypes, in particular,
to when the modeled outcome is the phenotypic difference between placebo and treated
matched pairs; the model in this case describes a causal effect modification, or, in a slight
abuse of terminology, a gene-by-treatment (G×T) effect. Herein, that treatment response
approach is extended further: to our more complex matching regime of quartets rather
than pairs, and with a different imputation procedure to deal with quartets that are in-
complete.
This section begins by reviewing the BayesDiallel model for single-outcome pheno-
types. This is used not only to analyze our primary baseline phenotype, body weight at
day 0 (D0 weight), but is also foundational for our subsequent analyses. Then we intro-
duce our definition of infection response based on matched quartets, which gives rise to
treatment responses defined for each of four time-points (D1, D2, D3, and D4 p.i.), and
describe how they are modeled using BayesDiallel. The analysis is then modified further
to estimate the impact of haplotype state at the resistance locus Mx1 , and we describe
how the interaction of haplotype pairs of this locus is examined by estimating relative de-
grees of haplotype additivity and dominance. Last we describe an illustrative comparative
analysis of the effect of the Mx1 locus on IAV response in pre-CC and CC-RIX mice.
2.3.1 Diallel model for single outcome phenotypes
Diallel effects for single outcome phenotypes, that is, phenotypes measured as a single
value per mouse, were modeled using the “fulls” model of BayesDiallel (Lenarcic et al.
2012; Crowley et al. 2014). BayesDiallel is a Bayesian linear mixed model that decom-
poses phenotypic variation into separate heritable components corresponding to additive
genetics, dominance/inbred effects, parent-of-origin (“maternal”), epistasis, and all sex-
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specific versions thereof. It models the phenotype value yi of mouse i as





i β + εi , (2.1)
where µ is the intercept, and εi is the residual error, normally distributed as εi ∼ N(0,σ2),
with variance σ2. The cTi α term represents the contribution of an arbitrary set of user-
specified fixed effect covariates, with predictors encoded in vector ci and fixed effects α;
the ∑Rr=1 u(r)i term represents the contribution of an arbitrary set of R user-defined ran-
dom effect covariates, which for single outcome phenotypes in this study always includes
an effect of experimental batch; and the dTi β term represents the contribution of heritable
components of the diallel, written as a linear combination of the diallel effects vector β
and diallel category vector di. Here di is shorthand for d{ jks}[i], where { j ks}[i] denotes
i’s diallel category, that is, its unique combination of mother strain j, father strain k and
sex s. The diallel category vector d{ jks} is defined with the diallel effects β so as to give
following linear combination:
dT{ jks}β = a j + ak︸  ︷︷  ︸
additive
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where a j is the additive effect of strain j (e.g., the additive effect parameter aAJ is the
expected increase in phenotype on adding one haploid genome of strain AJ), m j is an
additional increase in phenotype induced by strain j being the mother (parent-of-origin
effect), indicator I{X} is 1 if X is true and 0 otherwise, βinbred is the overall effect of being
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inbred, bj is the additional effect of being inbred for strain j, vjk is the additional effect
of the combining strains j with k regardless of which is the mother (symmetric epista-
sis), indicator S{X} is 12 if X is true and −
1
2 otherwise, w jk is a deviation from vjk induced
by parent-of-origin (asymmetric epistasis); φ is the effect of being female rather than
male, and φaj is the sex-specific deviation from additive effect a j , with other superscripted
φ terms (e.g., φm, etc.) defined analogously. Each set of related variables, e.g., the ad-
ditive effects a1, . . . , aJ for J parents, is modeled as a group via a constrained normal
distribution, that is, a1, a2, . . . , aJ ∼ marginally N(0, τ2a ), but subject to ∑j a j = 0, after
Crowley et al. (2014). The variance of each group, e.g., τ2a , was modeled with a weak in-
verse gamma prior, τ−2a ∼ χ2(d.f. = 0.2,mean = 0.2), with this prior also used for the
residual variance σ2. The prior for fixed effects, e.g., µ, is set to a vague normal distri-
bution, µ ∼ N(0, 103). A summary of the diallel effects parameters is given in Table 2.1.
Model fitting proceeded using Markov Chain Monte Carlo (MCMC) via Gibbs sampling
(algorithm in Lenarcic et al. 2012), with results based on samples from 12.5× 106 MCMC
iterations (5 chains of length 2500, after 500 iterations burnin). See also later section
Reporting BayesDiallel results.
2.3.2 Modeling infection response as mock-corrected percent change in body
weight post-infection
A standard measure used to assess pathogenesis in IAV-infected mice is weight loss.
Weight loss correlates with several host and viral factors, including viral load, immune re-
sponse phenotypes and lung histopathology (Ferris et al. 2013; Leist et al. 2016); as such,
it provides a simple, non-invasive measure of infection pathology that can be assessed for
a large number of mice. We measured the percentage change in body weight relative to
D0





for mouse i on day ∈ {D1,D2,D3,D4} in group ∈ {flu,mock}, where, e.g., weightD4[flu]i
and weightD0[flu]i are the body weight for IAV-infected mouse i at D4 and at D0, respec-
tively. These measures, which we describe as single outcome phenotypes, were analyzed
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Table 2.1 Model parameters, random and fixed (overall), from Eqn 2.1, Eqn
2.2, and Eqn 2.5.
Parameter Key Description Type Levels
µ (or θ) overall mean (or overall infection response) fixed 1
α D0 body weight fixed 1
u(batch) experimental batch random 44 or
52a
u(Mx1 diplo) Mx1 diplotype random 6
a j strain-specific additive random 8
m j strain-specific maternal (parent-of-origin) random 8
βinbred overall inbred penalty fixed 1
bj strain-specific inbred penalty random 8
vjk strain pair-specific symmetric epistasis random 28
w jk strain pair-specific asymmetric epistasis random 28
(parent-of-origin)
φ overall female fixed 1
φaj sex-by-strain-specific additive random 8
φmj sex-by-strain-specific maternal (parent-of-origin) random 8
φinbred overall female inbred fixed 1
φbj sex-by-strain-specific inbred penalty random 8
φv
jk
sex-by-strain pair-specific symmetric epistasis random 28
φw
jk
sex-by-strain pair-specific asymmetric epistasis random 28
(parent-of-origin)
aRandom effect levels for u(batch) differ according to the number of experimental batchs within each phe-
notype being modeled: 52 levels for D0, D1pct, D2pct, D1delta, D2delta, and 44 levels for D3pct, D4pct,
D3delta, and D4delta. In the text, h is used to indicate the level of batch for a given individual or quar-
tet.
using BayesDiallel as above (Table 2.2), but they were not the main focus of our study.
Our main focus was a derived measure, IAV infection response, defined next.
In defining IAV infection response we note that from a causal inference perspective
(described more fully in Appendix A.1), weight loss in an IAV-infected mouse (e.g.,
pctD4[flu]i ) reflects two confounded processes: weight loss due to IAV-induced pathogenesis
and weight loss due to other aspects of the experimental procedure. To obtain an uncon-
founded estimate of weight loss due to IAV-induced pathogenesis alone, we defined IAV
infection response as the difference between weight loss in mice subject to infection by
IAV and those subject to mock. Specifically, since in our experimental design we match
one mock mouse to three infected — this reflecting our expectation that phenotypes from
infected mice will be more variable and will thus need more replicates for comparable
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precision — infection response was defined in terms of “matched quartets”, q = 1, . . . , Q,
where each matched quartet q comprised four mice of the same diallel category from the
same experimental batch, with the first three mice, q[1], q[2] and q[3], being IAV-infected
and the last mouse, q[4], receiving mock treatment. Infection response at a given day for







q[ f ] − pct
day [mock]
q[4] , (2.4)
following the more general definition in Eq A2 in Appendix A.1.
Diallel effects on infection response were then modeled using BayesDiallel in manner
analogous to the single outcome case in Eq 2.1, as
deltadayq = θ + cTq α +
R∑
r=1
u(r)q + dTq β + εq , (2.5)
where now the unit of observation is the matched quartet q, rather than the individual i,
and where, for example, dq is shorthand for d{ jk,s}[q], the diallel category appropriate for
q. The shift to modeling treatment response does, however, change how the parameters
are interpreted. The intercept in the above formula, relabeled at θ, now acquires a spe-
cial meaning, representing an overall causal effect due to infection, and the diallel effects
in β now describe how that causal effect is modified by parentage, sex and their interac-
tion; for example, the additive effect parameter aAJ is the expected increase in infection
response on adding one haploid genome of strain AJ. Regarding covariates, as for the
single outcome phenotypes, this model included a random effect of batch, and, to reduce
potential dependence between the deltas and baseline body weight, we also included a




q[ f ]/4) in cq
(Table 2.2).
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Table 2.2 Models used for each analysis in this study.
Model No. Model a Phenotype(s) Unit Variance
Parameters
1 yi = µ+ u(batch)i + d
T
i β + εi pre b individuals 12 c




i β + εi post d individuals 12 c
3 deltaq = θ + u(batch)q + c(D0)q α+ dTq β + εq delta e quartets 12 c
4 deltaq = θ + u(batch)q + c(D0)q α + u(Mx1 diplo)q + dTq β + εq delta e quartets 13 f
aSee study design in Figure 2.1 for overview of analyses. See Table 2.1 and Statistical Methods for parameter and phenotype definitions.
bD0 [all].
cThis count includes τ2batch, {τ2a , τ2m, τ2b , τ2v , τ2w}, {τ2φa , τ2φm , τ2φb , τ2φv , τ2φw }, and σ2.
dD1pct, D2pct, D3pct, D4pct [mock] and D1pct, D2pct, D3pct, D4pct [flu]
eD1delta, D2delta, D3delta, D4delta
fThis count includes τ2Mx1 diplo and parameters in c.
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Although our experimental design stipulated even multiples of 4 mice per diallel cate-
gory, practical constraints on animal breeding and availability meant that in some cases
this number was 3 or 5, such that some quartets had either missing infecteds or surplus
mocks. To ensure the definition of delta in Eq 2.4 remained consistent, and in particu-
lar that deltas from different quartets had comparable precision, the diallel analysis was
performed on M = 1, 000 imputed versions of the data, with each imputed dataset being
composed of exact quartets in which missing phenotypes had been filled using stochastic
regression imputation and surplus mocks had been (randomly) deleted (details in Ap-
pendix A.2). On each imputed dataset we collected 125 MCMC samples from 12,500
total time steps (i.e., by recording values at every 100th timestep); results were based
on the aggregate of these samples from the M imputed datasets (i.e., on 125,000 MCMC
samples in total).
2.3.3 Reporting BayesDiallel results: HPD, MIP, VarP and TreVarP
Point and interval estimates of individual diallel effects, e.g., additive effect aAJ, are
reported as posterior means and 95% highest posterior density (HPD) intervals. The over-
all contribution of a particular inheritance group is reported in two ways: as a Variance
Projection (VarP), e.g., VarP[a] for the contribution of additive effects to a phenotype
or Treatment Response Variance Projections (TreVarPs), e.g., TreVarP[a] for the contri-
bution of additive effects to an infection response; and as a model inclusion probability
(MIP), e.g., MIP[a] for the probability of additive effects being included in the model.
The VarP is a heritability-like measure that predicts how much of the total pheno-
typic sum of squares would be explained by each component in a new, completely bal-
anced diallel. Unlike traditional heritability, it is calculated based on the effects, β, rather
than the variance components, τ2a , . . . , τ2w,σ2, and as such benefits not only from greater
interpretability but also from the stability and accuracy provided by hierarchical shrink-
age (as detailed in Crowley et al. 2014). Since the VarP is a function of the posterior
predictive distribution and calculated at each iteration of the MCMC chain, reported via
Bayesian posterior summaries, specifically, the posterior mean and the α-level equiproba-
ble central posterior quantile (posterior interval). The VarPs for infection response pheno-
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types are, following Crowley et al. (2014), given the special name of TreVarPs, to acknowl-
edge their more delicate interpretation.
The MIP reflects a different type of inference: rather than being a function of the
parameters estimated in the full, sexed BayesDiallel model of Eq 2.1 and Eq 2.2, it de-
scribes the results of model selection, that is, an assessment of which diallel categories
could be excluded without a substantial loss in fit. As in Crowley et al. (2014), we use
the exclusionary Gibbs group sampler of Lenarcic et al. (2012). Each diallel category is
set to have a prior inclusion probability of 0.5, reflecting a prior opinion that inclusion
and exclusion are equally likely. This prior is then updated by the phenotype data and
the model selection procedure to give a (posterior) MIP. MIPs are interpreted following
the conventions in Crowley et al. (2014): MIPs in the range (0.25,0.75) indicate that the
data does not provide sufficient evidence to make an informed decision about exclusion or
inclusion; MIPs within (0.05,0.25] or [0.75,0.95) represent positive evidence for exclusion
or inclusion respectively; (0.01,0.05] or [0.95,0.99) represent strong evidence; and [0,0.01]
or [0.99,1] represent strong to decisive evidence. These conventions are based on those
proposed by Kass and Raftery (1995) for Bayes factors, which are connected to MIPs by
the relation




where MIP0 is the prior inclusion probability, and where the above simplifies to MIP/(1 −
MIP) in our case of MIP0 = 0.5.
2.3.4 Estimating Mx1 effects in the diallel
The critical host resistance factor (Mx1 ) has been shown to drive IAV-resistance in
the CC founder strains and has been mapped in the pre-CC (Ferris et al. 2013). Mx1
was previously described as having three major, naturally occurring functional classes
of resistance to influenza H1N1 arising from the subspecies Mus musculus domesticus
(hereafter, dom; members include AJ, B6, 129, NOD and WSB), M. m. castaneus (cast;
CAST) and M. m. musculus (mus; PWK and NZO), of which dom is considered to be
null whereas mus and cast are protective. (Note that dom Mx1 in the CC founder strains
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is comprised of two unique null alleles, and that the subspecific Mx1 alleles observed in
the CC may not be representative of the those segregating in the wild.) To estimate the
contribution of Mx1 haplotypes as discernible in the diallel, and thereby also estimate the
extent of heritable effects that remain after Mx1 is controlled for, we define the following
haplotype combinations (diplotypes) as six levels of the random effect, u(Mx1 diplo): {dom
× dom}, {dom × cast}, {cast × cast}, {cast × mus}, {mus × dom}, and {mus × mus}; we
then repeat our diallel analysis with this effect included (Model 4 in Table 2.2).
Estimating a dominance index for Mx1 alleles
Dominance is typically defined in the context of bialleles. Since in this population,
Mx1 has a multiallelic series, we define dominance between allele pairs. Following Kacser
and Burns (1981), which is built on the work of (Wright 1934), we define the “dominance
index” for a wild-type (wt) against a mutant (mut) allele as
D(wt; mut) = u
(wt wt) − u(wt mut)
u(wt wt) − u(mut mut)
, (2.6)
where values for D are close to -0.5 when the effect of the wild-type is overdominant to
the mutant (the effect of the mutant is underrecessive), 0 when the effect of the wild-type
is completely dominant to the mutant (the effect of the mutant is recessive), close to 0.5
when the effect of the wild-type is additive (not dominant, or incompletely dominant)
to the mutant, close to 1 when the effect of the wild-type is recessive (the effect of the
mutant is dominant), and close to 1.5 when the effect is underrecessive (the effect of the
mutant is overdominant). Overdominance is given by values of D that are much less than
0 and underdominance by values that are much greater than 1. This definition is used to
define dominance indices u(cast; dom) and u(mus; dom), describing the degree of dominance of
the protective alleles cast and mus respectively against the null allelle dom. To assess the
degree to which cast and mus differ in their relation to dom, we further define a “domi-
nance difference index”,
DD(mus−cast; dom) = D(mus; dom) −D(cast; dom) , (2.7)
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where negative values indicate that mus has more of a dominance-based relationship to
dom than does cast, positive values indicate the converse, and zero indicates that the
relationships of cast and mus to dom show dominance equally.
When the BayesDiallel model includes Mx1 effects, the aforementioned dominance
index and dominance difference index are both functionals of the posterior; posterior
samples of these indices were therefore obtained by simply applying Eq 2.6 and Eq 2.7 to
the sampled Mx1 effects at each timestep of the MCMC chain.
The Kacser and Burns (1981) dominance index is a simple re-parameterization of the
degree of dominance parameter, aCR, defined by Comstock and Robinson (1948) and used
by Gardner and Lonnquist (1959). In the Comstock-Robinson model, the mean centered
phenotypes are coded as (translating from our model above): u(wt; wt) = w, u(wt; mut) = aw,
and u(mut; mut) = −w. This gives the relation D(wt; mut) = (1 − aCR)/2 or equivalently,
aCR = 1 − 2D(wt; mut). This alternate dominance parameterization is explored further using
BayesDiallel in Turner et al. (2017).
2.3.5 Estimating haplotype effects at the Mx1 locus in the pre-CC and
CC-RIX
The additive effect parameters estimated in the diallel do not precisely distinguish the
effects at the Mx1 locus because they are confounded with any potential effects genome-
wide that follow the same pattern of strain classification. An unconfounded estimate of
haplotype effects at Mx1 requires a population in which the remainder of the genome is
randomized, e.g., by recombination. To this end, we make use of two related data sets
on IAV-induced weight loss in two CC-derived MPPs: IAV (PR8) infection in the pre-
CC and IAV (CA04) infection in a set of CC-RIX lines. These two studies, described in
more detail below, were in other respects less rigorous than our diallel: the experimental
measurement of the infection response was based on infected mice only with no mocks
in the pre-CC, and although mocks were collected in the CC-RIX, their relative sparsity
(200-300 mocks to >1400 infecteds) complicates analysis based on matching alternate
treatment groups; the experimental batching was subject to a less exacting degree of ran-
domization across genetically distinct categories; the available combinations of Mx1 diplo-
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types are limited mostly to homozygotes in the pre-CC, and incompletely and unevenly
sampled in the CC-RIX; the Mx1 diplotype state for each line is known only probabilisti-
cally, having been inferred by hidden Markov models (HMMs) applied to genotyping data.
Nonetheless, if effects at the Mx1 locus were largely independent of those elsewhere in the
genome, we might expect that Mx1 effects in the pre-CC and CC-RIX would be broadly
consistent with those in the diallel.
Estimation of haplotype effects at the Mx1 locus was performed using the Diploffect
model (Zhang et al. 2014), a Bayesian hierarchical model that estimates effects of diplo-
type substutions at a specified QTL when the diplotype states themselves are known only
probabilistically. The effects estimated by Diploffect are analogous to those estimated by
BayesDiallel: phenotype yi of mouse i is modeled as





i β + εi , (2.8)
where dipi is a vector representing the diplotype state of mouse i at the QTL and is short-
hand for dip{ jk}[i], where { j k}[i] denotes i’s diplotype state composed of haplotypes from
CC founder strains j and k, β are the corresponding effects, and all other variables are as
in Eq 2.1. The diplotype vector dip{ jk} is defined with β so as to give the linear predictor
dipT{ jk}β = a j + ak + I{ j,k}γjk , (2.9)
where a j and ak are additive (haplotype) effects modeled as a j ∼ N(0, τ2add), broadly equiv-
alent to the additive effects in BayesDiallel’s Eq 2.2, and γjk ∼ N(0, τ2dom) are dominance
deviations, which are the converse to BayesDiallel’s inbred parameters. Dominance devia-
tions are expected to be poorly informed when heterozygotes are sparsely represented, as
in the CC-RIX and in particular the largely inbred pre-CC, but are nonetheless included
to stabilize inference of additive effects. For numerical stability, phenotypes were first
centered and scaled to unit variance, and variance parameters (σ2 or τ2effect, where effect
is add, dom or r ∈ R) were given mildly informative priors of the form τ−2effect ∼ Ga(1, 1).
Estimation proceeded by importance sampling (the DF.IS and DF.IS.kinship methods in
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Zhang et al. 2014) using integrated nested Laplace approximations (INLA; Martins et al.
2013), with 100 importance samples taken, and parameter estimates for additive effects
are reported as posterior means, posterior medians and HPD intervals.
Pre-CC study
In the study of Ferris et al. (2013), IAV infection response was measured on 155 mice
from as many pre-CC lines as weight loss following infection with IAV (PR8 variant, as
for the diallel). QTL mapping of D4 p.i. weight loss, equivalent to pctD4i in the diallel
study, identified a QTL, HrI1, containing the Mx1 gene, with peak marker JAX00072951
(chr16:98,148,641; Mouse Diversity Array of Yang et al. 2009). We estimated haplotype
effects at this peak marker using Diploffect (Zhang et al. 2014), applied to the phenotype
and the original HMM probabilities of Ferris et al. (2013), with the model including a
fixed effect covariate for D0 weight.
CC-RIX study
For the CC-RIX study of infection response to IAV (CA04 strain), we calculated
weight loss values for all 1,402 infected mice at D7 p.i. (analogous to a pctD7i measure),
and for all 105 CC-RIX lines obtained diplotype probabilities at marker UNC27478095
(16:97,591,482; MegaMUGA array, described in Morgan et al. 2016) from the Inbred
Strain Variant database (ISVdb; Oreper et al. 2017). Haplotype effects were then esti-
mated by Diploffect applied to debatched CC-RIX line means as follows. First, we fit
a linear mixed model (by REML using the R package lme4 of Bates et al. 2015) to the
individual-level phenotypes (n = 1, 402) with fixed effects of D0 weight and lab (2 levels),
and random effects of mating (107 levels: 105 RIXs + 2 additional levels distinguishing
minor breeding differences, when CC010 and CC042 strains were re-derived from breeder
females into a new facility) and infection date (59 levels). The residuals of this model
were then averaged over the ni mice of each CC-RIX line i, and used as the response yi
in Eq 2.8 with precision-weighting εi ∼ N(0,σ2/ni) and a between-line polygenic random
effect u ∼ N(0, Gτ2G), where 105 × 105 genetic relationship matrix G was calculated between
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all CC-RIX pairs based on the founder haplotype probabilities (dosages) at each locus,
according to the method described in Gatti et al. (2014).
2.3.6 Availability of Data and Software
Analyses were conducted in the statistical programming language R (R Core Team
2017). In addition to R packages cited above, we used the packages BayesDiallel (Lenar-
cic et al. 2012) and Diploffect.INLA (Zhang et al. 2014). The data, analysis software,
and scripts are available on flu-diallel repository on GitHub, at https://github.com/
mauriziopaul/flu-diallel. A static version is posted as a public, open access Zenodo
repository, at http://dx.doi.org/10.5281/zenodo.293015. Phenotype data from the
diallel and CC-RIX animals used in this study will be available on the Mouse Phenome
Database (Grubb et al. 2014), at https://phenome.jax.org with persistent identifier
RRID:SCR_003212.
File S1 contains an account of the supplemental files which can be used to reproduce
our analysis. File S2 contains the software packages used for this analysis. File S3 con-
tains the diallel data file, and File S4, S5, and S6 contain the data analysis files required
for analyzing the diallel, pre-CC, and CC-RIX, respectively. File S7 contains supplemen-
tal figures, tables, and an algorithm. After unzipping, the files FluDiData.csv, Flu-pre-
CC-data.csv, and Flu-CC-RIX-data.csv contain raw phenotypes, cross (or line, strain),
and mouse ID information from the three mouse populations used in this study. The
script files MIMQ*.sh are used in bash to call R scripts to run the BayesDiallel analysis
on diallel phenotypes. The script files main_analysis*.R are used with Diploffect to run
Diploffect analysis on the pre-CC and CC-RIX phenotypes. Additional *.RData, *.pl,
*.alleles, and *.csv files are uploaded which contain settings, genotypes, and founder hap-
lotype probabilities used by the scripts.
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2.4 Results
Mice from the eight inbred founder strains of the CC were used to generate a near-
complete 8× 8 diallel. This study used offspring (n = 1, 043) of both sexes (519 females, 524
males) representing 62 of the 64 crosses (Figure A1), including all inbred combinations
(n = 129) and all F1 hybrids (n = 914) except NZO×CAST and NZO×PWK. Within each
diallel category, defined as the combination of sex and (reciprocal) parentage, and in each
experimental batch, mice were randomly assigned at weaning to infection or mock groups
in a ratio of 3:1; complete sets of 3 infected with 1 mock were described as matched quar-
tets. Mice in the infected group were inoculated with IAV PR8 and in the mock group
with PBS. For each mouse, body weight was measured prior to infection (D0 or baseline
weight), and at days 1-4 post-infection (D1, D2, D3, D4). D0 weight is reported in grams
whereas post-infection weight is hereafter reported as a percentage of D0 weight, e.g.,
D4pct. Not all mice survived the protocol: one infected mouse died after D3 weights were
taken and one mouse died from anesthesia on D0.
2.4.1 F1 hybrids of the CC founders show a wide range of phenotypic outcomes
The CC founders include five strains we have previously characterized as susceptible
to IAV-induced pathology (AJ, B6, 129, NOD, and WSB), two strains as resistant (NZO
and PWK), and one (CAST) that exhibits a distinct intermediate weight loss phenotype
(Ferris et al. 2013). Results for the inbred founders measured in our diallel replicate those
earlier findings, and the post-infection weight loss among the infected F1 hybrids spanned
the range of phenotypes observed in the founders (Figure A3), consistent with the no-
tion of IAV-induced weight loss being a complex trait with contributions from multiple
loci.
2.4.2 Diallel effects on baseline mouse weight strongly replicate previous CC
founder diallel studies
The effects of parentage and sex on D0 weight were estimated using BayesDiallel. De-
scribed further in Methods, BayesDiallel decomposes the heritable effects observable in
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the diallel into 160 parameters (diallel effects) grouped into 13 distinct heritability classes.
In sketch form, it models the average phenotype of mice of sex s bred from mother of
strain j and father of strain k as
ave.phenotypejks = overall mean& covariates
+ a j + ak + inbredj + otherjks︸                                ︷︷                                ︸
diallel effects
,
where covariates always includes experimental batch, a j and ak are the additive effects of
the two parents, inbredj is an additional effect included only when j = k), and otherjks
models the effects of further nuances of sex and parentage as deviations from this base
model (listed in Methods and Table 2.1).
Diallel effects estimated for D0 weight are reported in Figure A6A as 95% HPD in-
tervals for each parameter, and two summary measures, VarPs and MIPs, for each of the
13 heritability classes are given in Figure A6B,C. Briefly, VarPs (Figure A6C) report
the contribution of the effect group as the proportion of the total phenotypic variance,
whereas MIPs (Figure A6B) assess the strength of support for whether an effect group
should be included at all, with probabilities near 1 providing stronger support for inclu-
sion, probabilities near 0 supporting exclusion, and probabilities near 0.5 reflecting a lack
of information either way.
The pattern of effects for D0 weight was strikingly similar to that seen for baseline
body weight in two previous diallels of the CC founders (Lenarcic et al. 2012; Crowley
et al. 2014), despite those earlier studies being independent experiments with no partic-
ular attempt made to align experimental protocols, and included substantial additive
effects, strain-specific parent-of-origin effects, signals of epistasis, and sex-specific versions
thereof. For example, we largely replicated the pattern of inbred, additive, and mater-
nal effects observed in both Lenarcic et al. (2012) and Crowley et al. (2014), and also
found a higher-order sex-specific PWK×CAST symmetric epistatic effect in Lenarcic et al.
(2012). We also observed some new epistatic and sex-specific epistatic effects largely due
to increased power from a larger sample size.
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2.4.3 Diallel effects on IAV infection response
Infection response was defined as the percentage change in body weight induced by
IAV infection, with more negative values indicating more severe pathology. This was cal-
culated at each timepoint, D1, D2, D3, and D4 p.i., as the difference between matched
infected and mock mice, yielding a single infection response number (a “delta”, e.g.,
D4delta) for each matched quartet (3 infected mice and 1 mock). The effects of parent-
age and sex on infection response were then analyzed for each timepoint separately using
BayesDiallel as above, with an additional covariate of D0 weight (see Methods for de-
tails). Although results are provided in Supplemental Materials for all timepoints, we will

























































































































































Figure 2.4 Influenza-induced weight loss in an 8×8 diallel cross of mice, through four
days post-infection. Mean weight change, as % D0 weight, is shown at (A) day 1, (B) day
2, (C) day 3, and (D) day 4 post-infection with 500pfu IAV (PR8) in male and female
inbreds and F1 hybrids of CC founder strains (n = 774 for D1 and D2, n = 382 for D3
and n = 381 for D4). Results from mock-infected mice not shown. Squares with a grey
“×” indicate matings that do not produce offspring.
IAV infection causes weight loss through day 4 post-infection, with greater sus-
ceptibility in females
IAV infection in the diallel induced an overall mean change in body weight (i.e., over-
all infection response θ in Eq 2.5 and Table 2.1) of -0.13% (95% HPD interval: -0.48,
0.22; MIP=1) on D1 p.i., -0.83% (-1.33%,-0.32%; MIP=1) on D2 p.i., -5.60% (-6.47%,
-4.73%; MIP=1) on D3, and -8.85% (-9.92%, -7.78%; MIP=1) on D4 (Table A3; see also
progression in Figure 2.4). Consistent with previous mouse studies of sex effects on in-
63
fection (Robinson et al. 2011; Lorenzo et al. 2011), females given the same dose of virus
as male mice had increased weight loss: a negative effect of female sex was estimated at
all four time points p.i., gradually increasing in magnitude from -0.89% (-1.45%, -0.36%)
at D1 p.i. to -2.11% (-3.87%, -0.30%) at D4 p.i. (Figure 2.5), suggesting that enhanced
susceptibility in females may occur at least as early as D1 p.i. Although all mice received
the same dose of virus regardless of starting body weight, heavier mice experienced a
transient increase in percent weight loss at D2 p.i. compared with lighter mice: the D0
weight effect (α in Eq 2.5) on the infection response at D2 p.i. was -0.31% (-0.52%, -
0.09%), such that for every 10 grams of starting weight beyond 0 grams, an additional ≈
3.1% weight was lost on D2; however, this effect disappeared by D3 p.i. No other signif-
icant effects of starting weight on IAV-induced weight loss were detected at other time
points, indicating that heavier mice were infected at least as effectively as lighter mice,
and that starting body weight does not in general confound our exploration of strain and
cross-specific effects.
Diallel effects on infection response reflect mostly additive genetics, consistent
with differences in Mx1 haplotype
Infection response in our diallel was strongly driven by additive effects. On D3 p.i., en-
hanced susceptibility to weight loss in infected animals was affected most by contributions
from strain AJ, -2.17% (-3.72%, -0.61%), and enhanced resistance from contributions of
NZO, 2.54% (0.72%, 4.27%), and PWK, 1.70% (0.12%, 3.23%), strains. On D4 p.i., en-
hanced suscepitibility was greatest from AJ, -2.77% (-4.66%, -0.86%) and WSB, -3.09%
(-5.01%, -1.18%), with enhanced resistance greatest from NZO, 4.07% (1.95%, 6.12%),
and PWK, 4.06% (1.97%, 6.08%) (Figure 2.5A). In terms of its additive effect, CAST
was more resistant than the Mx1 -null strains (AJ, B6, 129, NOD, and WSB) but about
half as resistant as the Mx1 -functional strains (NZO and PWK), consistent with it confer-
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Figure 2.5 Diallel effects on host weight IAV-infection response, before and after ac-
counting for Mx1 haplotypes. A) Effect estimates for additive, maternal, inbred, and
epistatic effects, including sex-specific effects, are presented as highest posterior density
(HPD) intervals across 163 individual effects categories for IAV-induced weight change at
D4 p.i. (phenotype D4delta). HPDs are given for each parameter, including 95% (thin
line) and 50% (thick line) intervals, and median (white break) and mean (black vertical
line). Parameters are labeled according to the methods. Symmetric epistatic, asymmetric
epistatic, and sex-specific parameters are indicated by “v:”, “w:”, and “f:”, respectively.
The overall treatment effect, θ, (not shown) is -8.85% (-9.92%, -7.78%). B-C) Treatment
Response Variance projections (TReVarPs), a generalization of heritability for diallel ef-
fects classes, at D4 are shown for three fixed (overall) effects, five random effects classes
and five corresponding sex-specific random effects classes (posterior median and 95%
quantile-based confidence intervals) before (B) and (C) after accounting for diplotypes
of the host influenza resistance allele, Mx1 . D-E) TReVarPs before and after Mx1 for all
four post-infection timepoints.
To summarize these effects: for each dose of AJ or WSB genomes inherited from a
parent, about 2%-3% of additional starting body weight is lost post-infection, indicating
enhanced susceptibility compared with the overall mean weight loss; for each NZO and
PWK genome inherited, about 4% more of starting body weight is retained post-infection,
compared with the mean treatment effect, indicating enhanced resistance.
Diallel effects explained over half of the total variance of infection response at D4,
with a treatment response VarP for all effect groups collectively of 57% (TReVarP[all]=0.571;
0.418, 0.721). The variance explained by additive effects only, which is related to the
narrow-sense heritability, was estimated as 34.8% (TReVarP[a]=0.348; 0.190, 0.491), and
also detected were potential additional contributions of epistasis (TReVarP[v]=0.069; -
0.001, 0.212) and maternal effects (TReVarP[m]=0.020; 0.000, 0.059) (Figure 2.5B,D,
Table A1).
Evidence for additive, inbred, epistatic and parent-of-origin effects mounts as dis-
ease progresses
The relevance of diallel effects to infection response became more marked with time
(Table A3, Figure A7-A10). At D1 and D2 p.i., model inclusion probabilities gave
strong support only to an overall infection response, with no evidence of this effect being
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modified by sex or parentage (Figure A7-A8). At D3 p.i., however, we found positive
to strong evidence of additive (MIP[a]=0.978), inbred (MIP[b]=0.958), and asymmetric
epistatic (MIP[w]=0.820; i.e., parent-of-origin epistatic) effects (Figure A9). By D4
p.i., support for additive (MIP[a]=0.998) and inbred (MIP[b]=0.999) effects had become
decisive (see Methods for MIP interpretation), and there was strong support for both
symmetric epistatic (MIP[v]=0.960) and asymmetric epistatic (MIP[w]=0.966) effects
(Figure A10, Table A3).
2.4.4 Modeling effects consistent with Mx1 haplotype
To help distinguish diallel effects that are consistent with the subspecies haplotype of
the resistance factor Mx1 (hereafter, Mx1 effects), we incorporated the Mx1 subtype ex-
plicitly into the model as a genotype covariate with three alleles, one for each subspecies
branch: dom (AJ, B6, 129, NOD, WSB), cast (CAST), and mus (NZO, PWK).
Mx1 effects are increasingly evident with disease progression; explain ∼40% of the
diallel effects at D4 p.i.
In keeping with the increased support seen for diallel effects over time, evidence for a
non-zero Mx1 effect increases from positive evidence of exclusion on D1 (MIP=0.035) to
no evidence for inclusion or exclusion on D2 (MIP=0.552), to decisive evidence for inclu-
sion on D3 (MIP=1.000) and D4 (MIP=1.000) (Figure A11-A14); a comparable level of
support for inclusion in the model was seen only for effects of overall treatment and batch.
After controlling for Mx1 , the variance explained by diallel effects at D4 was substantially
reduced, from 57% to 33.8% (TReVarP[all|Mx1]=0.338; 0.174, 0.537) (Figure 2.5C,E,
Table A2). This was consistent with Mx1 accounting for about 40% of the variance ex-
plained by the diallel, including most of the additive effects (mathematically the Mx1
term models effects that compete with a subset of the additive and dominance diallel
effects).
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Evidence for distinct additive and non-additive effects of Mx1 functional groups
After controlling for other diallel effects, the predicted weight loss over the course of
4 days varies in a manner consistent with Mx1 allele combination (Figure 2.6A). We
observed that, as expected, dom × dom crosses were predicted to have much more overall
post IAV-infection weight loss at D3 and D4 compared with all other crosses. Notably,
the most protected group appeared to be the dom × mus haplotype, at both D3 and D4
post-infection, although the HPD intervals overlap with other Mx1 -functional groups.
The rank order of effects changes from D3 to D4 due to the dramatic slowing of weight
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Figure 2.6 Time course of subspecies-specific Mx1 haplotype effects on IAV-induced
weight change in the diallel. A) Predictive means of Mx1 diplotype effects across four
days post-infection, modeled simultaneously with other diallel effects and covariates. B)
HPD intervals of Mx1 diplotype effects on weight change on day 4 post-infection. In-
creased resistance is indicated by values further to the right. Dashed lines highlight the
mode of interaction between Mx1 haplotypes: green ( ) shows the additive effect of
crossing cast with dom, blue ( ) the dominant effect of crossing mus with dom, and
orange ( ) the neglible effect of cast crossed with mus.
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Although we did not observe any strain- or pairwise-specific non-additive effects in the
diallel prior to inclusion of the Mx1 random effect, we did observe a pattern of dominance
in crosses between mus and dom, even as there was a pattern of additivity in the crosses
between cast and dom (Figure 2.6B). Whereas it might be expected that host alleles
from Mx1 -null strains should act in a recessive manner, this appears not to be the case
for this phenotype and time point in crosses of cast with dom, such that the functional
Mx1 allele from CAST appears to operate in an additive manner. This further supports
the previous observation that the CAST Mx1 alleles differ from the mus Mx1 alleles in
their protective host response to IAV (Ferris et al. 2013).
Dominance and additivity of Mx1 alleles against the functional null: mus is dom-
inant, cast acts additively
To better characterize how the Mx1 effects on infection response exhibit aspects of
genetic dominance vs. genetic additivity, we estimated for each functional Mx1 allele a
“dominance index”, after Kacser and Burns (1981). This measures the distance between
the expected phenotype of a homozygous functional allele, in our case mus or cast, and
the heterozygote formed with a null allele, in our case dom. On this scale, 0 denotes the
functional allele being dominant to the null, 1 denotes it being recessive and 0.5 indicates
pure additivity (see x-axis scale in Figure 2.7A, B, and more details in Methods).
The dominance indices of the two functional Mx1 alleles, mus and cast, were sharply
different (Figure 2.7A,B; Table A8). We found that mus against dom was -0.278
(=posterior mode of D(mus; dom); 80% HPD interval -2.547, 0.329) at D3 and 0.068 at
D4 (-0.568, 0.380), a clear signal of mus exerting classical dominance over the functional
null. In contrast, the dominance index of cast against dom was 0.421 (-0.534, 0.907) and
0.491 (-0.028, 0.836) for D3 and D4, consistent with cast and the functional null being
codominant (i.e., having an additive relationship). The difference of the two dominance
indices, whose posterior distribution is shown in Figure 2.7 for each timepoint, quan-
tifies the distinction between mus and cast more directly, putting the probability that
mus is more dominant than cast (i.e., P[D(mus; dom) > D(cast; dom)]) at 83.6% for D3 and
86.6% for D4.
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Figure 2.7 Posterior density of the dominance index on (A) D3 and (B) D4. C) Poste-
rior density of the dominance difference index, i.e., the difference between the dominance
indices of cast and mus, across all 4 days p.i.
2.4.5 Mx1 effects show consistent pattern in related multiparent populations,
pre-CC and CC-RIX
We examined effects associated with the Mx1 locus in two related recombinant CC
populations, the pre-CC of Ferris et al. (2013) and a set of CC-RIX lines first described
here, and observed that the pattern of locus-specific strain haplotype effects was strik-
ingly similar to that observed in our diallel Figure 2.8). This suggests that the pattern
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Figure 2.8 Additive CC-strain haplotype effects on IAV-induced weight loss across three
CC-related populations. A) Additive effects from the CC founder diallel of mice infected
with IAV (PR8) or mock virus (nflu= 393, nmock= 131) at day 4 p.i. (from Figure 1).
B) Additive strain haplotype effects at the Mx1 locus for female pre-CC mice (n = 15 )
infected with IAV (PR8) at day 4 p.i. C) Additive strain haplotype effects at Mx1 for
female CC-RIX mice (n = 1, 402) infected with IAV (CA04) at day 7 p.i. Estimates are
shown as HPD intervals as described in Figure 1, with blue lines connecting posterior
means. Parameter scales are given as additional IAV-induced weight loss per dose of
strain in % of (A) D0, and (B, C) normalized effect size.
of genome-wide additive effects in the diallel is largely driven by the effect of Mx1 hap-
lotypes in the founder strains. This similarity in pattern is consistent, even though the
virus isolate and the peak weight loss timepoint differed in the CC-RIX population (CA04
human pandemic strain, D7 p.i.) compared with the diallel and pre-CC (PR8 mouse-
adapted strain, D4 p.i.) (Table A4). In all three populations, NZO and PWK alleles
provide the most resistance to IAV-induced weight loss, and CAST alleles are slightly
less protective. In the pre-CC, effects of AJ, B6, 129, NOD, and WSB haplotypes are all
approximately the same, and clearly separated from the additive effects of strains with
functional Mx1 . In the diallel and in the CC-RIX (at Mx1 ), however, AJ and WSB haplo-
types are on average more susceptible than the B6 haplotype, and there is less separation
between additive effects of CAST and those from from Mx1 -null strains. The proportion
of variance in weight loss explained by Mx1 was estimated as 0.5 (95 % HPD interval:
0.43, 0.54) and 0.54 (0.42, 0.63) for pre-CC and CC-RIX mice, respectively (Figure A16
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and Figure A17). Note that an in-depth analysis of dominance indices for the Mx1 lo-
cus was not possible in these populations owing to the relatively sparse coverage of het-
erozygote diplotype states in the pre-CC and homozygous functional diplotype states in
the CC.
2.5 Discussion
We describe a general approach for investigating heritable effects on host susceptibility
to virus-induced disease — in our case pathogenesis induced by IAV — using a diallel
cross of the eight CC founder strains. The results from this diallel are informative not
only in more clearly defining genetic architecture of the host influenza response, but also
prospectively: they anticipate sources of heritable variation likely to be present in the
CC, the DO and other derived experimental populations, and therefore provide a ready
basis for the rational design of future studies. As an illustration of this, we demonstrate
concordant effects of viral resistance locus Mx1 across the CC founder diallel, pre-CC and
a set of CC-RIX lines.
With regard specifically to IAV pathogenesis, our study sought to better understand
host genetic effects on this outcome in terms of their (1) time-dependence, (2) consistency
across related populations, and (3) conditionality; for example, dependence on interac-
tions between alleles at the same locus (dominance, at Mx1 ) or at different loci (epista-
sis). Regarding time-dependence (1), we found that, whereas the effect of being female
rather than male is evident from day 1, the effects of genetics appear later, becoming
evident only on day 3 and then increasing through day 4 post-infection. Regarding consis-
tency (2), we found that the effects of the Mx1 alleles seen previously in the CC founders
remain stable across inbred, F1, and recombinant populations. Regarding conditionality
(3), we found something unexpected: evidence that the two Mx1 functional classes, cas-
teneus (CAST) and musculus (NZO and PWK), which were previously characterized as
being functional alleles, in fact behave differently when present in the heterozygous state
with susceptible Mx1 alleles from domesticus (AJ, B6, 129, NOD, WSB). Specifically, the
protection conferred by the presence of a musculus Mx1 allele is the same regardless of
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whether it is in the homozygote state or paired as a heterozygote with the null domes-
ticus allele; the musculus allele is therefore dominant to domesticus. But for the CAST
allele, when paired in the same way with domesticus, its protection is weakened, to an ex-
tent consistent with CAST and domesticus being codominant, that is, having an additive
relationship.
2.5.1 Level of resistance to IAV among different inbred mice is conditional on
IAV subtype and strain
Differences in Mx1 function have been identified between a variety of inbred mouse
strains, including the CC founders (Ferris et al. 2013; Xiong et al. 2014; Leist et al. 2016).
Our results were largely consistent with those studies.
Notably, in their examination of the CC founders with H3N2 infection, Leist et al.
(2016) identified AJ and WSB strains as being most susceptible, and NZO and PWK as
being most resistant, which agrees with our diallel additive effects. However, in contrast
with our results showing partial protection against H1N1 IAV with CAST Mx1 , which
is consistent with our prior findings in the pre-CC (Ferris et al. 2013), they found CAST
mice, grouping with AJ and WSB, to be highly susceptible. This difference could arise for
at least two reasons. First, across the influenza field, even in identical RI panels (Boon
et al. 2009; Nedelko et al. 2012), host genetic effects appear to be IAV subtype-specific.
Second, the effectiveness of Mx1 ’s antiviral activities can vary depending on IAV sub-
types (Riegger et al. 2015; Dittmann et al. 2008; Zimmermann et al. 2011; Mänz et al.
2013; Verhelst et al. 2012). Differentiating these two possibilities, however, is beyond the
scope of this work.
Although the molecular differences in CAST Mx1 that produce a deficient response
in comparison with mus Mx1 have not been defined, some work has been done in inbred
mice to better understand CAST/EiJ-(strain)-specific antiviral responses. In order to
interpret what they saw as a unique antiviral deficiency of CAST mice, transcriptomic
experiments by Leist et al. (2016) suggested enhanced susceptibility is due to leucocyte
recruitment deficiency (relative to NZO and PWK) in the lung. In the CC founder study
of Xiong et al. (2014), several transcriptomic differences separated the CAST response to
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PR8 from the that of the other strains, including differential splicing of Irak1 and lack
of Ifng expression at D4 p.i., which was consistent with Ifng deficiency observed by Earl
et al. (2012) leading to lethal monkeypox infection of CAST mice. Because these studies
were completed in inbred CAST mice, the role of CAST Mx1 is confounded with the
genome-wide differences between CAST and the other CC founders.
Thus, there are several challenges to understanding the unique IAV resistance profile
of CAST Mx1 based on existing studies: (1) studies in inbred lines are unable to probe
the overall or Mx1 -specific dominance architecture due to a lack of heterozygosity; and
(2) studies in non-recombinant lines that identify a unique phenotype in CAST compared
with other founders are unable to separate the effect of CAST Mx1 from effects arising
from the rest of the CAST genome. Our study in part circumvents these shortcomings by:
(1) additionally examining F1 hybrids, and (2) exploring the emerging phenotypes from
an ongoing IAV infection screen using CC-RIX, themselves F1s of RI strains.
2.5.2 Complex additive effects patterns mask strong signals of dominance
In our initial analysis, we found that most of the phenotypic variation explained in
infection response is driven by additive genetics with no particular signal of dominance.
However, when we explicitly modeled Mx1 status, using a term that competes with a
subset of the additive and dominance diallel effects, we found that the Mx1 functional
classes act in a manner consistent with a strong dominance pattern for musculus Mx1
(Figure 2.6). It seems striking that such a pattern of dominance could be underlying an
apparently heavily additive effect signal.
Identifying dominance requires a good basis for comparing inbreds with hybrids. How-
ever, since the diallel is mainly composed of F1 hybrids with relatively few (8 vs 54) in-
breds, this basis for comparison is often weak. The BayesDiallel model handles this by
considering the hybrid state as the baseline and treats the inbred state as the exception
(a deviation) relevant to a minority of categories, as discussed further in Lenarcic et al.
(2012).
Inferred dominance effects are therefore vague because the data that informs it is
sparse, and low estimates of dominance variance comes from absence of information
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rather than from information about the absence of an effect. Nonetheless, greater pre-
cision was available when considering dominance of substrain-specific Mx1 because domi-
nance information was pooled across multiple strains and strainpairs.
The fact that the proportion of estimated additive vs. non-additive variance is influ-
enced by model parameterization motivates careful consideration of both study design
and analysis. As Huang and Mackay (2016) have recently described, model parameter-
izations can have critical effects on the detection of non-additivity, with the same data
strongly supporting evidence for mostly additive or mostly non-additive effects, depending
on the model. Related issues have been described at the locus level by Sabourin et al.
(2015), who showed that when applying penalized regression to multi-SNP fine-mapping
in GWAS, genotype parameterization interacts with how priors/penalties are assigned
and can make biallelic dominance hard to identify in some cases. Yet even when domi-
nance is not of interest per se, failure to accommodate it can disrupt estimation of addi-
tivity: in the pre-CC QTL mapping study of Phillippi et al. (2014), dominance signals
arising from residual heterozygosity disrupted detection of an additive QTL for basal lev-
els of CD23 (encoded by Fcerii); this was resolved by treating heterozygote diplotypes,
whose occurence was too sparse to be modeled, as inherently noisier via downweighting.
2.5.3 Antiviral genes are expected to be dominant, but CAST Mx1 exhibits ad-
ditivity
The degree of genetic dominance of host resistance factors to viral infection in humans
and mice has not been thoroughly explored. In general, in the context of biochemical
and immunological studies one might expect, just as with musculus Mx1 combined with
domesticus Mx1, that genes encoding strong-acting antivirals when combined with a null
mutant would be mostly dominant. In quantitative genetics, however, it is more often
expected that genetic contributions will be mostly additive. In this study, at the Mx1
locus, we observe both.
In genetic crosses of functional and null mice, major host determinants of pathogenesis
are might normally be expected to be classified as either recessive or dominant: recessive
when null results in loss-of-susceptibility for a host factor required for disease suscepti-
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bility; dominant when null results in loss-of-function for a host gene required for virus
resistance. The recessive case is especially true of passive immunity gained by knockout
of host genes critical to viral entry and life cycle, and has been demonstrated in a vari-
ety of studies on crop resistance (Fraser 1990; Kang et al. 2005; Truniger and Aranda
2009; Hashimoto et al. 2016), and explored in studies of the effects of CCR5 deficiency
(CCR5-delta32 deletion) in resistance to HIV infection and pathogenesis in humans (Sam-
son et al. 1996; Liu et al. 1996; Hütter et al. 2009), however the degree of protection in
the CCR5-delta32 heterozygous individuals is not fully understood (Marmor et al. 2001;
Trecarichi et al. 2006).
The dominant case could be considered for a viral sensor, where a single inherited
functional copy still provides sufficient sensitivity for viral detection and control, resem-
bling that of an individual inheriting two copies, one from each parent. This type of domi-
nance is best explained by the model proposed by Kacser and Burns (1981), a metabolic-
enzymatic model for the architecture of dominance at specific loci, and has been explored
further in studies of viral resistance in plants, such as in Fraser and Loon (1986) and
Fraser (1992). The Kacser-Burns model also provides a mechanism that could in some
cases give rise to additivity.
Kacser and Burns (1981) predicted that, biochemically, for most enzymes, if there is
a 50% reduction in enzyme activity in the heterozygote of a null × functional cross, then
in most cases the resulting phenotype will resemble that in the homozygous functional
individual and the null allele would likely be characterized as operating in a “recessive”
manner. According to their model, the phenotype (or “flux”) resulting from a given en-
zymatic pathway with multiple enzymes joined by “kinetic linking” is a summation of
the change in flux due to each specific enzyme activity (“selectivity coefficient”). This
means that even a dramatic change in activity for any one enzyme in a physiological sys-
tem results in barely discernible changes in the system overall, as long as some functional
enzyme from the locus of interest is produced.
However, the authors also describe two cases where systemic flux can be partially re-
duced in the heterozygote: (1) in pathways where there are exceptionally few enzymes
involved in the system (this case is unlikely for an IFN-responsive antiviral pathway such
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as Mx1 ); and (2) in pathways where the selectivity coefficient (functional activity) of the
enzyme is very low, a case termed heterozygote “indeterminacy,” which we henceforth
equate to additivity. As further explored by Keightley (1996), dominance may be incom-
plete when less active allelic members of a series are involved in a cross with null mutants,
resulting in a more additive relationship; this seems most likely to explain our observa-
tion of CAST Mx1 effects, and the lower antiviral activity of CAST Mx1 observed in
Nürnberger et al. (2016), discussed below, appears to support this.
2.5.4 Recent work exploring CAST Mx1 antiviral deficiency
Important insights into why CAST Mx1 might be additive come from recent func-
tional studies. Nürnberger et al. (2016) engineered B6 mice expressing either the CAST-
derived or A2G-derived MX1 proteins. A2G encodes an MX1 protein sequence similar to
the NZO and PWK musculus class described in this study. CAST MX1 differs from A2G
and musculus, with corresponding amino acid changes G83R and A222V in the G domain,
which is important for enzymatic and antiviral function. Nürnberger et al. (2016) clearly
show that CAST provides intermediate protection from IAV, in their case using H7N7
(SC35M) and H5N1 (R65) viruses, and suggest that sequence changes in the CAST Mx1
allele result in reduced enzyme stability, metabolic instability, and possibly in altered
dimerization of MX1 monomers and/or changes in MX1 GTPase antiviral activity. It is
unknown whether the differences they observed would lead to changes in the dominance
of CAST and A2G Mx1 , although we might expect this to be the case given our mouse
infection results. We have verified that the same variants, G83R and A222V, differenti-
ate CAST coding sequence from NZO and PWK, as in Srivastava et al. (2009) and using
http://isvdb.unc.edu (Oreper et al. 2017), and that these are the only nonsynonymous
variants on coding transcripts of Mx1 that differentiate CAST from NZO and PWK. Al-
though we see substantial protection from weight loss in CAST mice, we see a deficiency
in the anti-viral effects (as measured by RNA-seq viral reads in infected lungs) of CAST
Mx1 on D2 and D4 post-infection (data not shown, via RNA-seq reads from Xiong et al.
2014, and transcript analysis in Ferris et al. 2013). Our work motivates further functional
studies of the MX1 protein using Mx1 transgenic mice.
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2.5.5 Mx1 -independent effects and their follow-up: new studies should leverage
CAST Mx1 additivity
A substantial proportion of heritable variance in the diallel was Mx1 -independent
(VarP[all | Mx1 ]=33.81, Table A2). This was broadly driven additive genetics and both
symmetric and asymmetric epistasis (i.e., differing by parent-of-origin) (Figure 2.5C,
Figure 2.5E). Relatedly, in our analysis of the Mx1 locus in the CC-RIX, we estimated
Mx1 -independent effects attributable to overall genome-similarity to account for 21%
of phenotypic variance. Both observations suggest the presence of additional QTL that
could be drawn out given a suitable follow-up design.
Consider the design of a second CC-RIX. Here our knowledge of differences in Mx1
dominance becomes a valuable guide: prioritizing CC F1s with one copy of musculus
Mx1 would reduce power because it would cause Mx1 -independent drivers to be masked;
however, prioritizing CC F1s with one or fewer copies of castaneus Mx1 would leave the
Mx1 -independent effects exposed and QTL underlying them more easily detected.
The inclusion of mice with a single functional Mx1 in a mapping population pro-
vides a basis for mapping loci that modify the effect of Mx1 , as well as mapping Mx1 -
independent loci controlling disease. Shin et al. (2015) showed that even the protective-
ness of Mx1 from the A2G inbred strain is conditional and depends on host genetic back-
ground. Thus, CC-RIX designs that incorporate heterozygous classes of domesticus Mx1
crossed with either CAST Mx1 or musculus Mx1 can be of substantial benefit for map-
ping novel loci affecting infection outcomes, and at least 40% of the F1 crosses in our
CC-RIX study incorporate lines which have one single copy (CAST or musculus) of Mx1 .
2.5.6 Practical use of the diallel in quantitative genetics
Diallels have a long history in quantitative genetics (Schmidt 1919; and refs in, e.g.,
Christie and Shattuck 1992; Verhoeven et al. 2006; Lenarcic et al. 2012), and have most
commonly been used as a way to assess the relative potency of different genomes with
respect to a studied trait, yielding, for example, estimates of generalized combining abil-
ity (GCA) for each strain and estimates of specific combining ability (SCA) for each F1.
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More ambitiously, they have been used to obtain an overall picture of a trait’s genetic
architecture. In many respects, this picture is clearly incomplete: even within the limited
genetic space spanned by the founders, the diallel shows only the effects of swapping in-
tact haploid genomes, with no ability to see the effects of recombination. But in other re-
spects it is comprehensive: in considering every F1 combination, one can observe evidence
for types of effects — dominance, epistasis, parent-of-origin, epistasis by parent-of-origin,
all sex-specific versions thereof — that would be hard or impossible to identify in other
settings, e.g., outbreeding populations derived from the same set of founders.
A number of studies have sought to combine the features of a diallel with those of
such derived outbred crosses to obtain picture of genetic architecture that is in some way
informed by both. These include studies that map QTL across multiple biparental (e.g.,
F2) crosses derived from a diallel or diallel-like population (e.g., Rebai and Goffinet 1993;
Xu 1998; Rebaï and Goffinet 2000; Liu and Zeng 2000; Ogut et al. 2015), and at least one
theoretical study, that of Verhoeven et al. (2006), examining the extent to which such
information can be analyzed jointly and reconciled with data from the original diallel
itself.
The goals of our study were more prospective: we use the diallel to prioritize follow-
up designs in target populations that segregate genetic material from the same set of
founders; the diallel provides evidence of heritable features that would be expected to ex-
ist in the CC, and that could be examined in more detail in a suitably designed CC-based
experiment. A comprehensive view of IAV resistance architecture, even within the genetic
space of the CC-founder genomes, would be achievable only asymptotically through count-
less, diverse studies; in this, the diallel can be seen as a compass, identifying promising
initial directions.
2.5.7 Summary
Our study demonstrates the use of diallel crosses for identifying different types of heri-
table effects that can affect host responses to IAV infection. As such, we find reproducible
effects of Mx1 alleles across first order crosses and recombined populations (despite inex-
act coordination between protocols), confirming our previous findings that the CAST Mx1
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allele exhibits an intermediate resistance phenotype against H1N1 strains of influenza
virus (Ferris et al. 2013), and also identifying novel attributes of the CAST and musculus
Mx1 alleles with respect to additivity and dominance. Despite a body of literature on the
effects of null mutations in Mx1 , the importance of allelic variation at this antiviral gene
is just beginning to be understood. A GWAS study published in 2011 found that Mx1 al-
lelic variation likely plays a role in viral disease manifestation in humans, specifically with
regards to West Nile virus infection (Bigham et al. 2011), highlighting a need for further
study of the role of natural allelic variation in Mx1 on virus infections in future research.
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CHAPTER 3
Characterization of Parent-of-Origin Effects on Influenza Virus Pathogenesis 1
3.1 Introduction
The outcome of viral infections varies within a diverse host population, and a sub-
stantial portion of variation is attributed to viral as well as host genetics. The overall
magnitude of the genetic contribution to variation in morbidity and mortality from in-
fectious diseases is substantial, even in comparison with common high-burden diseases
in humans (Sørensen et al. 1988; Petersen et al. 2005). In order to determine the extent
of host genetic effects on viral pathogenesis, a number studies have uncovered heritable
genetic effects that are important important for innate immunity, virus infection, and
the vaccine response. However, some of the contribution of heritable genetic effects are
masked by the complex patterns of inheritance, e.g. the presence of non-additive genetic
interactions, which limit the phenotypic effect depending on environmental, epigenetic
or parental context. There are a variety of non-additive effects which arise from inher-
ited alleles. These can be characterized as dominance, epistasis, or parent-of-origin ef-
fects (POE). The impact of POE, mediated by molecular imprinting of the genome on
influenza virus pathogenesis has been largely unexamined in the literature.
Genomic imprinting effects have been well established in humans and mice, and have
been reviewed extensively elsewhere (Sha 2008; Reik and Walter 2001; McGraw et al.
2013). Despite the small proportion of mammalian genes known to be imprinted, the ef-
1This chapter is based on a manuscript in preparation: Maurizio PL, Ferris MT, Linnertz C, Morrison
CR, Plante KS, Pardo-Manuel de Villena F, Valdar W† & Heise MT†. Host parent-of-origin effects mod-
ulate influenza virus severity and post-infection gene expression in the lung in F1 reciprocal cross mice.
(† = corresponding authors.). What I hope to demonstrate in this chapter is that: (1) there is a signifi-
cant effect of reciprocal cross on the host response to influenza virus in female F1 cross mice; (2) the effect
is not removed when controlling for postnatal maternal fostering, suggesting that significant reciprocal
effects on infection are likely to arise from parent-of-origin effects; and (3) imprinting contributes to dif-
ferences in gene expression in infected lungs, implicating the role of inherited epigenetic effects on causal
alleles that modify infection response phenotypes in F1 reciprocal cross mice.
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fects of imprinting on phenotypes can be profound, as has been demonstrated especially
for reproduction and development, and to some extent, for traits across the lifespan of
mice and humans. For example, early evidence for genomic imprinting in mammals in-
cluded studies examining POE on viability during mouse reproduction (McGrath and
Solter 1983a,b; Surani and Barton 1983; Barton et al. 1984), and highlighted a particu-
larly important role for imprinting in the placenta (Coan et al. 2005; Li and Sasaki 2011).
However, the extent to which imprinting affects adult disease, including infection-related
morbidity and mortality, remains unclear.
While potentially challenging in human studies, attempts have been made to use next-
generation sequencing and/or genome-wide genotyping arrays to understand POE in
family groups by quantifying total and allele-specific expression (ASE), with some suc-
cess in characterizing imprinting (Chuang et al. 2017), and mapping POE-specific effects
on baseline phenotypes (Perry et al. 2014). However, much of the recent progress in de-
tection of POE through RNA-seq has been in reciprocal F1 crosses using inbred model
organisms, as discussed below. In model organisms for influenza pathogenesis, such as in
mice, our ability to generate biological/genetic replicates, controlled treatment-response
groups, and conduct invasive phenotyping all make studies of POE more tractable than in
human populations.
Imprinting that overlaps with strain-specific differences in regulatory regions can lead
to differential total expression. Imprinting that causes allelic imbalance (AI), i.e. a bias
or asymmetry in the proportion of gene expression from parental haplotypes, may alter
the functional output of transcripts that encode for different proteins or for different non-
coding functions based on allelic variants between the parental lines at imprinted loci.
Given that imprinting effects can be measured directly from gene expression assays, a
number of studies have taken advantage of the increased availability of high-throughput
RNA-seq technologies, and advanced analysis models and software (Wang and Clark 2014;
Zou et al. 2014; Mott et al. 2014) to rigorously and comprehensively examine ASE and
AI in tissues from mice (Babak et al. 2008; Lagarrigue et al. 2013; Crowley et al. 2015;
Pinter et al. 2015).
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Importantly, in order to detect allele specific imprinting effects on our phenotype of
interest, one must vary the parental origins (epigenetic state) of imprinted regions, as well
as vary the underlying alleles (strain origin), and there must be an impact of the different
alleles under imprinting control on the overall phenotypic outcome. In our design, we vary
the strain and parental origin, and explore a variety of pathogenesis phenotypes, in con-
junction with ongoing RNA-seq analysis of expression in the lung to determine whether
there are imprinted genes and/or genes influenced by imprinting that likely contribute to
disease outcomes.
In this work, we hope to define the immunological and transcriptomic basis of POE
affecting influenza A virus pathogenesis, focusing on studies using female F1 reciprocal
cross mice. The differential expression analysis of total read counts from RNA-seq that is
presented in this chapter is preliminary, and is based on mapping to the reference B6 and
129 genomes, and will be followed-up by rigorous differential expression analysis of total
and allele-specific counts, based on mapping to B6 and 129 transcriptomes. Despite dif-
ferences in some of the clinical phenotypes of influenza virus in humans and mice, many
of the pathological and inflammatory signatures of disease in the lung are reproduced in
mice,and a recent study, using transcriptome analysis, showed that the human gene ex-
pression signature, in the blood, following influenza virus infection is reproduced in CC
founders (Elbahesh and Schughart 2016). Thus, the transcriptional differences that are
measured in cohorts of mice differing in their host pathology could help elucidate causal
gene networks that are important for the human host response to influenza infection. Our
study focuses on gene expression in the lung, which is the primary site of viral replication
and severe host pathology for standard influenza infections in mice.
In summary, in this chapter, I hope to show that: (1) pathological outcomes in female
F1 reciprocal cross mice infected with influenza A virus (H1N1 PR8), including weight
loss and lung histopathology, differ significantly depending on the parental origin of in-
herited genomes; (2) these effects are not removed after accounting for maternal fostering
effects; and (3) gene expression profiles in the lung at 4 days post-infection reveal a num-
ber of immune-related genes that differ significantly in total gene expression, suggesting a
causal role for genome imprinting for modifying disease progression in hybrid mice. Fur-
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Table 3.1 Table of inbred strains and reciprocal F1 cross lines used in the influenza POE
study. Cross-fostering took place with dams from the reciprocal genotype as described in
the Experimental Methods.
Maternal Strain Paternal Strain Abbreviation
(long) (short)
1 C57BL/6J × 129S1/SvImJ B6 × 129 BC
2 129S1/SvImJ × C57BL/6J 129 × B6 CB
3 C57BL/6J × 129S1/SvImJ (cross-fostered) B6 × 129[XF] BC[XF]
4 129S1/SvImJ × C57BL/6J (cross-fostered) 129 × B6[XF] CB[XF]
5 C57BL/6J × WSB/EiJ B6 × WSB BH
6 WSB/EiJ × C57BL/6J WSB × B6 HB
7 C57BL/6NJ × 129S1/SvImJ B6N × 129 NC
8 129S1/SvImJ × C57BL/6NJ 129 × B6N CN
thermore, experiments with additional strains suggest that POE on infection, though
subtle, may be pervasive, partially sex-dependent, and that POE on variance could play a
role in the observations of phenotypic differences between reciprocal lines.
3.2 Experimental Materials and Methods
Inbred mouse sourcing. Male and female mice from four standard laboratory in-
bred strains we ordered from the Jackson Laboratory (Jax) and directly used as parents
to breed F1 reciprocal cross mice: C57BL/6J (B6; Jax Stock No. #000664); 129S1/SvImJ
(129; #002448), WSB/EiJ (WSB; #001145) and C57BL/6NJ (B6N; #005304).
The names of the reciprocal F1 lines, and abbreviations, are given in Table 3.1. The
first four sets of crosses are the primary focus of this chapter, and the remaining four
represent crosses that were used experimentally to explore the extent of POE on host
response to IAV infection across genetic backgrounds. The focus of our analysis was on
effects observed in females, since female F1 reciprocals, unlike male F1’s, have genetically
identical sex chromosomes as well as autosomes, simplifying our reciprocal contrast, and
because of the generally more severe infection pathology experienced in females, which
provides additional phenotypic breadth to detect differences in pathology. However, we
also infected males from the corresponding genotypes, and provide some limited analysis
of sex and sex-interaction effects in the discussion.
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Mouse breeding. A basic overview of the breeding protocol and experimental de-
sign is shown in Figure 3.2. In short, adult B6 and 129 mice were intercrossed in both
directions in order to produce reciprocal F1 cross offspring. We used several adult individ-
uals from each inbred strain and sex as parents, to ensure that peculiar effects of specific
dams or sires would not confound our analysis. Mice were mated in cages as triads, i.e.
one male B6 with two female 129, and pups were reared in cages with multiple dams,
i.e. two female 129’s, to average out specific individual dam effects as much as possible
(this was not the case in the batch with cross-fostered cages, as those pups were reared
with just one dam). Litters were weaned at ∼ 21 days of age. On the date of weaning, we
recorded the body mass of pups, to be able to account for reciprocal effects on early age
body weight, as a baseline phenotype that may be correlated with maternal or litter size
effects.
Environmental and social effects: co-housing. In order to control for environ-
mental and social effects on infection outcomes, we co-weaned age- and sex-matched
BC and CB mice (born approx. 0-3 days apart) into the same cages, based on pseu-
dorandom assignment, and set them up where possible in a balanced design based on
parentage, i.e. ∼2 BC mice and ∼2 CB mice per cage. The majority of cages were set
up with 4 animals per cage, to control for potential density-dependent housing effects
on F1 offspring physiology (Arndt et al. 2009) and subsequent infection response. Recip-
rocals remained co-housed throughout the course of infection. Mice were maintained
under standard specific pathogen-free conditions, with cycles of 12 h light, 12h dark,
and food and water available ad libitum. All breeding and infection experiments were
carried out in full compliance with the Guide for the Care and Use of Laboratory Ani-
mals (Institute of Laboratory Animal Resources, National Research Council, 1996, https:
//www.ncbi.nlm.nih.gov/books/NBK232589/). All animal protocols used in this study
were pre-approved by the Institutional Animal Care and Use Committee of UNC-Chapel
Hill.
Mouse infections. For infections including mock treatments, mouse cages were ran-
domly assigned to treatment or control prior to the date of infection. On the date of
treatment, day 0 (D0), we anesthetized mice with isoflurane and subsequently inoculated
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Figure 3.1 Experimental timeline for detecting reciprocal effects in B6×129 F1 mice.
them intranasally with diluent (phosphobuffered saline; PBS) as a mock control, or 500
plaque-forming units (PFU) of IAV PR8 (mouse-adapted H1N1 A/Puerto Rico/8/1934)
as a treatment. Body mass was recorded on D0 and once on every subsequent day p.i.,
through the assay date (Figure 3.1). We treated a total of 138 female mice (135 males)
across 6 batches, including 77 BC and 61 CB females (76 BC and 59 CB males). Of these,
28 females were assayed only through D3 p.i. (16 BC and 12 CB; one batch), 79 females
were assayed only through D4 p.i. (38 BC and 41 CB; four batches), and 31 were assayed
only through D7 p.i. (23 BC and 8 CB; one batch). Four batches were included as part
of the phenotyping phase labeled “discovery”, and a subsequent two batches (D4 assayed,
including one naturally fostered and one cross-fostered as described below) were part of
the follow-up phenotyping phase used for validation and RNA-seq.
Discovery: D4 p.i. weight loss. For the discovery study for D4 p.i. weight loss
response, to determine whether reciprocal cross effects significantly affected IAV response,
we use the D4 weights for animals from three batches assayed through D4 and D7 p.i. (39
BC and 24 CB female mice; 32 BC and 24 CB male mice; total 119 mice).
Discovery: D3 and D7 p.i. titer and pathology. For the discovery study for D3
and D7 post-infection pathology, to determine whether reciprocal cross had a significant
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effect on IAV disease, as measured by viral burden and host immunopathology in the
lung, at earlier and later time points (D3 and D7 p.i.), we infected (mock and PR8) 16
BC and 12 CB female mice (18 BC and 13 CB male) across 1 batch through D3 p.i., and
we infected (no mocks) 23 BC and 8 CB female mice (16 BC and 8 CB male) across 1
batch through D7 p.i.
Histological analysis. Mice were anesthized using isoflurane, and after humane
euthanasia, mouse lungs were harvested and lung lobes were sectioned for downstream
analysis, with the following assignments: RNA-isolation (left lung, sagittal cut distal),
histology (left lung, saggittal cut proximal), and viral titer (right lung, top lobe). At the
respective harvest timepoints, once the lung was extracted for each mouse, substantial
gross hemorrhage of the lung was noted by visual inspection (present, not present). Sec-
tions to be used for in depth histological assessment were isolated and immediatedly and
fixed in 4% paraformaldehyde (PFA) in PBS at pH 7.3, and then stored for ≥ 1 week at
4°C. The tissues were submitted to the Animal Histopathology & Laboratory Medicine
Core Facility at the University of North Carolina to be embedded in paraffin, sectioned
into (5 µm thick) sections, and stained with hemotoxylin and eosin (H&E). Lung sections
were visualized on a Motic BA400 Scope, with 20× magnification using bright field light
microscopy, and a single expert mouse pathologist scored the slides, blindly.
Histology scoring: D3 and D7. Slides were scored based on seven criteria: airway
damage & debris, airway cuffing, vascular cuffing, alveolar inflammation, edema, overall
pathology, and hemorrhage.
Histology scoring: D4. Slides from D4 post-infection were scored based on an ex-
panded set of 12 criteria: airway debris, airway denuding, vascular cuffing, airway cuffing,
alveolar inflammation, pulmonary edema, hyalin membrane, lymphocytes, neutrophils,
eosinophils, macrophages, and exudate. We note that neutrophil and eosinophil scores are
highly correlated, and may not be truly independent measures of histological phenotypes
without further staining and analysis.
The descriptive scoring critera used for D3, D4, and D7, are coded as follows: pathol-
ogy scores (all): none (0), very mild (1-2), mild (3-4), moderate (5-6), severe (7-8), and











Wean and co-house reciprocal F1s at ~21 days
Infect with IAV (or mock) at 8-12 weeks old
- Weight loss (all days; both sexes)
- Histopathology (D3, D4, D7; both sexes)
- Viral titer (D3 and D7; both sexes)
- Gene expression (D4; females only)
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Figure 3.2 Design for detecting reciprocal effects in B6×129 F1 mice.
scores, the following percentages and counts were as guidelines used to calibrate scores
with the pathology score key above: debris score (airway debris): < 25% (mild), ∼ 50%
(moderate), > 50% (severe); cuffing scores (vascular cuffing and airway cuffing): 1-2 cells
thick (mild), 3-5 cells thick (moderate), 6+ cells thick (severe). Cellular scores (lympho-
cytes, neutrophils, eosinophils, and macrophages) ranged from 0 to 5 rather than 0 to
10.
Quantifying viral load. We determined viral burden in reciprocal cross mice using
lung sections based on six, 10-fold serial dilutions of virus infected samples, followed by
immunostaining (anti-NP) of virus foci grown on Madin-Darby canine kidney (MDCK)
epithelial cells. Cells were overlaid with 1.75% CMC in assay media, supplemented with
1.0 ug/mL TPCK-treated trypsin, and incubated approximately 72 hours prior to remov-
ing CMC, washing two times with PBS, and fixing with a mixture of methanol:acetone,




Switch inbred dams within ~0-1 day post-birth of litters







Wean and co-house reciprocal F1s at ~21 days
Infect with IAV (or mock) at 8-12 weeks old







Figure 3.3 Design for cross-fostering to control for postnatal maternal effects in B6×129
F1 mice.
with PBS, and immunostained with anti-IAV (CA04) H1N1 NP (clone 2F4, BEI NR19868),
followed by HRP-conjugated antimouse IgG, and Vector VIP substrate for visualization.
Maternal effects: cross-fostering. Maternal effects are a type of indirect genetic
effect that can confound studies of genetic effects in studies of offspring from bi- or multi-
parental crosses (Ashbrook and Hager 2017). To control for postnatal maternal (dam)
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fostering effects, we include a batch of cross-fostered animals. We co-housed parental
mice, attempting to synchronize mating schedules for BC and CB matings, and shortly
after birth of F1 litters (∼ 0− 1 days post birth), reciprocal dams were exchanged between
cages where litters were born within ∼ 1 day of each other; for instance, the B6 mother
from a cage housing a litter of newborn BC pups is exchanged with a 129 mother from a
cage housing a litter of newborn CB pups. To control for postnatal paternal (sire) effects,
pups from both BC and CB were housed in the absence of sires. A basic overview of our
cross-fostering experimental design is shown below in Figure 3.3.
RNA-Seq Overview: D4 p.i. For the RNA sequencing study, to determine whether
reciprocal cross has a significant effect on IAV response, as measured by weight loss, host
immunopathology in the lung, and total gene expression in the lung, on D4 p.i., we in-
fected (mock and PR8) female animals (nmock = 7; nflu = 38; comprised of 22 BC and
25 CB female mice) across 2 batches (5 cages per batch), with batching described below.
Males were also infected (26 BC and 22 CB), and assayed similarly for weight loss and
lung histopathology, but their lung tissues were not submitted for RNA-sequencing.
RNA-seq: isolation and quality control. The experimental layout for the RNA-
seq is shown in Figure 3.4. We extracted RNA from 45 samples using Trizol (Life Tech-
nologies, Carlsbad, CA) and purified extracted RNA using DNase I digestion and the
Qiagen RNeasy kit (Netherlands). We did not use polyA+ purification, as we intended to
detect expression differences on noncoding RNAs and other non-messenger RNAs, which
lack polyA tails. We obtained scores for RNA integrity (RIN) using an Agilent Bioana-
lyzer. Two samples were excluded from downstream analysis due to having RIN values
less than 7, which indicated lower than desirable RNA integrity for RNA-seq, resulting in
a total of two batches (batch A n=23; batch B n=22), with mock and infected samples
included in each. We barcoded samples, with each sample obtaining two different bar-
codes, to reduce barcode sequence-dependent biases in read coverage. One sample was
run in triplicate, in order to control for within sample variability due to barcoding, library
preparation, and sequencing.
RNA-seq: library preparation and run. Library preparation for our samples
was performed at the University of North Carolina (UNC) High-Throughput Sequencing
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Facility (HTSF). We conducted stranded, phased, 100bp paired-end RNA-seq on total
RNA, using a rapid run on an Illumina HiSeq 2500 next-generation sequencing platform.
Each sample was run in both sequencing lanes of a single flow cell.
Additional viral strains, host substrains, and timepoints. The majority of our
focus in this chapter is on D4 post-infection timepoints using the virus strain influenza A
(H1N1, PR8). In order to understand the extent to which reciprocal effects are pervasive
across viruses strains, we included additional batches infected with a different strain of in-
fluenza A virus (H1N1, CA04) at a dose of 5,000 PFU in a limited set of reciprocal cross
animals (n=31). In order to determine whether longer-term reciprocal effects, beyond the
response on D0 to D7, were observable, we performed a limited set of studies out to D10
and and D15. We also examined reciprocal cross effects in crosses listed in rows 5-8 of
Table 3.1.
Experimental Rigor for Isolation of Parent-of-Origin Effects. Throughout
the results, we describe our observed effects on infection outcome as “recipirocal effects”.
These effects may arise from several sources, including: (1) maternal effects, including pre-
natal effects, dependent on maternal genotype alone; (2) maternal fostering effects, depen-
dent on the maternal genotype alone; (3) effects of the environment and other covariates,
including investigator handling, litter size, cage density, body weight, social effects, and
microbiota; and (4) POE, depenent on F1 offspring genotype alone. Reciprocal effects
that can effectively rule out sources (1) through (3) are likely to be true POE. Effects
due to (1) are technically challenging to control for, and beyond the scope of this work.
As described above, we have used postnatal maternal cross-fostering as an experimental
technique to control for maternal fostering effects, (2). We have additionally designed our
experimental protocols throughout in such a way as to reduce the impact of effects in (3).
3.3 Statistical Models and Methods
Power simulation. In order to determine the number of animals per cross that are
required to detect a reciprocal/POE on post-infection weight loss, we used data on ef-
fect sizes for asymmetric reciprocal cross effects in a diallel, estimated from previous
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III. Characterizing parent-of-origin effects on infection Background



















= B6 ⨉ 129 mouse
= 129 ⨉ B6 mouse
= B6 ⨉ 129 [XF] mouse





Maurizio, P.L. (UNC-Chapel Hill) Host Response to Influenza January 9th, 2018 38 / 1
Figure 3.4 Experimental layout for interrogating reciprocal effects on infection in F1
crosses of B6 and 129 inbred mice. The housing of mice (post-wean) is shown schemati-
cally, with each square representing a distinct social environment of mouse cage. Cages
are composed of 3-5 individual female mice, indicated by the colored circles, with parental
genotypes indicated by color. Mice were weaned into cages at ∼3 weeks of age, and
treated at 8-12 weeks old with mock or influenza (PR8) infection. There were a total
of 20 BC and 25 CB mice, with about half of the mice cross-fostered (22 of 45, as indi-
cated by the “×” symbol within colored circles) with the reciprocal dam genotype (right
two columns), from approx. 0 to 1 days post-birth until weaning, to control for postnatal
maternal fostering effects.
work (Maurizio et al. 2017), to determine the approximate number of mice that would
be required to detect a reciprocal effect in a new F1 population of infected mice alone
(Figure 3.6). We obtained posterior predictive diallel effect estimates (mean and vari-
ance) from the previous study, and simulated predictive reciprocal F1 cross mice pheno-
types across a range of balanced population sizes, and asked what number of mice of a
given sex would be needed, per reciprocal group, to detect a reciprocal effect on weight
loss at a power of β = 1 − α = 0.8, using the simple model 1 from table Table 3.2 below
(excluding batch).
Detecting reciprocal effects: weight loss, viral load, and histopathology. We
use a linear model using the package lm in R (R Core Team 2017) to model our pheno-
type, and subsequently assess significance of factors using analysis of variance via the
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Table 3.2 Linear models for detecting reciprocal effects on phe-
notypes in F1 cross mice. Mock animals were not included in this
analysis, but were observed for signficant reciprocal and sex differ-
ences independently. All models contain an overall intercept (not
shown).
Number Model
1 pct ∼ batch + cross + sex + cross:sex
2 pct ∼ cross + sex + cross:sex
3 pct ∼ batch + cross + sex
4 pct ∼ batch + cross
5 pct ∼ batch + sex
anova package in R. In particular, we are interested in detecting weight loss effects on day
4 p.i. with influenza A virus H1N1 (PR8), as mice at this timepoint are generally close
to peak weight loss and death due to infection is minimal. Viral load is approximately
log-normally distributed. We used the same method as in the weight loss modeling, with
log(base=10)-transformed viral load data to improve the normality of the phenotype and
residuals.We use a generalized linear mixed model, i.e. proportional odds via the polr
function from the MASS package in R (Venables and Ripley 2002), to detect reciprocal
effects on IAV-induced histopathology. Since histopathology phenotypes are ordinal (or
in some cases binary), a generalized linear model framework is necessary to handle the
assumptions in the model. We otherwise construct the model similar to that used above
for weight loss, but applied to the respective subset of animals and timepoints.
RNA-seq: analysis. The RNA-seq analysis, conducted by the Systems Genetics
Core in the Department of Genetics at UNC, is ongoing, with additional results forth-
coming. Briefly, fastq files were obtained from RNA-seq samples, and were subjected to
quality control using FastQC (ver 0.11.5), aligned using STAR (ver 2.5.3a), duplicated
reads marked using Picard (ver 2.2.4), and BAM files constructed prior to analysis of dif-
ferential expression (DE) of total gene counts using summarizeOverlaps in the R package
DESeq2 (ver 1.16.1). Ongoing analysis using Kallisto (ver 0.43.1) and DESeq2 / Sleuth,
and exploring transcriptome-based mapping to obtain differential allelic expression (DAE)
is underway. The workflow is summarized in Figure 3.5. The following models were used

























Figure 3.5 Mapping and analysis workflow for RNA-seq data. The data is aligned using
STAR, deduplicated with Picard, and total expression is analyzed with DESeq2. The
Kallisto-based transcript abundance analysis is ongoing.
Table 3.3 Data and models for DESeq2 (Love et al., 2014, Genome Biology) analysis of
total reads in RNA-seq in the influenza POE study.
Number Model Samples
1 y ∼ cross + treat + cross:treat all
2 y ∼ cross mock-treated only
3 y ∼ cross influenza-infected only
3.4 Results
Prior study suggested asymmetric F1 effects. In prior work (Maurizio et al.
2017) (Chapter 2), we observed a signal of asymmetric effects in multiple pairs of recipro-
cal F1 mice from an 8×8 diallel cross of CC founder mice infected with influenza A virus
(PR8), at D4 p.i., including evidence from variance projections (VarPs), model inclusion
probabilities (MIPs), and asymmetric epistatic effect contributions (data not shown). To
confirm these findings, and determine whether asymmetric effects were reproducible in
carefully controlled setting, we focused our analysis on a more limited reciprocal cross,
namely B×C and C×B. We conducted a power simulation based on the magnitude of
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Power Simulation!
Figure 3.6 Power simulation for the influenza POE study. The red and blue lines indi-
cate the relative power (x-axis; proportion of times significant effects were detectable in
simulations) across varying numbers of female and male mice (y-axis), respectively, pro-
viding a way of estimating the number of animals required to observe a significant effect
based on the chosen level of power.
predictive asymmetric epistatic effects obtained from the diallel study, which indicated
that approximately 40 BC and 40 CB mice would be required to be bred, within each
given sex, to be able to detect a reciprocal effect of a size comparable to that previously
observed.
Discovery of Reciprocal Effects. In brief, we infected BC and CB mice with 500
pfu of IAV, across four experimental batches. We observed a significant difference in
weight loss based on reciprocal effects, at D1 p.i., and D4 p.i., and additionally a trend,
from D3 through D7 post-infection, for CB mice to have delayed kinetics of weight loss
post-infection compared with their counterpart BC mice (Figure 3.7). We additionally
observed a significant effect of reciprocal cross on D7 airway damage and debris, but no
reciprocal effects at other timepoints. No reciprocal effects were observed on viral load.
The results are decribed in more detail below.
Weight loss. To obtain the animal numbers necessary for detection of reciprocal
effects, as indicated by our power analysis, we had to spread our assays across several ex-
perimental batches. To determine the importance of experiment-to-experiment variability
on IAV-induced weight loss, we examined whether there was a significant effect of batch
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Figure 3.7 Reciprocal effects on influenza-induced weight loss in F1 reciprocal crosses
of B6 and 129 mice. In our “discovery” experiment, we observed a significant effect of
reciprocal cross on D4 post-infection weight loss. Grey coloring indicates phenotypes for
mice that are BC, and pink indicates phenotypes for mice that are CB.
on D1 through D4 p.i. by doing an analysis of variance (ANOVA) on models 1 and 2 in
Table 3.2. We found a significant effect at all p.i. timepoints (p = 1.057 × 10−6, 4.316 ×
10−4, 7.518 × 10−3, and 3.946 × 10−4, for D1 through D4 respectively). D7 assayed animals
came from a single batch, and so batch effect analysis of IAV-induced weight loss was not
possible at timepoints D5, D6, and D7, which were thus excluded from this analysis.
We then asked whether there was a significant sex-by-reciprocal effect on IAV-induced
weight loss, by an ANOVA comparing models 1 and 3 for D1 through D7 p.i. (In this
and subsequent analyses, linear models for D5 through D7 were analagous to those for
D1 through D4, however they excluded the batch term.) We did not find any significant
effects at D1 through D7. To determine whether there was a significant effect of sex, we
compared models 1 and 4 (and models 3 and 4, not shown, but with similar effect) by
ANOVA, and found that there is a significant effect on D3 through D7 (p = 2.186 × 10−7,
3.446× 10−7, 9.151× 10−7, 1.376× 10−3 and 2.189× 10−3, respectively). Overall, females were
more susceptible to weight loss compared with males, when given the same dose of virus
in the same experimental conditions, and experienced increased disparity in weight loss
96
































































Figure 3.8 Reciprocal effects on influenza-induced histopathology. Airway damage and
debris scores are shown for a total of 24 F1 reciprocal cross mice (16 BC and 8 CB) on
D7 p.i. with IAV PR8.
relative to males, ranging from (βsex = 2.3152) about 2.3% more weight lost in females
on D3 p.i. and gradually increasing to 8.7% additional weight lost (βsex = 8.73130) on D7
p.i. Note: significant effects were observed for intercepts at all time points, but are not
reported here.
To determine whether there was a significant effect of reciprocal cross on IAV-induced
weight loss, our primary question of interest in this stage of the study, we used an ANOVA
comparing models 1 and 5 (also models 4 and 5, with similar results, not shown), and
found that there was a significant effect of reciprocal cross on D1 (p = 6.546 × 10−3) and
on D4 (p = 8.213 × 10−4). The CB cross mice were slightly more resistant to weight loss
at D1 p.i. compared with BC, with an estimated effect (βCB = 0.8829) indicating that CB
retained about 0.9% more percent starting weight compared with BC, after controlling for
batch and sex. We note that D1 p.i. is typically too early to detect IAV-induced weight





















































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.9 Cross-fostering does not remove reciprocal effects on influenza-induced weight
loss. Reciprocal effects on influenza-induced weight loss in F1 reciprocal crosses of B6 and
129 mice (natively-fostered or cross-fostered). Mock animals not shown.
vs BC mice at this timepoint post-infection. On D4, CB cross mice showed additional
resistance to weight loss as well (βCB = 2.8674), resulting in about 2.9% more starting
weight retained compared with BC animals. These significant effects were not removed by
including mock animals in the model (analysis not shown).
Histopathlogy. A number of factors appear to contribute to, or correlate with, se-
vere influenza disease in mice, including weight loss, immunopathology and gene expres-
sion in the lung. Fatal human disease due to 1918 pandemic H1N1 is characterized by
severe host immunopathology in the lung, including edema and fast kinetics of neutrophil
and macrophage infiltration into the lung (Perrone et al. 2008). Given the demonstrated
relevance of lung histopathology in human clinical outcomes and experimental outcomes
in mice in response to severe influenza infection, we decided to measure histopathology
phenotypes using blinded, expert pathologist scoring.
To ask whether there was a significant effect of reciprocal cross on IAV-induced histopathol-
ogy, we used an anova on models 1 and 5, fit with the proportional odds function in the
MASS package in R, on D3, D4, and D7 p.i. Notably, we did not observe any signifi-












Figure 3.10 Sample counts for RNA-seq study based on genotype and treatment.
or 4 post infection. However, at day 7 post infection, we observed a significant effect of
reciprocal cross, with CB mice exhibiting increased levels of airway damage and debris
compared with BC animals (Figure 3.8).
No reciprocal effects on viral load. Since the difference in virus-induced disease
can be mediated by alterations in virus-induced pathology/inflammation, viral load, or
both (Ferris et al. 2013), we evaluated viral loads within the lungs of both CB and BC
crosses. To ask whether there was a significant effect of reciprocal cross on IAV-induced
viral load, we used an ANOVA on models 4 and 5 (no multiple batching at each time
point) for log-transformed viral load data on D3 and D7 p.i. We observed no differences
in viral load between the two crosses (data not shown), which suggests that the weight
loss and histopathology effects in the B×C or C×B crosses are not due to alterations in
viral load within the lungs.
Cross-fostering does not remove reciprocal effects on infection. Cross-fostering
has been used as a technique to modify offspring susceptibility to virus-induced disease,
presumably by transfer of maternal antibody (Lemke et al. 2004). In addition to antibod-
ies, maternal care may substantially affect immune development. It is likely, therefore,
that a number of innate immune characteristics important for the acute response to virus
challenge, and it is our goal to control for these by using experimental maternal cross-
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Figure 3.11 Dispersion plot for RNA-seq total expression data in influenza reciprocal
effect study.
fostering (henceforth, cross-fostering) to remove these effects and distinguish them from
the POE we are most interested in understanding. Having confirmed that there are re-
ciprocal effects on weight loss and histopathology in the discovery phase, for BC and CB
mice, we then bred BC and CB mice for which we could perform IAV infections through
D4 p.i., for which we could measure weight loss and histopathology. We hypothesized
that maternal effects (postnatal, pre-weaning) might be responsible for the significant
differences in virus-induced disease which we observed, and wanted to test whether we
could remove the weight loss effect by reciprocally exchanging parental dams at birth. We
thus examined IAV-induced weight loss in a batch of natively-fostered mice (BC and CB)
and cross-fostered mice (BC[XF] and CB[XF]), to determine if reciprocal effects would be
ablated due to the reciprocal fostering by counterpart dams.
We found that there was a significant effect of reciprocal cross on IAV-induced weight
loss in cross-fostered mice, and that the direction of the effect remained consistent after
cross-fostering, suggesting that the reciprocal effect was independent of whether F1 cross
mice were fostered by their natural dams (BC mice fostered by BB dam; CB mice fos-
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tered by CC dam) or by reciprocal dams (BC mice fostered by CC dam; CB mice fostered
by BB dam) (Figure 3.9).
RNA-seq analysis (preliminary). What follows is a preliminary analysis of the
RNA-seq experiment that was run on 45 samples of female BC and CB mice (Figure 3.10)
as a method for identifying imprinted genes underlying POE on IAV-induced host pathol-
ogy. Gene expression is regulated both by genetic regulatory factors (promoters, en-
hancers, and their allelic variants, etc.) as well as epigenetic regulatory factors (histone
modifications, transcription factors, DNA methylation, etc.). Transgenerational epigenetic
effects, are transmissible from parent to offspring, and a subset of those effects arising
from molecular imprinting of the genome, are sustained in such a way that they regulate
the gene expression of offspring in a parent-of-origin dependent manner. Since gene ex-
pression in the lung, which is the primary site of viral replication in murine IAV (PR8)
intranasal challenge, would likely reflect important differences in the host response to
the virus, and phenotypic differences between reciprocals would likely be mediated by
asymmetric gene expression in this compartment, we hypothesized that we could identify
imprinted gene expression in the lung (asymmetric total or allelic expression between re-
ciprocal crosses) through RNA-seq of total RNA isolated from lung tissue sections. We
thus conducted an RNA-seq expression study in two batches (natively- and reciprocally-
fostered) of mock- and PR8-infected mice, and used DESeq2 (Love et al. 2014) to analyze
total gene expression differences based on treatment (mock vs. infected) and reciprocal
cross (BC vs. CB).
RNA-seq: Mapping. We hypothesized that we would observe differences in gene ex-
pression between BC and CB mice in the lung might, which may underlie the differences
in weight loss and lung pathology that we observed in BC and CB mice, and we would
observe differential expression of imprinted genes. In order to follow up on this hypothe-
sis, we present preliminary data on total expression differences in 45 female (BC and CB)
mice at day 4 post-infection, in both mock (n=7) and influenza-infected (n=39) animals,
based on total RNA-seq analysis the mouse lung at 4 days post IAV infection.
RNA-seq: Dispersion plot. The dispersion, as a function of normalized gene count,































































Figure 3.12 Principal components plot of gene expression in F1 reciprocal cross animals,
BxC and CxB, post-infection. Triangles indicate mocks, circles are flu-infected. Grey
color indicates BxC, and salmon color indicates CxB.
imately 1 × 10−1 to 1 × 105. Across that range, there is a diversity of dispersion observed.
The black dots indicate the gene-level estimates of dispersion, prior to model-based ad-
justment. The red line indicates the model fit of the raw dispersion estimates for each
gene, and the blue dots represent the final dispersion. The black dots in the lower left
hand of the figure indicate dispersion estimates which are of low confidence, due to low
count/representation in our data set, and thus are “shrunk” toward the fitted line. Ap-
parent outlier (blue open circles) dispersion estimates are presented above, and are not
shrunk, as this may increase false positive rates for genes with real biological dispersion
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Figure 3.13 Volcano plot of log p−value vs. log fold change in F1 reciprocal cross ani-
mals. Red color indicates genes which were identified by DESeq2 analysis as significantly
differentially expressed between mock and infected.
in mean expression. The normalized means and adjusted dispersion estimates are then
modeled using DESeq2 to identify genes that significantly differ in their total expression
based on factors included in the linear mixed model we specified earlier.
RNA-seq: PCA plot of expression. We find that, looking exclusively at infected
samples, 54% of the variance in gene expression is explained by PC1 and PC2. A princi-
pal components plot of total gene expression in infected animals shows that, in general,
there does not seem to be a difference in PC1 and PC2 values based on reciprocal cross.
However, we observe that only CB animals take on values of PC1 < −13, and only BC

























































Figure 3.14 Normalized gene-level counts for top differentially expressed gene
subtle difference in overall gene expression based on reciprocal effects. Further PCA anal-
ysis on total expression levels can be used to determine the extent to which reciprocal
cross is differentiated by the most substantialy PC’s.
RNA-seq: Joint analysis. In order to verify that our differential expression anal-
ysis identifies known modulators of the host infection response, we examined the most
significant differentially expressed genes, comparing infecteds vs. mocks. The differential
expression, by normalized gene count, of the top DE gene, Oasl2 (2′-5′ oligoadenylate
synthetase-like 2, Ensembl ID: ENSMUSG00000029561, chr5: 114896936-114912234), is
shown in Figure 3.14, showing more than a 10-fold increase in expression in the infected
samples in comparison with the mock samples. The expression of this gene did not ap-
















































































































Figure 3.15 Genome track for top differentially expressed gene, Oasl2, in joint mock and
infected DESeq2 analysis.
We found that there are many hundreds of genes which are differentially expressed in
the lung in these mice, using the joint model, for which all are confidently attributable
to differences in infected vs. mock animals, rather than reciprocal cross, the effect of
which appears to be hidden or obscured due to the dramatic effect of treatment on gene
expression.Oasl2, lies in a region on chr5 (Figure 3.15) with a number of differentially
expressed genes identified by DESeq2 in this study (gene list not shown). The analy-
sis of this data is ongoing, however our main focus is on identifying genes differentially
expressed due to reciprocal cross direction, so we present below the results from our
treatment-stratified DESeq2 analysis, which reveals a number of potentially imprinted
genes underlying phenotypic differences in BC and CB.
RNA-seq: Stratified analysis. In order to factor out the effect of infection on dif-
ferential gene regulation, we decided to analyze differential total expression, based on
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reciprocal cross, and stratified by treatment group—mock samples (n=7) and infected
samples (n=39). We found that a handful of genes (n=2 for mock, and n=10 for in-
fected) appear pass our significance threshold for differing significantly based on parent-
of-origin, matching reasonable expectations for post-treatment detectable differences in
total gene expression between genetically identical but epigenetically distinct individ-
uals. Our results include three protein coding genes, three gene segments, two pseudo-
genes, two unclassified non-coding RNA genes, one lincRNA gene, and one predicted gene
(Table 3.4 and Table 3.5). Among these are the immune-related genes, Ighv8-12 (chr12)
and Igkv15-103 (chr6) in mock animals, and, in infected animals, an additional Ig heavy
chain gene (Ighv5-6 ) (chr12), and genes known to be impacted by molecular imprinting,
e.g. the lncRNA A230057D06Rik (chr7), and Rasgrf1 (chr9).
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Table 3.4 Table of stratified differential expression results in the influenza POE study (mock only).
gene name description chr. start end Ensembl ID gene type
1 Ighv8-12 Immunoglobulin heavy chain 12 115647945 115648387 ENSMUSG00000062479 segment
variable V8-12
2 Igkv15-103 Immunoglobulin kappa chain 6 68437440 68437925 ENSMUSG00000076523 segment
variable 15-103
Table 3.5 Table of stratified differential expression results in the influenza POE study (influenza-infected only).
gene name description chr. start end Ensembl ID gene type
1 A230057D06Rik RIKEN cDNA A230057D06 7 61705850 61927574 ENSMUSG00000108824 lincRNA
2 Gm3257 predicted gene 3257 7 61938237 61938911 ENSMUSG00000109178 pseudogene
3 A330076H08Rik RIKEN cDNA A330076H08 7 61930137 61982358 ENSMUSG00000109321 unclassified ncRNA
a.k.a. Mirh1
4 Gm19032 predicted gene, 19032 7 61882972 61883563 ENSMUSG00000109465 predicted
5 Pcdhb7 protocadherin beta 7 18 37341702 37345202 ENSMUSG00000045062 protein coding
6 Gm38143 predicted gene, 38143 7 73948423 73958042 ENSMUSG00000102384 unclassified ncRNA
7 Ighv5-6 Immunoglobulin heavy 12 113625506 113625956 ENSMUSG00000094951 segment
variable 5-6
8 Zfp264 zinc finger protein 264 7 6977246 6991087 ENSMUSG00000109176 pseudogene
9 Rasgrf1 RAS protein-specific guanine 9 89909908 90026977 ENSMUSG00000032356 protein coding
nucleotide-releasing factor 1
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Figure 3.16 Suggestive viral strain-dependence of reciprocal effect in BC vs CB F1 cross
mice.
Reciprocal effects may be dependent on viral strain. We were able to show
replicability of reciprocal effects on influenza pathogenesis in separate batches BC and
CB mice. However, we additionally wanted to know whether these effects would be easily
detected in infection studies with heterologous strain of IAV, namely CA04, which is
an H1N1 IAV strain that was isolated from a clinical sample obtained during the 2009
human IAV pandemic (Itoh et al. 2009). Although our sample size was small (BC n=7;
CB n=11), we observed what appeared to be a reversal in the rank kinetics of weight
loss based on parent-of-origin, whereby CB mice seemed to lose weight earlier p.i. than
BC mice, which differed from our weight loss result using PR8 (Figure 3.16). Exploring
virus-specific interactions with host genetic effects on immune pathogenesis is an area of
ongoing interest.
Mouse substrain-dependent reciprocal effects: suggestive effect on variance.
We wanted to determine the sensitivity of our reciprocal effect phenotype to “subtle” ge-
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netic change in the host. We decided to use a closely related strain, B6N, to determine
whether the reciprocal effect we observed was stable in the presence of host genetic vari-
ants introduced by genetic drift (Kumar et al. 2013). B6N is a substrain of B6. In 1951,
the B6N strain was separated from the inbred B6 strain at Jax at generation F32, and
maintained at the NIH. After several rounds of crossing with sibling and parents, and
several rounds of cryopreservation and thaw, frozen embryos of B6N were sent back to
Jax. Genetic differences between the B6 and B6N strain have been explored elsewhere,
and they include more than 1 × 104 SNPs, as well as over 2 × 104 indels and several hun-
dred structural variants (Keane et al. 2011; Simon et al. 2013; Fontaine and Davis 2016;
Srivastava et al. 2017).
We bred 8-12 week old B6N×129 (NC, n=10) and 129×B6N (CN, n=7) F1 reciprocal
cross mice. We intranasally infected them with 500 pfu of PR8, as above, and measured
IAV-induced weight loss across 7 days p.i., weighing mice twice daily, once in the AM and
once in the PM (∼ 6 hours apart) (Figure 3.17). We observed no differences in mean
weight loss, however we observed suggestive differences in mean percent starting weight
based on the time of day (see especially D1 and D2 p.i., demonstrating differences of
2.5% starting weight or more in a single day). We also observed a suggestive difference
in variance based on the direction of the cross, with NC mice exibiting both more and
less severe weight loss than CN mice. Thus, we note that the magnitude and direction of
reciprocal effects that we observed may require careful genotyping of lines, consideration
of timepoints for phenotyping, and rigorous controls for environments and maternal care.
3.5 Discussion
Summary. In this chapter, based on the preliminary observation of asymmetric
strainpair effects in reciprocal F1 cross mice in a diallel cross of inbred Collaborative
Cross founder mice, we describe a study of reciprocal effects on influenza A virus H1N1
(PR8) infection outcomes in female B6×129 (BC) and 129×B6 (CB) F1 cross mice, which
are both null for the strong-acting host antiviral factor, Mx1 , and thus highly susceptible
to infection-related pathology. Specifically, we have characterized significant reciprocal
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Figure 3.17 Suggestive reciprocal cross variance effect for crosses of C57BL/6NJ with
129S1/SvImJ. The y-axis indicates percent starting weight, and the x-axis indicates twice-
daily timepoints post-infection. Phenotypes for B6N×129 are given by the blue points,
and those for 129×B6N are given in the orange points, with corresponding boxplots indi-
cating approximately 50% (box) and 95% (whisker) coverage of the data.
effects on viral pathogenesis in BC and CB mice. We have described significant differ-
ences in host immunopathology in the lung at D3 and D7 post infection, and reproducible
differences in IAV-induced weight loss at D1 p.i. and D4 p.i. between BC and CB mice,
in the absence of any differences in viral load, which we eamined at both D3 and D7 p.i.
We found that controlling for postnatal maternal fostering effects, in BC[XF] and CB[XF]
mice which were fostered by reciprocal maternal parents at D0-D1 post-birth, did not
ablate the difference we observed in virus-induced weight loss at D4 post-infection, sug-
gesting that reciprocal effects in this study are likely caused by POE, and mediated by
differential gene expression effects caused by molecular imprinting of the genome. From
this outcome, we hypothesized that differential total expression or differential allelic ex-
pression in B6 and 129 lungs, at day 4 post-treatment in baseline (mock-treated animals)
or post-infection, may contribute to the differences we observe in clinical phenotype based
on parent-of-origin. We thus quantified total RNA expression in lung samples from two
batches of mock (n=7) and infected (n=38) mice, and found differentiall expressed genes
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(DEGs) based on reciprocal cross, as quantitated with RNA-seq of total RNA in lung
sections from infected mice. These DEGs included several known imprinted genes, sug-
gesting that inherited epigenetic differences between BC and CB mice may modulate dif-
ferential pathogenesis between these mice via differential expression of causal transcripts
in the lung, with the mechanism(s) of immune modulation via the differential transcripts
yet to be elucidated.
The total read analysis presented here is based on genome alignment, and will be
followed-up by more rigorous differential total expression and ASE analysis resulting from
transcriptome-based alignment, as well as a targeted assessment of differential (total and
allelic) expression of all currently known imprinted genes that are observed as expressed
in our data set in the lung. Also, for the present analysis, we have pooled the native and
cross-fostered (BC[XF] vs. CB[XF]) F1 samples based on simply considering reciprocal
genotype in our model. In future work, we will additionally determine whether the post-
natal maternal fostering effects contribute to transcriptome-wide variation by including
cross-fostering as a covariate in our differential expression model.
Notably, in our stratified DESeq2 analysis, separately conducted using mock or influenza-
infected samples only, the three gene segments (Ighv8-12, Igkv15-103, and Ighv5-6 ) are
most apparently immune-related, with two others being putatively important for immune
function (Gm3257, Pcdh18 ), and several imprinted genes wer also identified as signifi-
cantly differentially expressed (A230057D06Rik, Zfp264, Rasgrf1 ). Three genes, Pcdhb7,
Ighv8-12, and A330076H08Rik, are candidates for airway-related function and disease
(severe asthma, chronic airway surface dehydration, and pulmonary function, respectively)
(Slager et al. 2013; Saini et al. 2014; George et al. 2017). It appears that none of the
twelve candidates have previously been identified as having a role in influenza A virus
infection, in humans or mice. Thus, if follow-up studies are able to confirm a role for one
or more of these genes in driving differential susceptibility to influenza-induced disease, it
will demonstrate the utility of this approach, identifying putative host genes acting under
non-additive conditions, for uncovering new biological pathways contributing to common
disease.
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Monoallelic gene expression arises both from deterministic (imprinting) and random
(X inactivation, autosomal) processes. Thus the identification of a number of Ig gene
segments that are DE based on reciprocal cross is a bit perplexing, as the Ig loci have
typically been found to exhibit random monoallelic expression (RME) along with other
autosomal genes, T cell receptors (TCRs) and odorant receptors (Chess 2016). Allelic
exclusion was discovered for Igs via Pernis et al. (1965), and for odorant receptors via
Chess et al. (1994), however imprinting effects on Ig expression, at baseline and upon
stimulation, is lesser explored.
In order to explore how widespread the effect of parental origin appeared to be, we
additionally sought to identify the role of reciprocal effectcs on viral pathogenesis in ad-
ditional F1 crosses. In C67BL/6NJ × 129 crosses, we did not observe effects on the mean
IAV-induced weight loss effect, but observed suggestive effects on the variance. In the
B6×WSB/EiJ crosses we examined (data not shown), we also observed significant re-
ciprocal effects on IAV-induced weight loss and histopathology, suggesting the influence
of parent-of-origin effects may be a more general phenomena influencing infection out-
comes, both in terms of the mean and variance of susceptibility in F1 lines, for a variety
of crosses of mice.
The identification of POE on infection has a variety of implications for both genetics
and virology. First of all, regarding the problem of missing heritability (Manolio et al.
2009), non-additive effects such as POE, dominance, and epistasis may make up some
of the difference in heritability as estimated from family-based versus genome-wide map-
ping studies. By having a more complete recognition of the diverse types of effects that
contribute to heritable variation in virus-induced disease in genetically diverse popula-
tions can lead to better implementation of experimental and clinical studies, finely-tuned
toward detection of non-additive effects and considering parental effects more critically.
Second, the heavy reliance on inbred lines and transgenic knock out mice in immunology
and viral pathogenesis studies may have left a gap in the literature regarding epigenetic
and otherwise complex genetic effects of host factors, reducing the detectability of those
factors and our overall understanding of acute disase.
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Figure 3.18 Summary and overview of future directions for imprinted gene analysis.
Future Work. This work has opened up several avenues relevant for further in-
vestigation. I outline some of these directions below. First of all, we would like to per-
form a targeted analysis of known imprinted genes and their expression, and differen-
tial expression, in the lungs of these F1 reciprocal cross mice (Figure 3.18). Once the
transcription-based alignment has been completed, this will enable us to pursue this av-
enue further.
Secondly, in these heterozygous mice, as well as in recombinant and intercross mice
such as the CC and CC-RIX, are gene expression profiles observed in infected humans
reproduced in mouse blood and lungs? One might expect a closer correspondence of
infection-related gene expression in recombinant and heterozygous animals compared
with inbred animals. Additionally, identifying corresponding human genes and SNPs for
targeted validation of our findings from 2009 pandemic outbreak patient genetic data
could be especially intriguing. Cross-validation of experimental findings with human out-
break or experimental samples could be really informative regarding the clinical relevance
of these studies in F1 reciprocal cross mice.
We recognized that prenatal maternal effects may be substantial, and prior work has
shown the value of differentiating and identifying prenatal maternal effects from postnatal
effects (Wolf et al. 2011), and a number of strain-specific differences have been observed
in maternal behaviors in rodents (McIver and Jeffrey 1967; Peripato et al. 2002; Peripato
and Cheverud 2002). Although it is beyond the scope of this investigation, future studies
may explore the role of prenatal maternal fostering effects using reciprocal transplanta-
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tion of embryos from BC and CB mice to surrogate mothers, in order to determine if
such effects play a role in modifying the acute immune response to influenza in adult F1
offspring. Depending on the extent of strain-specific differences in prenatal development
between B6 and 129 dams, we might expect to see additional effects of maternal geno-
type on F1 offspring outcomes that are independent of any POE we have observed in this
study. Further studies should attempt to disentangle genetic effects of complex architec-
ture with indirect genetic effects, and those based on maternal effects, and social effects
on infection response, as explored recently in a study in macaques by Snyder-Mackler
et al. (2016).
We observed a suggestive reciprocal effect on variance in influenza-induced weight
loss across 7 days post-infection, using reciprocal F1 crosses of B6N×129. Due to the low
sample size of this experiment, the differences in variance are inconclusive, but suggested
additional effects of parent-of-origin on variance of phenotypic outcomes, and provide
further justification for the use of closely related inbred lines to use reduced complexity
crosses, or crosses that utilize closely-related murine substrains as breeding partners, for
analyzing genetic architecture and doing QTL mapping in F2’s or backcross populations.
We intend to detect imprinting, by focusing on ASE whereby the ratio of maternal to
paternal allelic expression is biased toward one parent or the other, depending on the di-
rection of parental silencing. There are currently ∼ 151 known imprinted genes annotated
for mice, and ∼ 23 known imprinting regions (Blake et al. 2010). 2 We found significant
DE genes, in our stratified analysis, on mouse chromosomes 3, 6, 7, 9, 12, and 18. There
are no previously known imprinted genes on mouse chr3, suggesting that there are new
imprinted genes, or imprinting-impacted gene networks affecting expression on chr3.
In this study, we analyzed a subset of phenotypes that are critical indicators of host
pathology following influenza infection in mice. Additional phenotypes, such as serum cy-
tokine and antibody levels and gene expression and immune cellular composition in other
compartments (central and peripheral immune organs, blood, etc.), are also important
2Additinal resources at: www.geneimprint.com, http://mousebook.org/catalog.php?catalog=imprinting,
and www.otago.ac.nz/IGC
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indicators of disease, and they be similarly influenced by effects of imprinting which we
observed in this study, and it would be useful to examine them in order to determine the
degree of pleiotropy of these parent-of-origin effects.
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CHAPTER 4
Quantitative Trait Locus Mapping of Influenza Virus Lung Pathology 1
4.1 Introduction
Genome-wide mapping of infection-related complex traits presents peculiar challenges,
including controlling for population structure, confounding covariates, viral strain and
dose, and biological variability, which diminish the power of human studies to detect
significant loci associated with enhanced disease. There is an opportunity, however, with
the advent of replicable genetic refrence populations, to enhance phenotyping precision
in genetically diverse individuals, and to map quantitatitve trait loci (QTL), with the
intent of identifying signficant genes or causal quantitative trait nucleotides (QTNs) that
underlie differences in virus-induced disease.
Collaborative Cross strains are generated by several rounds of systematic outbreeding
among eight inbred founder strains in an attempt to balance representation of founders
among breeding funnels, followed by many generations of inbreeding, and have produced
over 70 recombinant inbred strains (CC-RI’s), the genomes of which represent mosaics of
the founder genomes. The CC founders are comprised of five classical inbred strains, A/J,
C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, and NZO/HlLtJ, and three wild-derived strains,
CAST/EiJ, PWK/PhJ, and WSB/EiJ, arising from three subspecies of Mus musculus: M.
m. musculus, M. m. castaneus, and M. m. domesticus.
1This chapter is based on a manuscript in preparation: Maurizio PL, Keele GR, Cai Y, Ferris MT, Miller
DR, Whitmore AC, West A, Morrison CR, Noll KE, Plante KS, Cockrell AS, Pardo-Manuel de Villena F,
Baric RS, Heise MT† & Valdar W†. Influenza-induced pulmonary immunopathology is driven by QTL on
Chromosome 2 in Collaborative Cross F1 intercross mice. († = corresponding authors). What I hope to
show in this chapter is that: (1) diverse pulmonary infection-response phenotypes are under the control
of host genetics, (2) distinct loci contribute significantly to host pathology, and (3) emerging methods are
powerful tools for systematically mapping QTL in multiparental population, and, along with statistical
and systems genetics techniques, for readily identifying likely candidate genes contributing to virus disease
susceptibility in mice.
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The use of recombinant inbred intercrosses (RIX) for QTL mapping was proposed
in in 2001 (Williams et al. 2001; Threadgill et al. 2002). An alternate, but related, de-
sign uses RI lines crossed with inbred lines, which may in some cases be better suited
to detection of dominant QTL (Hallin et al. 2016). In plants, this sort of population is
known as an immortalized F2 population (IF2), given the genetic similarity with F2 pop-
ulations from inbred lines, combined with its theoretically infinite reproducibility (hence
“immortalized”) (Xu 2013; Wen and Wu 2014). Some examples of successful CC-related
mapping studies include prior studies in pre-CC populations, which have been useful for
mapping inflammatory QTL in the lung, in the absence of infection (Rutledge et al. 2014;
Donoghue et al. 2017). As well, CC mice have been used to map QTL in the response to
SARS (Gralinski et al. 2017).
While the exploration of different types of QTL mapping software for multiparental
populations is beyond the scope of this chapter, it is worth mentioning several resources
which have been made available in recent years. For the initial purpose of mapping in
heterogeneous stock (HS) multiparental populations, HAPPY was introduced by Mott
et al. (2000). More recently, one software package which has gained popular use among
the multiparental population mapping community, especially among those using the Col-
laborative Cross and Diversity Outcross, is DOQTL (Gatti et al. 2014). DOQTL is able to
make use of genotype intensity values, using an HMM, to generate founder haplotype
probabilities. These are then used for QTL scans, via an additive model, via the regres-
sion on probabilities (ROP) method. In this manuscript, we use an emerging software
resource, miqtl, which is in development in the Valdar lab and implemented in the statis-
tical programming language R (R Core Team 2017). We also use an updated version of
Diploffect (Zhang et al. 2014) for estimation of haplotype (and diplotype) effects at single
loci, and an implementation of merge analysis for identification of especially promising
SNPs (Yalcin et al. 2005). Merge analysis was able to successfully isolate causal SNPs
for a CC mapping study, under a QTL for drug-induced liver injury, in protein coding
regions in a recent study by Mosedale et al. (2017). Additional software includes work by
Gong and Zou (2012) that is specifically designed for CC-RIX-like mapping populations,
using nonparametric models to map QTL.
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Thus, what follows is a first exploration in mapping the genetic regions contributing
to host lung pathology and resistance to disease, as mapped in the CC-RIX F1 hybrid
panel, and enabled by the completion of inbreeding and genotyping/sequencing of over 70
CC strains, and the emerging mapping software resources specifically tuned to handling
the experimental designs and kinship relations within this population.
4.2 Materials and Methods
Animal Breeding and Housing. CC-RIX mice were bred in specific-pathogen free
conditions at the Systems Genetics Core Facility at the University of North Carolina
(UNC) (Welsh et al. 2012) and provided to our lab at 6-8 weeks of age. Animals were
then housed, infected, and assayed under BSL-2 conditions. The experimental breeding
design of the CC-RIX is shown in Figure 4.1A. For this QTL mapping study, a total of
63 CC parents were crossed one to another in a circular (round robin) breeding design to
yield 286 female animals from 84 unique CC-RIX lines infected in 26 batches. All animal
experiment protocols were approved by the UNC Institutional Animal Care and Use Com-
mittee. The Office of Laboratory Animal Welfare of the NIH approved the UNC protocol
(A3410-01). These studies were carried out in strict accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals (National Institutes of
Health). Mice were co-housed with animals of the same genotype and similar birth dates,
approximately 3-4 per cage.
Virus preparation and mouse infections. All infections in this study were com-
pleted using IAV (A/California/04/2009; short name CA04), a human H1N1 influenza
isolate from the 2009 pandemic (Itoh et al. 2009). Viral stocks were prepared from plas-
mids. At 8-12 weeks of age, CC-RIX mice were infected intranasally with 5,000 PFU of
CA04, diluted in 50 ul of phosphobuffered saline (PBS) (Figure 4.1B). No mock pheno-
types are included for this analysis.
Histological analysis. After anasthesia using isoflurane and humane euthanasia,
mouse lungs were harvested, pulmonary lobeswere isolated and immediatedly fixed in 4%
















































































































































II. Mapping Infection QTL Methods
Experimental methods




day 5 6 7 8 9 10
section lungs
Fix, paraffin embed, H&E stain lung sections
Pathologist scoring (blinded)
QTL mapping (haplotype-based association) via a Bayesian linear
mixed effect model, accounting for kinship
Maurizio, P.L. (UNC-Chapel Hill) Modelling Influenza in Mice December 18th, 2017 26 / 31
Figure 4.1 Breeding design, infection and phenotyping protocol for CC-RIX mice in
this study. (A) Breeding design for the CC-RIX population used in this study. Each
filled-in square represents one of 84 CC-RIX lines generated in a sparse diallel cross of
64 CC strains (n=286 female mice total). (B) Infection protocol for the Collaborative
Cross recombinant inbred cross (CC-RIX) study on influenza A virus (IAV)-induced
histopathology. Mice were infected with 5000 PFU of CA04.
to processing. Lung tissues were embedded in paraffin, s ctioned (5 µm thickness), and
stained with hemotoxylin and eosin (H&E), at the Animal Histopathology & Laboratory
Medicine Core Facility at the University of North Carolina. Each lung section was visual-
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ized by bright field light microscopy, using a Motic BA400 Scope, with 20× magnification,
and scored blindly by a single expert mouse pathologist, based on twelve criteria: airway
damage and debris, airway denuding, vascular cuffing, airway cuffing, alveolar inflamma-
tion, pulmonary edema, hyalin membrane, exudate, lymphocytes, neutrophils, eosinophils,
and macrophages.
The scoring critera are coded as follows. For pathology scores (all): none (0), very
mild (1-2), mild (3-4), moderate (5-6), severe (7-8), and very severe (9-10). To determine
the airway damage and debris, airway denuding, vascular cuffing, and airway cuffing and
alveolar inflammation, the following percentages and counts were as guidelines used to
calibrate scores with the pathology score key above: debris score (airway damage and
debris): < 25% (mild), ∼ 50% (moderate), > 50% (severe); cuffing scores (vascular cuff-
ing and airway cuffing): 1-2 cells thick (mild), 3-5 cells thick (moderate), 6+ cells thick
(severe). Cellular scores (lymphocytes, neutrophils, eosinophils, and macrophages) ranged
from 0 to 5 rather than 0 to 10. Several areas were examined, and some scored samples
received midvalues (1.5 instead of 1 or 2) based on an intermediate (or averaged) degree
of severity.
4.2.1 Statistical Models and Methods
PCA. Principal component analysis was carried out using the prcomp function in the
stats package in R (R Core Team 2017), useing eigenvalue decomposition of centered
and scaled data.
Correlation. Correlation analysis was completed with the cor function in the stats
package in R, using pairwise-complete observations, via Spearman’s rho statistic. Spear-
man’s rho is calculated between two phenotypes, a and b, by first transforming variables,
ya and yb into their rank versions, yranka and yrankb , obtaining the standard deviations of
the rank variables, sa and sb, and then calculating their pairwise Pearson correlation





Kinship. There are various methods for the calculation of a kinship matrix, or an
N × N matrix of relatedness. We used two methods, which for simplicity we call Kbreeding
and Krealized. For the first, all CC-RIX that share both CC strain parents are given the
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breeding realized
Figure 4.2 Comparison of breeding and realized kinship matrices. The left displays the
breeding kinship matrix, and the right shows the realized kinship matrix, calculated ac-
cording to (Gatti et al. 2014) between all 84 unique CC-RIX lines included in this study.
Each row or column corresponds to a single CC-RIX line.
value 1, because they are genetic replicates. CC-RIX that share one parent are given
the value 0.5, because they share identity at approximately half of their polymorphic
sites. All other “unrelated” CC-RIX that share neither parent and are given the value
0. For the second method, we use a kinship calculation based on haplotype probabilities,
previously published in (Gatti et al. 2014) and implemented using the
calc.kinship.from.genomecache.with.DOQTL function in miqtl. We obtain similar
results using both methods, and present our QTL scan results using the Kbreeding kinship
in the analyses that follow.
The full kinship matrix contains multiple identical rows/columns for the replicate
animals within each CC-RIX line. A collapsed kinship matrix is generated which contains
a single row and a single column for each unique CC-RIX genotype. A comparison of the
collapsed Kbreeding and Krealized kinship matrices is shown below, where it is clear that
the realized and breeding kinship values are similar, but more intermediate values are
observed in the realized matrix (Figure 4.2).
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Phenotype pre-processing. Prior to mapping, the data is transformed, through
several steps of processing. First, the residuals of the data are obtained, removing the
effects of starting body weight and batch. To do this, we fit an lmer model, using lme4
(Bates et al. 2015):
yi = µ+weighti · βweight + β{cross}[i] + βh[i] + εi (4.1)
where individual mice are indicated by i, y is the phenotype, {cross} is a CC-RIX
cross, µ is the overall mean phenotype (fixed effect), weight is starting body weight at
day 0, βweight is the body weight effect (fixed effect), β{cross} is the effect of each CC-RIX
cross { j k} (random effect, with 84 levels), and βh[i] is the effect of batch h (random effect,
26 levels). The residual error, ε is assumed to be normally distributed.
The residual mean value, yresidi , is given by the following:
yresidi = yi −weighti · βweight − βh[i], (4.2)
from which centered and scaled phenotype values are calculated, yresid.csi , using the
scale function in R (R Core Team 2017). These resid.cs are then used for QTL mapping.
It is often necessary or desirable to use mean phenotypes, based on strain identity,
for QTL mapping. Each individual mouse can be considered a genetic or biological repli-
cate of a given CC-RIX genotype. The phenotype values of each CC-RIX line are shrunk
to the overall line mean, and the means can then be used, in a weighted regression with
weights based on measures of within-line variance or sample size, to carry out genome-
wide mapping. We analyze our data using three types of measures: (1) the original repli-
cates; and collapsing the phenotypes to arithmetic means using two methods: (2) the
arithmetic mean based on CC-RIX; and (3) the deordinalized mean based on CC-RIX
(unweighted, and using inverse precision weights).
The calculation of the arithmetic mean is straightforward, and does not include shrink-
age of the estimates to an overall mean. The number of replicates is used as an inverse
precision weight in the regression. The calculation of the deordinalized mean from the
raw phenotype values, using a cumulative probit model, is elaborated below. It is fit us-
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ing the software package brms (Bürkner 2017), which implements the MCMC modeling
language STAN (Stan Development Team 2016) in R.
The following details the cumulative probit model we use, as described in (Agresti
2012). First of all, we consider that the raw phenotype yi takes categorical (in our case,
integer or half-integer) values across j = 1, · · · , J categories, with c cutpoints where
c = J − 1, and is drawn from a multinomial distribution, with mean parameter p. We define
the probability that individual i belongs to category j as pi j , and define the cumulative
probabilities for thath individual as, γi j = P(yi ≤ j) = pi1 + · · · + pi j . We then transform
the cumulative probabilities to a latent scale using the probit link, g(·) = Probit(·), which
is the inverse of the cumulative distribution function (CDF) of the Gaussian distribution:
Probit(x) = Φ−1(p). We then model the probit-transformed cumulative probability using a
hierarchical linear mixed model:
Probit(γi j) = µ j + βcross[i]xcross[i] + βbatch[i]xbatch[i] + εi (4.3)
The cross and batch effects are randomly drawn from normal distributions with class-
specific variance components (τ2), as follows:
βcross[i] ∼ N(0, τ2cross) (4.4)
βbatch[i] ∼ N(0, τ2batch) (4.5)
εi ∼ N(0,σ2) (4.6)
We use the probit link, because the regression error on the latent scale will be nor-
mally distributed—the errors from the logit function are logistic. This enables us to fit
the deordinalized values, which have normal errors, more apporpriately, using traditional
mapping software. Although we obtain strain-specific variance estimates, we choose not
to use these for mapping, as the deordinalized values are already shrunk toward the over-
all mean, and use of precision weighting may possibly contribute to a further loss of map-
ping power. For additional insight regarding modeling multinomial-distributed categorical
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data, see the following references: (Gelman and Hill 2006; Faraway 2016; Venables and
Ripley 2002; McCullagh and Nelder 1989; Fullerton and Xu 2016; Greene and Hensher
2010). Regardless of the measure chosen for mapping (replicates, means, or deordinalized
values), within the regression, we use the rank inverse normal transform (rint) on the
phenotype prior to mapping to improve performance.
QTL Mapping. All mapping was carried out using the R software package miQTL,
which provides functions useful for haplotype-based mapping of QTL in multiparental
populations, using the additive model. Haplotype reconstructions for CC strains that
were used to generate the CC-RIX were performed using DOQTL, as in (Mott et al.
2000), and were based on genotypes obtained from MegaMUGA (Morgan et al. 2016).
Thresholds at the α = 0.05 significance level were obtained by permutation tests, and for
comparison, null phenotype bootstrapping. Allele effects were calculated at each locus,
according to the eight founder haplotypes. Parametric positional bootstrapping (Visscher
et al. 1996; Phillippi et al. 2014; Wood 2017) was used to obtain genome confidence inter-
vals, indicating uncertainty about the location of the peak QTL signal on the given chro-
mosome, for which we chose to use the 85% confidence interval region for follow-up. We
used merge analysis (Yalcin et al. 2005), which compares the likelihood of a SNP/indel-
based model, using CC founder variants catalogued in (Oreper et al. 2017), to that of
the haplotype model, as in miqtl, to identify polymorphisms that provide a better fit in
the reduced allele model than the eight haplotype model within the 85% QTL positional
bootstrap region.
4.2.2 Availability of Data and Software
Analyses were conducted in the statistical programming language R (R Core Team
2017). The data, analysis software, and scripts are available on flu-histo repository on
GitHub, at https://github.com/mauriziopaul/flu-histo. Phenotype data from the
diallel and CC-RIX animals used in this study will be available on the Mouse Phenome
Database (Grubb et al. 2014; Bogue et al. 2017), at https://phenome.jax.org.
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4.3 Results
In order to test the impact of host genetic variation on IAV-induced pulmonary pathol-
ogy and inflammation, the lungs from n IAV or mock infected CC F1 lines were assessed
for airway pathology, pulmonary edema, and inflammatory cell infiltration on day 10 post
infection.
Phenotype Distributions. We find that there is a diverse spectrum of lung histopathol-
ogy scores across the twelve phenotypes we examined in the CC-RIX lines (Figure 4.3).
Whereas the mean values appear to continuously span a spectrum of histology scores, the
shape of the raw distribution of scores is more discrete, and the shape of the distribution
varies widely depending on the phenotype (Figure 4.9).
Principal Components. In order to understand the relationship between and over-
all variance contribution of histopathology scores, and to characterize groups of samples
with different pathological compositions, we did a principal component analysis of the
12 histopathology phenotypes in this population of samples. Due to the original shape
and range of the phenotypes, we centered and scaled the phenotypes, and report the over-
all results below. Almost half (46.6%) of the variation in the data set is explained by
the first two principal components, and about 80% of the variation is explained by the
first five. Each of the remaining principal components contributes around 5% or less of
variation, with the final component, PC12, explaining just 0.1% of the variation, discrim-
inating the highly correlated (see correlation analysis below) neutrophil and eosinophil
phenotypes (Figure 4.4, Table 4.1). We also transformed the data using the values ob-
tained from Box-Cox power transformation analysis, from the MASS package (Venables
and Ripley 2002), and obtained similar results (data not shown).
From the PCA loadings in Figure 4.11, we find in general, for example, that PC1
is loaded heavily on overall histopathology, PC2 is negatively loaded on neutrophils and
eosinophils, PC3 is positively loaded on cuffing scores, lymphocytes and macrophage
scores and negatively loaded on edema, hyalin membrane and exudate scores, and PC4 is
heavily loaded on airway phenotypes and negatively loaded on macrophage scores. Com-
bining the information about loadings with variance explained, we find in general that
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Figure 4.3 Distribution of raw histology scores for CC-RIX mice on D10 post-infection,
grouped by strain (y-axis), and ordered by mean score (x-axis). The grey boxplots repre-
sent approximately 50% (solid bars) and 95% (dotted lines) coverage of the data within
each group. The neutrophil and eosinophil phenotypes are highly correlated, and are to
be re-configured and collapsed into a single “granulocyte” score prior to mapping.
Variance Explained PC1 PC2 PC3 PC4 PC5 PC6
Proportion 0.310 0.157 0.138 0.116 0.077 0.053
Cumulative Prop. 0.310 0.466 0.605 0.720 0.798 0.851
Variance Explained PC7 PC8 PC9 PC10 PC11 PC12
Proportion 0.043 0.034 0.031 0.024 0.016 0.001
Cumulative Prop. 0.894 0.928 0.959 0.983 0.999 1.000
Table 4.1 Table of proportion of variance explained by each principal component of our











































































Figure 4.4 Plot of proportion of variance explained by each principal component of our
lung histopathology data for day 10 post-infection.
overall pathology and neutrophil/eosinophil scores determine nearly half of the variance
(46.6%) in pathology we observe in the CC-RIX population.
Correlation. Prior to mapping, it is useful to examine the correlation structure of
phenotypes from the population. As a first-pass, we take a look at the Spearman’s rank-
based pairwise correlation between phenotypes (Figure 4.10). We find that most of
the histology phenotypes are postively correlated, although some are uncorrelated such
as lymphocytes with neutrophils (0.01) and with eosinophils (0.03). We also find and
that many of the histology phenotypes, especially airway debris, alveolar inflammation,
and pulmonary edema, have a moderate to strong correlation with post-infection weight
loss, especially for weight loss measured on D4 through D10. Eosinophil and neutrophil
scores are > 98% correlated, suggesting that they are not truly independent measures of
pathology, and that we only use one of them for QTL scans.
Multiple imputations QTL mapping. In the following section, I use a multiple
imputation-based method for QTL mapping, via correspondence with Gregory Keele,
and implemented in the software package miqtl which is available online at https://
github.com/gkeele/miqtl. The miqtl mapping software is based on a linear model with
normally distributed errors. We use the replicate data, CC-RIX arithmetic means, or CC-
RIX deordinalized means as phenotypic inputs. Deordinalized values are based on fitting
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the raw data with a cumulative probit generalized linear mixed model. As our data, even
after taking means and after deordinalizing, is still not quite normally distributed, we
adjust the data using the rank inverse normal transform, the effects of which, on the
overall phenotype distribution, are shown in Figure 4.13.
The mean values are similar between the arithmetic and deordinalized methods, with
a correlation of 96.96%, however there is some divergence in the values obtained, espe-
cially in CC-RIX lines whose means are near the extremes (high or low) (Figure 4.14).
QTL scan heritability. For lympocyte scores, the overall point estimate of heritabil-
ity (h2), as calculated from the polygenic model, is 14.22%. When, instead of running
scans directly on replicate measures, we scan mean or deordinalized mean measures, the
heritability estimate is reduced substantially, to estimates between 3.70% and 7.26%.
Significant peak on Chromosome 2 for lymphocyte score. We found that a sig-
nificant QTL was present on chromosome 2 for the lymphocyte phenotype Figure 4.5.
This peak was confirmed as reliable, after using multiple imputations. Whereas the chro-
mosome 2 peak is well past the significance threshold in the replicate scan, we note that
the peak has dropped below the significance thresholds when using the arithmetic mean
or deordinalized mean mapping approaches. It is likely that the mean scan still reaches
a suggestive genome-wide significance level, however the deordinalized mean scan is not
likely to reach a significance threshold. The difference between these scans is of interest
for further exploration in our research, as we are interested in learning more about: (1)
the loss of power in mapping that may occur due to choice of transformation; and also (2)
the increase in false discovery with data that does not sufficiently match the assumptions
behind the linear model (non-normal residuals, etc.) From here on, we use the replicate
scans to obtain estimates of allele effects, parametric positional bootstrap intervals, and
merge analysis.
Positional bootstrapping to obtain QTL peak location confidence interval.
In order to determine a reasonable confidence interval around the QTL peak, we use
parametric positional bootstrapping method, as implemented in miqtl (Figure 4.6).
The grey band indicates the 85% confidence interval, the blue lines indicate the individual
128
lymphocytes (replicates)
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Figure 4.5 QTL scan of lymphocyte histology scores in the lung in D10 post-infection
CC-RIX mice. The top represents the native ROP scan, the middle represents the
weighted regression scan of the cross means (weighted by sample count). The replicates
scan using multiple imputations very closely resembles the replicates scan using ROP,
and is not shown. The bottom scan represents the ROP scan of the deordinalized values
(weighted by inverse precision).
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bootstrap iterations, with the black vertical lines below the scan indicating the QTL peak
locations observed across of all the boostraps.








QTL interval type: 85% Parametric Bootstrap
Width: 16.27Mb
peak locus: UNC3697849 (105.969Mb)
(closest) lower locus: UNC3536464 (93.447Mb)






Figure 4.6 Confidence interval for lymphocyte score QTL peak, using ROP on replicates,
based on parametric positional bootstrap methods (n=200).
The peak locus, along with the 85% bootstrap interval, as determined by four QTL
scan methods, is shown below in Table 4.2. Note that: (1) the major Chr2 peak locus
marker (UNC3697849) remains the same for the replicates (model 1) and means (model
2), however the deordinalized unweigted and weighted scans (model 3 and model 4) have
lost the peak near 105Mb and instead show a peak ner 36.7Mb; (3) the replicates MI scan
peak, not shown, differs for some reason from all other peaks (B602104253454S); and (4)
the weighted and unweighted deord scan peaks are identical (UNC29050671).The cause
of these discrepancies is being examined, however, with the consistent peak between the
ROP and MI scans using replicates, we decided to proceed with all following analyses
presented for the replicates scan peak and using the ROP interval (93.447Mb-109.722Mb).
Within the region 94Mb to 110Mb, there are 169 genes. The summary of the gene types
is given in Table 4.4, with the most frequent annotation being protein coding gene (63
coding).
Allele Effects: Region. We find that the founder allele effects in this QTL region
are complex. In order to understand the effect of founder alleles within the QTL region,
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Table 4.2 Table of peak locus and confidence interval across methods.
data weights peak marker chr2 location confidence
interval
1 replicates - UNC3697849 105.969Mb 93.447Mb-
109.722Mb
2 means count UNC3697849 105.969Mb 77.022Mb-
134.128Mb
3 deord.means - UNC29050671 36.702Mb 31.749Mb-
49.298Mb
4 deord.means inverse precision UNC29050671 36.702Mb 31.262Mb-
49.298Mb
we visualize the lymphocyte scan allele effects for chromosome 2 using miqtl. There
are distinct patterns of effects across the chromosome, notably: one near 95Mb which
groups strains high (AJ, NOD, NZO, CAST, PWK) and low (B6, 129, and WSB). There
is another, beyond the peak interval (93Mb to 110Mb) which groups high (CAST), in-
termediate (AJ, 129, NOD, NZO), and low (B6, PWK, WSB). Notably, the very high
CAST effect in the latter region is based on low confidence allele effect estimates, and not
especially meaningful for our analysis.
Allele Effects: Locus. The peak locus has a slightly differing grouping of allele
effects. At a single locus, the Diploffect software implements a Bayesian haplotype ef-
fect model for multiparental populations, and presents founder additive and dominance
effects along with corresponding Bayesian confidence intervals (Zhang et al. 2014). Al-
though the effects suggest multiple possible distribution patterns of founder strains, we
can generalize the additive effect patterns from the founder haplotypes at this locus into
the following groups: low (B6, 129, PWK), medium (NOD, NZO, CAST), and high (AJ)
(Figure 4.15). Notably, the diploffect-based estimate of the locus-specific heritability is
approximately 31%, with slightly more dominance effect contribution than additive effect
contribution.
Probability plot. One way to visualize the effect of dosages of groups of strains,
based on the strain distribution pattern (SDP), is to plot the collapsed haplotype dose
against the ranked mean phenotype. Thus, within each column, we have an individual
CC-RIX line, ranked from low phenotype (centered, scaled residual means) to high phe-
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Chr 2 Position (Mb)
rint(lymphocytes.resid_scaled) ~ 1 + locus.fixef (additive)
n = 281
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Chr 2 Position (Mb)
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Figure 4.7 Allele effects plot for chromosome 2 for lymphocyte histology score scan. The
top plot is genome-wide, whereas the bottom plot is z omed in near the peak locus region
from the QTL scan.
notype, and with the colors indicating the number of doses from each group of founder
strains, collaped into their low, medium, high groups. We show this SDP probability plot
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Figure 4.8 The probability plot, collapsing by strain distribution pattern at the peak
locus on chr2, UNC3697849.
tinct pattern leading us to use this SDP as the basis for future, downstream gene filtering
within the QTL.
Merge analysis. Although it is useful to use strain distribution patterns to filter
variants within a given locus based on genotypic patterns (SNP and indel genotypes, etc.)
that match the phenotypic patterns (strains 1+2 high, strains 3 through 8 low, for in-
stance), this decision-making process can be arbitrary or biased. Notably, merge analysis
does not depend on the investigator supplying a strain distribution pattern, but is able
to generate a list of potentially causal SNPs, which can be used in conjunction with SDP
analysis to arrive at the most likely causal variant(s). Preliminary merge analysis revealed
the following top 20 genes as those containing the variants of higest significance within
the QTL region: Cd59a, Commd9, Cstf3, D430041D05Rik, Fjx1, Gm13799, Gm13804,
Gm13813, Gm13866, Gm24318, Gm26396, Hipk3, Ldlrad3, Lrrc4c, Pamr1, Pax6os1,
Prr5l, Slc1a2, Tcp11l1, and Trim44. Details about the genes listed are shown in the table
below (Table 4.5). All -logP values for the variants (SNPs/indels) were observed to be
greater than 3.
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Among the top twenty candidate genes following merge analysis, 13 are protein coding
genes, three are pseudogenes, two are snoRNA genes, one is a lincRNA gene, and one is
an antisense lncRNA gene.
4.4 Discussion
QTL models. Our preliminary comparison of replicate score mapping, arithmetic
line mean mapping, and deordinalized line mean mapping shows some substantial differ-
ences between the methods, suggesting, among other possibilities, that there is either: (1)
a significant difference in the statistical power when we use line means vs. replicates that
deflates the significance of our peak, or (2) a notable modeling issue when using replicates
that may inflate the significance of p-values. We decided to proceed with the replicate
scans based on the substantial significant signal we observed using this method, however,
we proceed with caution knowing that using (even weighted) summary measures may
reduce the observed significance of our peak substantially.
Significant QTL locus on Chromosome 2. There are a number of promising can-
didates within the Chr2 locus, and specifically within the subset of genes identified by
the preliminary merge analysis. Notably, Trim44 was found to be important for the host
innate antiviral response, via its interaction with virus-induced signaling adaptor (VISA)
(Yang et al. 2013)—Trim44 knockdown was found to reduce the cellular response to infec-
tion, and is part of a family of proteins known to be involved in antiviral responses. Also,
Longhi et al. (2007), showed that CD59a was shown to contribute to lung inflammation.
Finally, one additional candidate gene, Prr5l, is within a confirmed pediatric arthritis ge-
netic risk locus (Chiaroni-Clarke et al. 2014). Further analysis is needed to verify if these
candidate genes are likely to be causal for differences observed in our lymphocyte score
phenotype.
Future Work. In the following section, I outline some additional avenues of research
extending the results I have presented.
Validation studies. We intend to validate effects of specific genes under the QTL and
use additional modeling to further filter our the genome region candidates. Validation
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studies in CC-RI mice and/or DO mice would enable us to confirm allele effects using
related, but distinct populations. In addition, further analysis of other phenotypes col-
lected at day 7, day 10, and day 15 post-infection in this CC-RIX population, which are
available but yet to be analyzed for this study, should yield some critical insights regard-
ing the likely candidate gene(s) responsible for the chromosome 2 peak discovered in this
study. These additional follow-up studies will complement the merge analysis results we
obtained, and help to narrow down candidates that may be specifically driving the effects
under our locus on chr2.
Identification of lines exhibiting extreme pathology as new models of disease. The
CC-RIX lines are useful both in constructing QTL mapping populations, as well as for
identification of new model CC strains or CC-RIX lines which can capture some aspect of
disease not presently captured by other model systems. We can use the same data and set
out to identify CC-RIX lines that may be of particular interest due to exhibiting extreme
or abnormal pathology post-infection. Hierarchical clustering methods and/or further
exploration of the PCA analysis may lead to identification of extreme responders that are
highly resistant, highly susceptible, or display unusual patterns of phenotypic values, sug-
gesting the potential for genetic decomposition of complex traits in these lines into their
component parts. This type of analysis is of particular interest moving forward, especially
as it has been fruitful in a CC infection study, identifying lines useful for modeling Ebola
virus disease (Rasmussen et al. 2014).
Analysis of additional phenotypes. We have presented an in depth analysis of the
results for the lymphocyte scan. We will additionally scan the other 11 phenotypes and
report results from any loci detected. Preliminary analysis indicated one or more peaks
in the airway debris scan, however, further modeling is needed to ensure the peculiar
distributions of the data are not contributing to artificial inflation of the -logP values.
Modeling skewed ordinal phenotypes as binary outcomes. The distribution of just
over half of the phenotypes we examined were skewed heavily, and easily re-coded into
non-responders and responders—see airway debris, airway denude, pulmonary edema,
hyalin membrane, neutrophils, eosinophils, and exudate in Figure 4.9. Modeling these
phenotypes based on binary phenotypic outcomes, using similar latent scale means (“de-
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binomialization”), may possibly be more appropriate and yield better results for mapping,
rather than using the raw data or deordinalization procedure described above. A more
thorough exploration of the effects of mapping using summary measures, such as line
means and deordinalized line means, is forthcoming.
Improving significance thresholding. Our methods for generating significance thresh-
olds, additionally, could be made more rigorous by using a more advanced permutation
procedure, not yet available, that permutes parental genotype combinations among the
founder CC lines used in this experiment, and then regenerates kinships and runs thresh-
old scans with the null phenotype or permuted values across the newly generated haplo-




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.13 The distribution of the lymphocyte score data before and after rank inverse
normal transformation. There are n=286 values represented in the top row, and n=84 in
the middle and bottom rows. The left column represents the distribution of the centered,
scaled, residuals prior to transformation, and the right column represents the data after
transformation.
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) r2 = 0.9696
Figure 4.14 The correspondence between
arithmetic mean values and deordinalized
mean values for D10 post-infection lung his-
tology scores in the CC-RIX.
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lymphocytes.resid_scaled ~ 1 + locus(UNC3697849)
INLA samples: 100
Haplotype Effects
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lymphocytes.resid_scaled ~ 1 + locus(UNC3697849)
INLA samples: 100
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Figure 4.15 Diplotype effects plot for for chromosome 2 lymphocyte scan peak locus.
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Table 4.3 Table of CC-RIX lines used in the IAV histopathology experiment.
A total of 286 female mice from 84 CC-RIX lines (approximately 3.5 mice per
strain; range: 1 to 10), originating from a sparse diallel cross of 64 CC strains,

























































































Table 4.4 Summary of gene types un-












unclassified non-coding RNA 10
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Table 4.5 Table of merge analysis results from chromosome 2 locus for lymphocyte scores.
gene name description gene type ensembl id position (chr2)
1 Cd59a CD59a antigen protein coding ENSMUSG00000032679 104095801-104115354
2 Commd9 COMM domain containing
9
protein coding ENSMUSG00000027163 101886247-101901646
3 Cstf3 cleavage stimulation factor,
3′pre-RNA, subunit 3
protein coding ENSMUSG00000027176 104590523-104665429
4 D430041D05Rik RIKEN cDNA
D430041D05 gene
protein coding ENSMUSG00000068373 104143073-104409993
5 Fjx1 four jointed box 1 protein coding ENSMUSG00000075012 102449366-102452499
6 Gm13799 predicted gene 13799 lincRNA ENSMUSG00000087537 95838088-95840594
7 Gm13804 predicted gene 13804 pseudo ENSMUSG00000080802 98291403-98291574
8 Gm13813 predicted gene 13813 pseudo ENSMUSG00000082435 100407493-100408279
9 Gm13866 predicted gene 13866 pseudo ENSMUSG00000081774 102209412-102210379
10 Gm24318 predicted gene, 24318 snoRNA ENSMUSG00000077678 94621958-94622088
11 Gm24318 predicted gene, 26396 snoRNA ENSMUSG00000077281 94792205-94792336
12 Hipk3 homeodomain interacting
protein kinase 3
protein coding ENSMUSG00000027177 104426481-104494446
13 Ldlrad3 low density lipoprotein
receptor class A domain
containing 3
protein coding ENSMUSG00000048058 101950203-102186385
14 Lrrc4c leucine rich repeat contain-
ing 4C
protein coding ENSMUSG00000050587 96318169-97631666
15 Pamr1 peptidase domain contain-
ing associated with muscle
regeneration 1
protein coding ENSMUSG00000027188 102550012-102643041
16 Pax6os1 paired box 6 opposite
strand 1
antisense lncRNA ENSMUSG00000086029 105536080-105670330
17 Prr5l proline rich 5 like protein coding ENSMUSG00000032841 101716241-101883027
18 Slc1a2 solute carrier family 1
(glial high affinity glu-
tamate transporter),
member 2
protein coding ENSMUSG00000005089 102658659-102790784
19 Tcp11l1 t-complex 11 like 1 protein coding ENSMUSG00000027175 104657288-104712169
20 Trim44 tripartite motif-containing
44
protein coding ENSMUSG00000027189 102300119-102407828
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CHAPTER 5
Dissertation Conclusions and Future Directions
5.1 Conclusions & Discussion
In this disseration, I have presented several novel lines of investigation into the genet-
ics of the host response to influenza A virus infection, and I have specifically focused on
the dual roles of additive and non-additive genetic variation using statistical and systems
genetics approaches, empowered by advanced genetic reference populations and system-
atic breeding designs using F1 cross mice. I presented three related studies that are part
of my pursuit toward unraveling some of the character of the genetic architecture of the
host response to infection with influenza A virus.
5.1.1 Infection response diallels: Uncovering genetic architecture and
dominance of resistance
In the first study, presented in Chapter 2, I demonstrate the experimental utility of
the diallel cross in studying the host infection response, and the quantitative utility of
the BayesDiallel model in conjunction with stochastic regression imputation and quar-
tet matching, to define heritable variation and degree of allelic dominance in the CC
founder diallel population. I described the overall contribution of types of genetic inheri-
tance classes to the acute host response to influenza A virus in a diallel cross of mice, and
specifically investigated the effects of ancestral haplotype origins of the Mx1 locus on the
degree of dominance of functional, protective Mx1 alleles, when combined with null Mx1
partners. This work builds on prior studies using infection diallels, but takes a rather
rigorous modeling approach toward deeply characterizing the heritability and genetic ar-
chitecture of a varity of classes of effects, including additive, maternal, inbred, epistatic,
and sex-specific. Many prior infection diallels focused more simply on the additive vs.
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nonadditive contributions, or did not account for mock infection thoroughly. In addition,
building on the BayesDiallel model of Lenarcic et al. (2012), we have attempted to quanti-
tatively extend our analysis of dominance using classical quantitative genetic parameters,
giving a more concrete characterization of allelic differences in genetic dominance between
different ancestral origins. Below, I summarize some of the historic work using diallels to
explore the genetic architecture of the host response to pathogen challenge, and discuss
how our study fits into and helps advance this ongoing endeavor.
Infection diallels in plants. The use of inbred diallel crosses to decipher the genetics
of (virus) infection resistance has been rather sparse, although a number of examples can
be found, primarily for studies in plants, as well as some in insects and vertebrates. In a
genetic cross of lines of corn, Zea mays L., Josephson and Naidu found that resistance to
the aphid- and mechanically-transmitted maize dwarf mosaic virus (MDMV; family: Po-
tyviridae) was largely dominant and not strongly polygenic (Josephson and Naidu 1971),
with subsequent studies revealing an important host resistance locus driving the herita-
ble effects, namely Mdm1 (Findley et al. 1973; McMullen et al. 1989; Jones et al. 2007).
More recently, in a 10×10 half diallel study of host resistance of sweetpotato, Ipomoea
batatas (L.), to Sweetpotato virus disease (SPVD), which is caused by a dual virus infec-
tion with Sweetpotato feathery mottle potyvirus (SPFMV) and Sweetpotato chlorotic stunt
crinivirus (SPCSV), researchers found that additive effects on host resistance appeared
more important than dominance effects (Mwanga et al. 2002), and studies this past year
have identified several simple sequence repeat (SSR) markers associated with inherited
resistance to SPVD (Yada et al. 2017). In a study of host resistance (and tolerance) to
Cucumber mosaic virus (CuMV; family: Bromoviridae) using a complete 13 × 13 diallel
cross of distinct maternal families of Mimulus guttatus (seep monkeyflower, a.k.a. Ery-
thranthe guttata; family: Phrymaceae), excluding self-pollinations (‘inbreds’), investigators
found very low estimates of additive, narrow-sense, heritability to CuMV, however they
uncovered significant maternal effects on one measure of infection tolerance, highlighting
the diverse genetic and non-genetic sources of host resistance and tolerance architecture
(Carr et al. 2005). In contrast, in a 10 × 10 diallel cross studying the genetic architecture
of maize streak virus (MSV) resistance in five quality protein maize (QPM) inbred lines
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and five known resistant maize cultivars, resistance heritability was dominated by specific
combining ability (SCA) effects, i.e., non-additive genetic action, (Bello 2017). Thus, in
plants, the diallel has been used for decades toward the improvement of crops for food
security and resource improvement, as a preliminary study design for characterizing her-
itability, assisting in guiding study designs for follow-up investigations to select resistant
hybrids, and to map markers and loci important for host resistance to virus-induced dis-
ease.
Like several of these studies, our infection diallel was comprised of founder strains
which strongly differed in their resistance profile to the pathogen under investigation (IAV
PR8), with three being highly resistant (NZO, CAST, and PWK), and five being highly
susceptible (AJ, B6, 129, NOD, WSB) to the disease phenotype (IAV-induced weight
loss). Our use of ancestral allelic origin at the major host resistance locus segregating
in the parental lines led us to conclude that two distinct dominance profiles segregated
between the three resistant founder lines. Future infection diallels, and/or reanalysis of
prior diallels, may be able to build upon this approach, modeling contrasts of dominance
among functional vs. null (or functional vs. resistant) host alleles more explicitly, in order
to understand the basis of non-additive variation, and indeed even dominance underlying
additive signals, to uncover distinct genetic dominance effects that are otherwise obscured
by the complexity of phenotypes in a large-scale cross.
Infection diallels in invertebrates and vertebrates. In invertebrates, a recent study
examining a complete 8 × 8 diallel cross of Drosophila lines selected from the DGRP (4
resistant and 4 susceptible) and challenged orally with Pseudomonas entomophila, an en-
tomopathogenic bacterium, demonstrated significant signals of additivity (general combin-
ing ability; GCA), dominance (SCA), reciprocal effects, and maternal interaction effects
in the p.i. resistance profiles, as measured by survival at D3 p.i.; heterosis appeared to
contribute to resistance and survival in a subset of F1 crosses (Bou Sleiman et al. 2015),
suggesting that the resistance was in part, due to epistatic effects. A preliminary reanal-
ysis on power-transformed survival data from this study, using the BayesDiallel model
and VarP analysis, gives the result that ∼47.2% of the total variance explained is addi-
tive, with ∼18.2% contribution from epistatic (symmetric and asymmetric), and ∼6.5%
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contribution, in agrregate, from other non-additive classes (maternal, inbred overall, and
strain-specific inbred), suggesting that most of the non-additive variation is due to partic-
ular dominant (or recessive) effects within specific line combinations. Bou Sleiman et al.
(2015) subsequently identified 27 QTLs affecting resistance to pathogenesis, confirming
distinct additive effect loci underlying disease variability, even in the presence of strong
signals of epistatic variation. Thus, diallel crosses using lines from recombinant inbred
genetic reference populations are a useful complement to mapping studies in the same
populations, helping characterize the aggregate patterns of inheritance effects at loci that
may or may not be detected using common interval mapping approaches.
In vertebrates, there are few examples of the diallel being used to study host viral
infection resistance, with additional studies having used diallels to explore immunity and
various non-viral challenges. In a 3 × 3 diallel cross of lines of chicken (Gallus gallus do-
mesticus), embryos from F1 cross hybrids were found to have asymmetric resistance to
in reciprocal crosses when challenged with infectious bronchitus virus (IBV; family Coro-
naviridae) (Purchase et al. 1966). In addition, diallel cross studies in poultry explored
the host response to Marek’s disease virus (MDV; family Herpesviridae) (Gavora 1979;
Gavora et al. 1980), followed by QTL mapping studies identifying regions significantly
affecting host susceptibility to infection-induced disease (Vallejo et al. 1998; Yonash et al.
1999) and QTL for hen immune responsiveness (Siwek et al. 2003). Again, the diallel has
been used in invertebrates to guide the direction of quantitative trait mapping studies
on infection response, providing a basis for inclusion or exclusion of particular lines or
crosses in the test population.
The utility of the diallel, beyond host infection resistance. Some of the value of the
advances in diallel modeling which we have promoted through our influenza diallel study
has been useful beyond studies of host resistance to disease. The dominance analysis,
which I implemented using Bayes Diallel posterior estimates, is based on classical metrics
and was intended for use in our analysis of relative levels of Mx1 allelic dominance, and
was immediately useful to our collaborators at the University of Wisconsin who were
interested in the genetic architecture of shoot growth in a 6× 6 diallel cross of inbred lines
of wild carrot, Daucus carota L. They were interested in understanding the line-cross-
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specific dominance, and visualized this using a related degree of dominance parameter.
My contributions to that work resulted in co-authorship in a publication by Turner et al.
(2017), whereby we found that non-additive effects were especially impactful in the early
growth season traits, and that heterosis may play an important role in an indicator of
plant yield, root biomass (details about the degree of dominance parameter are included
in Appendix B.1). In addition, adaptations of the linear mixed effects model of Bayes
Diallel to acommodate non-Gaussian phenotypes (binomial- and Poisson-distributed) has
been useful for modeling litter size variation and sex ratio distortion in an 8 × 8 cross of
the CC founders, in an ongoing study in preparation for submission to G3 (the model is
described in brief in Appendix B.2).
Genomics and transcriptomics: Advancing our knowledge of genetic and immunologic
regulation. Diallel experimental designs are proving incredibly productive in genomic stud-
ies exploring regulation of gene expression and parental and allelic biases in gene expres-
sion levels. In a study by Kiekens et al. (2006), the investigators carried out a genome-
wide screen for cis-regulatory variation using a classical diallel crossing scheme (Kiekens
et al. 2006). In a diallel study of the three wild-derived CC founder lines (CAST, PWK,
WSB), Crowley et al. (2015) uncovered significant parent-of-origin effects and identified
global allelic imbalance, with a bias toward paternal expression, expanding our under-
standing of gene expression regulation in diverse populations. Thus, the transcriptomic
analysis of F1 reciprocal cross animals (with or without the inclusion of parental strains)
is becoming a popular and powerful technique for assessing cis-regulation of gene expres-
sion and for identifying parent-of-origin effects in specific tissues and timepoints of inter-
est across evolutionary divergent individuals. The further extension of these techniques to
single-cell sequencing studies is sure to be fruitful for unraveling the mechanisms behind
disease and regulatory functions in the years to come.
Causal effects analysis in the diallel. We built our treatment response diallel analysis
upon a simpler treatment-control matching scheme, described in Crowley et al. (2014).
We took the perspective of potential outcomes, from causal inference, and were interested
in measuring the effect modification of genetic parentage on average treatment effects
(ATE; as described in detail in Gelman and Meng (2004), Pearl et al. (2016), and Hernán
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and Robins (2018)). Our study was unique in that the imbalance was intentional and
systematic, with a ‘quartet’ design, including 1 mock treated plus 3 infected animals,
within each experimental group. Thus, in a given batch, there were multiples of four an-
imals with a quarter of them being mock controls, and three quarters being infecteds,
with some degree of missingness due to availability and breeding. We used stochastic re-
gression imputation, built on the principle of missing data multiple imputation (Gelman
and Hill 2006; van Buuren 2012), requiring a model fit followed by a posterior predic-
tive imputation within an appropriate treatment group, to fill in values for the ‘missing’
individuals, and averaged over the possible space of 1000 imputed data sets, fitting the
Bayes Diallel model to each one of these and subsequently modeling difference scores, as
described in Appendix A. This allows a more fair assessment of variance within each
diallel category, sex and batch.
5.1.2 Parent-of-origin effects on infection
In the second study, in Chapter 3, I go on to define clinical and transcriptomic effects
of parent-of-origin in mock and influenza-infected mice, and demonstrate the utility of
the reciprocal cross breeding design to: enable the identification of genes under epige-
netic control; discover novel genes underlying disease pathogenesis; and uncover genome
imprinting effects on host response to viral infection.
Parent-of-origin effects, and the promise of genomic studies of host response to in-
fection. Next-generation genomic technologies provide rich data sets with the potential
for characterization of correlates of protection for vaccination and challenge studies. A
recent paper by Lee et al. (2016) predicted vaccination success using machine learning
techniques, and successfully isolated the influence of a gene, EIF2AK4, regulating the
likelihood of successful patient immunization, and predicting immunization outcomes
with an accurracy over 90%, based on clinical phenotypes and high-dimensional molecu-
lar indicators. Additional studies have attempted to use immunogenomics techniques to
predict vaccination success (Nakaya et al. 2011). In addition, proteomic analysis is under-
going substantial improvement in the immunology field, and shows promise, along with
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gene expression, in helping characterize novel functional subtypes of immune cells, and
communication and relationship networks among cells (Rieckmann et al. 2017).
RNA-seq differential expression results. Although our RNA-seq analysis is incom-
plete and ongoing, we identified a number of differentially expressed genes in our DE-
Seq2 analysis stratified by treatment category, including, perhaps surprisingly, several
immunoglobulin gene segments that significantly differed in their total expression, with
segments from: Ighv8 (mock), Igkv15 (mock), and Ighv5. The immunolobulin (Ig) genes
in mammals are complex genetic sites, subject to germline rearrangement in somatic cells,
that encode antigen-binding proteins important for autoimmunity and the adaptive (and
innate) humoral immune response (Murphy and Weaver 2016). There are heavy and light
chains, and within the heavy chains, there are Ighv, Ighd, and Ighj genes, with the V, D
and J standing for variable, diverse, and joining regions. So, the Ighv and Igkv genes en-
code for proteins that make up the heavy chain and light chain segments, respectively,
of various types of secreted antibody (immunoglobulin), including IgM, IgG, and IgA. It
has been shown that Ighv genes are highly divergent between C57BL/6J and BALB/c,
with only 5 of the 99 known B6 genes shared with BALB/c (Collins et al. 2015), and this
seems to be largely determined largely by subspecies origin at that locus. There is, also,
a high level of genetic predetermination of B cell clonal expansion and Ig V gene usage
in the antibody repertoire of mice (Greiff et al. 2017), and antibody-forming cells (AFCs)
are known to form when B cells first encounter IAV in the respiratory tract, with B cells
playing an important role in early clearance kinetics in the host response to IAV (Ger-
hard et al. 1997; Waffarn and Baumgarth 2011). These studies suggest a fairly strong
germline-dependent segregation between inbred strains of different ancestral origin in the
potential for natural antibody-mediated protection (prior to somatic hypermutation and
rearrangement, as at our early timpoint p.i., at 4 days), and also potential for differences
in the adaptive response. If imprinted gene networks affect gene expression at Ig loci, it is
possible that germline differences between strains would manifest as differences between
reciprocals, in a parent-of-origin dependent manner. Germline rearrangement capacity at
the Ighv loci is known to be important for determining the efficacy of broadly neutralizing
antibodies to influenza (Fu et al. 2016), warranting a more in depth exploration of the
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imprinting effects on immunoglobulin in mock and infected tissues. Natural IgM, secreted
by B1 (and B2) B cells, exists as a polyreactive secreted host factors in the absence of
virus challenge, and plays a role in complement-mediated innate neutralization capacity
of IAV (Jayasekera et al. 2007). Levels of natural IgM may differ between reciprocals—
whether the differences we observed in total gene expression of Igh and Igk genes in this
study relates to a difference in levels of natural IgM important for innate resistance to
IAV remains to be determined.
5.1.3 Mapping quantitative trait loci for virus-induced disease in
recombinant inbred crosses
Finally, in the third study in Chapter 4, I use newly available mapping tools in con-
junction with a recently completed CC-RIX influenza infection screen to define a QTL
that significantly impacts disease pathogenesis in the lung on day 10 post-infection, as
measured by lymphocyte scores in H&E stained histology sections. New methods are
emerging for properly dissection strain-specific, maternal, and parent-of-origin effects
in reciprocal crosses (Takada et al. 2017) and in mapping populations (Liu et al. 2017).
Thus, in combination with advanced analytical methods, MPP-derived mapping pop-
ulations provide complex platforms for studying a variety of genetic effects, as well as
mapping additive effects alone.
Studies mapping viral resistance, as discussed above in plants, have long used inbred
crosses and recombinant inbreds and/or other GRPs. The maize (Zea mays L.) RIL map-
ping population, called the nested association mapping (NAM) resource, is derived from
a set of 25 diverse founders which were all mated with a common reference founder, and
subsequently intermated to generate over 5000 recombinant inbred mapping lines (?Mc-
Mullen et al. 2009). In a mapping study of viral resistance in Drosophila melanogaster,
using Drosophila C virus (DCV; family: Dicistroviridae) and Drosophila melanogaster
Sigma virus (DMelSV; family: Rhabdoviridae), resistance to DCV is nearly monogeni-
cally determined by allelic variation in the gene pastrel (explaining 47% of the resistance
heritability), and resistance to DMelSV by only a few genes (together explaining 37% of
resistance heritability) (Magwire et al. 2012). As they performed association mapping in
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inbred D. melanogaster lines only, they note that they cannot specifically predict resis-
tance in outbreds without knowing the level of dominance or additivity of the resistance
genes, which, due to their study design, they are unable to assess. Thus, for infection
studies, for which known and unknown resistance factors may have a high likelihood of
dominant action, the use of an inbred cross design, such as in the RIX, has the advantage
of providing the potential for estimates of dominance at various loci, and mapping can be
conducted using an additive or full (diplotype state parameters included) linear model, as
in miqtl (see an example of the package, as used in (Keele et al. 2017)). Our work is a
first attempt at maping pulmonary pathology phenotypes related to the host response to
influenza in the CC-RIX, building upon prior IAV studies in the preCC (Ferris et al. 2013;
Gralinski et al. 2015) and the CC (Rasmussen et al. 2014; Graham et al. 2015), and other
virus studies in the CC-RIX (Graham et al. 2017), and sets the stage for future mapping
studies of infection response in this population.
5.2 Future Directions
Microbiome. Future work is certain to reveal important effects of microbiome composi-
tion, especially as investigated in the gut (and, noninvasively in feces), on host immunity
in response to infection. The host microbiome can be thought of as a source of epigenetic
effects on host phenotypes (Geva-Zatorsky et al. 2018), serving as a largely mutualist pop-
ulation guiding the development and behavior of the host immune system. Experiments
using reciprocal transfers of wild and laboratory-derived murine microbiota resulted in
striking differences in survival, post-IAV infection (Rosshart et al. 2017). Future stud-
ies on genetic architecture of the host IAV response should at the very least be sure to
include controls for host microbiota; we have attempted to keep environments shared be-
tween individuals we intend to contrast, with the intention of controlling for microbiota
effects, however the use of antibiotics or microbial screening to determine the extent of
microbiota effects on infection outcomes is an ongoing interest in our work.
Evolution and selection. Some prominent evidence for infection and immunity-related
positive selection in natural populations include recent signals of selection at TLR genes
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in Europeans (Barreiro et al. 2009), and malarial resistance genes in African and South-
east Asian populations (Tishkoff et al. 2001). Interstingly, in bats, specific residues in
Mx1 were found to have significant signatures of positive-selection, suggesting that Mx1
has long played a role in antiviral responses, impacting species fitness in diverse mam-
malian orders (Fuchs et al. 2017). In addition, genetic adaptation in humans, due to
environmental effects, seems likely to have been dominated by strong contributions from
pathogens (Fumagalli et al. 2011; Brinkworth 2017). Ancient hybridizations between
humans and Neanderthals, appear to have been followed by adaptive introgression (intro-
gression followed by positive selection) of immune genes, leading to potentially important
ancestral effects on gene regulation and immune function (Racimo et al. 2017). Thus, the
question remains: what is the ultimate impact of the mode of inheritance of loci for in-
fectious disease resistance and susceptibility loci? Importantly, the mode of inheritance
of host factors may have an impact on natural selection in the host, leading to shifts
in population-level allele frequencies for infectious dissease susceptibility and resistance
genes, as suggested by signals of positive selection on immune genes in primates (Nielsen
et al. 2005), and other evidence for pathogen-driven balancing selection at blood group
antigen (BGA) genes (Fumagalli et al. 2009), human leucocyte antigen (HLA) genes
(Prugnolle et al. 2005), and potential co-evolution with killer immunoglobulin-like re-
ceptor (KIR) genes (Single et al. 2007). Differentiating between the effects of positive/pu-
rifying selection, and neutral evolution and requires some caution, however, including
careful study design and statistical modeling (Bamshad et al. 2002; Sabeti et al. 2005),
and thus the true evolutionary impacts from additive and non-additive effects at disease
resistance loci remain to be understood. Furthermore, dominance or recessivity of host
resistance genes may change the fitness landscape of allelic variants over the long term,
with infection over a sustained period of time possibly leading to selection at specific vari-
ants, which may then have an impact on a variety of other host disease susceptibilitiy,
such as diabetes (Nejentsev et al. 2009) or various forms of autoimmunity. The relation-
ship between these non-infectious phenotypes and infection-related selection at specific
nucleotides is thus an interesting avenue for future exploration.
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Closing Remarks. Analyses that are able to integrate emerging multivariate data sets,
containing data from genomics and other “omic” approaches and deep phenotyping, may
provide further understanding of the heritable host response to infection. As well, ex-
tending systems studies to related, but more naturally evolving populations may help
translate findings from the CC and related genetic reference populations into evolutionary
insights on genetic susceptibility to infectious disease (Quintana-Murci et al. 2007). In
addition, integrative quantitative trait mapping of the host and pathogen (Power et al.
2016) may help us finally arrive at a deep genetic understanding of host-pathogen interac-
tions in a way that was not available before the arrival of the genomic era.
Through this work, I hope that I have demonstrated that we are at a critical turn-
ing point in our ability to explore the systems genetics of immunity to viral infections.
Just as some of the foundational work of quantitative genetics and statistics began with
experimental crosses of inbreds, strain crosses are currently enabling the next genera-
tion of systems genetics research and insight into disease resistance and host pathology.
Complex traits modeling with genetic crosses can reveal important, novel heritable archi-
tecture of resistance to infection, and reciprocal crosses reveal that epigenetic effects on
infection may be critical, and mediated via specific immune-related pathways. As well,
recombinant inbred crosses reveal that there are novel genetic loci across the genome that
control infection outcomes. Non-additive effects (dominance, parent-of-origin) play a sub-
stantial role in explaining heritable variation. It is interesting to hypothesize whether
non-additive effects play a more substantial role when it comes to host infection response,
and other G×E or G×T contexts, in comparison with baseline traits.
Finally, it is clear that reproducible and replicable results in viral pathogenesis will
only be truly generalizable if they rely increasingly on resources such as the Collaborative
Cross and other GRPs, complementing studies in knockouts, to integrate out the effects
of genetic background on the effect of causal genetic variants underlying infectious disease
traits, and to uncover otherwise cryptic host heritability contributing to disease.
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APPENDIX A: Influenza Diallel Supplement
The following three sections include supplemental appendices, published along with
the paper, for the influenza diallel study described in Chapter 2.
Appendix A.1: Defining a potential outcomes model of treatment response
with quartets
In the potential outcomes framework of Neyman (1923) and Rubin (1974) the causal
effect of an applied treatment on a measured outcome in an individual i is defined as the
difference between the outcome under treatment and the outcome that would have been
observed if i were instead to have received the control. In our case, for some outcome






where yflui and ymocki are “potential outcomes”, one of which is observed (the factual) and
other of which is unobserved (the counterfactual). Since it is impossible to observe both
simultaneously, the causal effect ∆i can never be measured directly (Holland 1986). It can






with the accuracy of this estimate depending on how closely i′ matches i. Our desire for
lack of bias in this measure motivates our treatment assignment being randomly ascribed
within a group of matched individuals.
In the treatment-response diallel, we are primarily interested not in infection response
for a particular mouse but rather the expectation of this quantity for mice within a given
diallel category, or more generally within a group of matched individuals q,
∆q = E(yfluq − ymockq ) = E(yfluq ) −E(ymockq ) , (A1)
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where in our case q is defined as mice specific to a given diallel category and experimental












where q[flu] and q[mock] are, respectively, the set of mice in group q assigned to flu and








and if it is considered likely, as in this study, that the infected phenotypes will be more
variable than the mock, Var(yflu) > Var(ymock), then it is most efficient experimentally to
devote more individuals to the the infected arm than the mock arm, i.e., nflu > nmock.
In our experimental design, we have flu:mock in the ratio 3:1 for each group q. It is
therefore natural to define the unit of observation q as a quartet, that is, Eq A2 with
nflu = 3 and nmock = 1. This means that each diallel category can be represented by
multiple quartets, corresponding to multiple observations of ∆̂q, denoted in the Methods
as deltaq.
We now note several assumptions and connections. Eq A1 equates unit-level with
marginal causal effects and thereby assumes no interference between units, specifically,
that mice in the same quartet do not affect each other’s outcomes; this is approximately
true based on the well-established evidence that mice do not transmit H1N1 influenza
virus (Lowen et al. 2006; Edenborough et al. 2012), a finding we have also verified by
weight loss profiles and RNA-seq of CC founder strains co-housed with H1N1(PR8)-
infected mice (Xiong et al. 2014). Last, the definition of ∆̂q in Eq A2 is analogous to
an inverse probability weighted causal effect estimate.
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Appendix A.2: Stochastic regression imputation of missing quartet partners
The equation for the variance of ∆̂q, namely Eq A3, implies that modeling the resid-
ual in Eq 2.5 as homoskedastic would require nflu and nmock to be constant throughout —
in other words, in order to ensure comparable precision of infection responses, all quartets
should be complete. However, in the diallel experiment some combinations of batch and
diallel category had one or more flu mice missing. In these cases, quartets were defined
to have missing values that would be filled in by imputation. The imputation scheme
used here corresponds to stochastic regression imputation (e.g., Gelman and Hill 2006)
whereby the incomplete dataset is repeatedly augmented to a completed data set using
sampled variates from a prediction model, each completed dataset is subject to the Bayes-
Diallel analysis described in Methods, and then results across the completed datasets
are aggregated.
Each imputation required two steps: since the target phenotype of a missing mouse,
namely its p.i. weight loss, was considered potentially dependent on its day 0 weight, we
first imputed missing values for D0 and then imputed missing p.i. weight loss conditional
on D0. In addition, at each day p.i., there was one batch/diallel category combination
with 1 mock and 4 infecteds; for this case only, in each round of imputation, we created a
completed quartet by randomly deleting one of the four infecteds.
The two-step stochastic regression imputation was performed as follows. Define the
observed diallel data for D0 and pctday[flu] as D0obs and pctday[flu]obs respectively, and lett
sim
∼
represent regression with BayesDiallel followed by stochastic regression imputation, that
is, sampling from the posterior predictive. For each t = 1, . . . , 1000 round of imputation,
we first impute missing D0 values as
D0(t)mis
sim
∼ BayesDiallel (D0obs) , (A4)
where BayesDiallel is fitted as Model 1 in Table 2.2. These imputed values are then

































Each of the 1000 infection response data sets is analyzed separately using BayesDial-
lel (Model 3 in Table 2.2). The MCMC chains from each replicate are aggregated and
thinned (sampled across even intervals) and the aggregate results are reported, according
to the procedure outlined in Algorithm 1 in the Supplement.
The number of animals imputed were 33 at D1, 33 at D2, 15 at D3, and 16 at D4,
in each case corresponding to a small proportion (2.8%-3.1%) of the total data set. Phe-
notypes were not impputed non-productive diallel genotypes (which contain no mock or
infected mice at all), i.e. j k ∈ {NZO×CAST, NZO×PWK} (Chesler et al. 2008).
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Appendix A.3: Data upload details
Data and analysis files in this supplement include:
• File_S1_Readme.pdf - read me file providing overview of data upload.
• File_S2_Packages.tar.gz - packages used for analysis.
• File_S3_FluDiData.csv - diallel data file.
• File_S4_diallel.tar.gz - diallel analysis files.
• File_S5_preCC.tar.gz - pre-CC data and analysis files.
• File_S6_CC-RIX.tar.gz - CC-RIX data and analysis files.
After unzipping supplemental files S2, S4, S5, and S6 in a common folder, the direc-
tory structure will be as follows:
DATA UPLOAD DETAILS
Data and analysis files in this supplement include:
• File_S1_Readme.pdf - read me file providing overview of data
upload.
• File_S2_Packages.tar.gz - packages used for analysis.
• File_S3_FluDiData.csv - di llel data le
• File_S4_diallel.tar.gz - diallel analysis files.
• File_S5_preCC.tar.gz - pre-CC t and analysis files.
• File_S6_CC-RIX.tar.gz - CC-RIX data and analysis files.
After unzipping supplemental files S2, S4, S5, and S6 in a com-














The files that are needed to reproduce the diallel analysis
are given in the “diallel” folder, which includes the raw phe-
notype file, FluDiData.csv, and the following settings files,
CategoriesToImputeD4.csv, and settings.config.D4. Addi-
tional *.R, *.sh, and *.pl scripts necessary to run the analysis are
included.
To run the analysis for D4 treatment response on a macOS ma-
chine with both R and Perl installed, first install prerequisites, as
necessary, and then install BayesDiallel, BayesSpike, and treatmen-
tResponseDiallel. On a bash shell, from the “diallel” directory, use
the following command (example using D4):
bash MIMQ_Run_D4.sh &
When the jobs on all cores are complete, then run:
bash MIMQ_PostRun_D4.sh &
Again, when the jobs on all cores are complete, run the follow-
ing to clean up temporary files:
bash MIMQ_cleanup.sh &
pre-CC Analysis
The files that are needed to reproduce the pre-CC anal-
ysis are given in the “preCC” folder. The raw pheno-
type file is Flu-preCC-data.csv, and the analysis script is
main_analysis_preCC.R. To run the analysis, install the required
prerequisites, and then INLA and Diploffect; proceed to run the
analysis script from R.
CC-RIX Analysis
The files that are needed to reproduce the CC-RIX anal-
ysis are given in the “CC-RIX” folder. The raw pheno-
type file is Flu-CC-RIX-data.csv, and the analysis script is
main_analysis_CC_RIX.R. To run the analysis, install the required
prerequisites, and then INLA and Diploffect; proceed to run the
analysis script from R.
Packages
The specific versions of the main analysis software packages used
in this paper are provided in the “packages” folder. The pack-
ages, data and code required to reproduce the analysis in this
manuscript are available as a data repository at http://dx.doi.org/10.
5281/zenodo.293015, which is a static version of the GitHub reposi-
tory maintained here: https://github.com/mauriziopaul/flu-diallel. The
BayesDiallel and Diploffect software packages have been previ-
ously published (Lenarcic et al., 2012, Genetics; Zhang et al., 2014,
Genetics), and are available at the Valdar lab website software page
(http://valdarlab.unc.edu/software.html). The R package that facil-
itates the treatment response analysis in this paper is provided
in the file treatmentResponseDiallel_0.0.0.9000.tar.gz, and
is available at the following GitHub site: https://github.com/
mauriziopaul/treatmentResponseDiallel. It can be installed accord-
ing to instructions on the website. It can also be installed us-
ing the command ‘R CMD INSTALL treatmentResponseDial-
lel_0.0.0.9000.tar.gz’ in a terminal. The following prerequisite pack-
ages for treatmentResponseDiallel can be installed in a similar
fashion: configfile_0.11.tar.gz and cmdline_1.1.tar.gz.
File Types
• *.R - These are R scripts used for analysis of the respective
populations.
• *.pl - This is a Perl script used in the diallel analysis.
• *.sh - These are bash scripts used for the diallel analysis.
• *.RData - These files in the happy_format and happy_cache di-
rectories contain data that can be loaded in R that is necessary
for the Diploffect models to run.
• *.csv - These are comma-separated files containing raw data
and/or analysis settings.
• *.alleles - This file can be used to generate a full model in the
happy cache.
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iallel Analysi . The files that are needed to reproduce the diallel analysis are given
in the “diallel” folder, which includes the raw phen type file, FluDiData.csv, and the fol-
lowing settings files, CategoriesToImputeD4.csv, and settings.config.D4. Additional
*.R, *.sh, and *.pl scripts necessary to run the analysis are included.
To run the analysis for D4 treatment respons on a macOS mac ine with both R
and Perl installed, first install prerequisites, as necessary, and then install BayesDiallel,
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BayesSpike, and treatmentResponseDiallel. On a bash shell, from the “diallel” directory,
use the following command (example using D4): bash MIMQ_Run_D4.sh &. When the
jobs on all cores are complete, then run: bash MIMQ_PostRun_D4.sh &. Again, when
the jobs on all cores are complete, run the following to clean up temporary files: bash
MIMQ_cleanup.sh &.
pre-CC Analysis. The files that are needed to reproduce the pre-CC analysis are
given in the “preCC” folder. The raw phenotype file is Flu-preCC-data.csv, and the
analysis script is main_analysis_preCC.R. To run the analysis, install the required pre-
requisites, and then INLA and Diploffect; proceed to run the analysis script from R.
CC-RIX Analysis. The files that are needed to reproduce the CC-RIX analysis are
given in the “CC-RIX” folder. The raw phenotype file is Flu-CC-RIX-data.csv, and the
analysis script is
main_analysis_CC_RIX.R. To run the analysis, install the required prerequisites, and
then INLA and Diploffect; proceed to run the analysis script from R.
Packages. The specific versions of the main analysis software packages used in this
paper are provided in the “packages” folder. The packages, data and code required to
reproduce the analysis in this manuscript are available as a data repository at http://
dx.doi.org/10.5281/zenodo.293015, which is a static version of the GitHub repository
maintained here: https://github.com/mauriziopaul/flu-diallel. The BayesDiallel
and Diploffect software packages have been previously published (Lenarcic et al., 2012,
Genetics; Zhang et al., 2014, Genetics), and are available at the Valdar lab website soft-
ware page (http://valdarlab.unc.edu/software.html). The R package that facilitates
the treatment response analysis in this paper is provided in the file treatmentResponseDiallel_
0.0.0.9000.tar.gz, and is available at the following GitHub site:
https://github.com/mauriziopaul/treatmentResponseDiallel. It can be installed
according to instructions on the website. It can also be installed using the command ‘R
CMD INSTALL treatmentResponseDiallel_0.0.0.9000.tar.gz’ in a terminal. The following




• *.R - These are R scripts used for analysis of the respective populations.
• *.pl - This is a Perl script used in the diallel analysis.
• *.sh - These are bash scripts used for the diallel analysis.
• *.RData - These files in the happy_format and happy_cache directories contain
data that can be loaded in R that is necessary for the Diploffect models to run.
• *.csv - These are comma-separated files containing raw data and/or analysis set-
tings.
• *.alleles - This file can be used to generate a full model in the happy cache.
164




































A B C D E F G H
A B
Figure A1 Diallel crossing design for the influenza diallel experiment. (A) Eight inbred
Mus musculus strains were crossed in both directions to generate animals used in this
experiment. All of the animals were followed from D0 through D2. Approximately half
of the animals were followed through D4, and the remaining half of the mice were sacri-
ficed on D2 (for analysis not included in this manuscript). (B) Of the 1,043 mice in this
experiment, 268 received mock treatment, and 775 received influenza (flu) inoculation,
or approximately 1 mock for every 2.9 infected mice within each category. There were
one hundred twenty-nine inbred mice and 914 heterozygous (hybrid F1) mice used in
this study. Crosses that were not observed (marked with a "-") include NZO×CAST and















































































































































Figure A2 CC-RIX crossing design for the influenza infection experiment. As part of a
larger CC-RIX QTL mapping experiment, 65 Collaborative Cross (CC) RI strains were
crossed, approximately once as dam and once as sire in a round robin breeding scheme,
to generate female animals in 105 CC-RIX lines, aged 8-12 weeks, that were sacrificed
on day 7 (D7) post-infection, and used in this experiment. Weights for all of the animals
were measured from D0 through D7. There were 1,402 heterozygous (hybrid F1) mice




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure S2 Raw weight loss curves for influenza infected and mock-infected mice, as percent starting weight.

































Figure A3 The raw distribution and timecourse of mock- and flu-induced weight change
in the diallel. (A) Rank-ordered distribution of individual mock- and flu-induced percent
weight change of inbred and F1 animals at D4 p.i. (B) Rank-ordered distribution of in-
bred and F1 flu-infected percent weight change at D4 p.i. (C) An example of raw weight
change curves for AA (AJ×AJ) male and female mice. (D) The panel of raw weights for
the 62 possible diallel categories. In (C) and (D), y-axes indicate percent of D0 weight,
and x-axes indicate day(s) post-infection, while grey lines indicate individual weight
change trajectories; colored lines indicate mean male (blue) and mean female (red) weight
trajectories, and among these means, colored line styles indicate mock (dashed) and in-
fluenza (solid) treatment means within each group. In (D), the large X’s in EF and EG
indicate non-productive F1 matings. Inbred mouse lines AJ, B6, 129, NOD, NZO, CAST,
PWK, and WSB are indicated by letters A through H, respectively, with the first letter
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Figure A4 Body mass in a diallel cross of inbred mice. (A) Baseline body weight (in
grams) for (B) male and (C) female 8-12 week old mice (n=1,043), presented as mean


























































































































































Figure A5 Weight loss in influenza-infected mice from a diallel cross of inbred mice. (A)
Change in body weight on (A) day 1 (D1), (B) D2, (C) D3, and (D) D4 post-infection,
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Figure A6 Diallel effect o D0 body weigh in a diallel cross of inbred mice. (A) Ef-
fect estimates for additive, maternal, inbred, and epistatic effects, including sex-specific
effects, are presented as highest posterior density intervals (in grams) for adult baseline
body weight in 8-12 week old mice (n=1,043). Parameters are labeled according to the
methods, and intervals are presented as in Figure 2.5A. Symmetric epistatic, asymmet-
ric epistatic, and sex-specific parameters are indicated by “v:”, “w:”, and “f:”, respec-
tively. The overall mean, µ, (not shown) is 23.97 (23.56, 24.41) grams. (B) Posterior
mean model inclusion pro abi ities (MIPs) are given for effect parameter classes. (C)
Variance projection (VarPs), a generalization of heritability to the diallel effects classes,
are shown for three overall effects, five random effects classes, and five corresponding
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Figure A7 Diallel eff cts on host infection response (w ght change) at D1 post-infection,
using multiple imputation matched quartets. Effect estimates for additive, maternal,
inbred, and epistatic effects, including sex-specific effects, are presented as highest poste-
rior density intervals (in percent starting weight) in 8-12 week old mice (n=1,042). Pa-
rameters are labeled according to the methods, and intervals are presented as in Figure
2.5A. Symmetric epistatic, asymmetric epistatic, and sex-specific parameters are indi-
cated by “v:”, “w:”, and “f:”, respectively. The overall treatment effect θ is -0.131% (-
0.484%,0.223%). (B) Model inclusion prob iliti s (MIP ) are given (posterior mean ±
1 s.d.) for effect parameter classes. (C) Treatment response variance projections (TRe-
VarPs), a generalization of heritability to the diallel effects classes, are shown for three
overall effects, five random effects classes, and five corresponding sex-specific random

































































model inclusion probability (MIP)



















−10 −5 0 5 10

























































−10 −5 0 5 10





























































































































−10 −5 0 5 10































































−10 −5 0 5 10















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































0.0 0.1 0.2 0.3 0.4 0.5








































































































































































































































































































































































































































































Figure A8 Diallel eff cts on host infection response (w ght change) at D2 post-infection,
using multiple imputation matched quartets. Effect estimates for additive, maternal, in-
bred, and epistatic effects, including sex-specific effects, are presented as highest posterior
density intervals (in percent starting weight) in 8-12 week old mice (n=1,042). Parame-
ters are labeled according to the methods, and intervals are presented as in Figure 2.5A.
Symmetric epistatic, asymmetric epistatic, and sex-specific parameters are indicated
by “v:”, “w:”, and “f:”, respectively. The overall treatment effect θ is -0.833% (-1.328%,-
0.318%). (B) Model inclusion probabilities (MIPs) are given (posterior mean ± 1 s.d.) for
effect parameter classes. (C) Treatment response variance projections (TReVarPs), a gen-
eralization of heritability to the diallel effects classes, are shown for three overall effects,
five rando effects classes, and five corresponding sex-specific random effects classes (with
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Figure A9 Diallel eff cts on host infection response (w ght change) at D3 post-infection,
using multiple imputation matched quartets. Effect estimates for additive, maternal, in-
bred, and epistatic effects, including sex-specific effects, are presented as highest posterior
density intervals (in percent starting weight) in 8-12 week old mice (n=514). Parameters
are labeled according to the methods, and intervals are presented as in Figure 2.5A. Sym-
metric epistatic, asymmetric epistatic, and sex-specific parameters are indicated by “v:”,
“w:”, and “f:”, respectively. The overall treatment effect θ is -5.594% (-6.470%, -4.729%).
(B) Model inclusion proba ilities (MIPs) are given (posterior mean ± 1 s.d.) for effect
parameter classes. (C) Treatment response variance projections (TReVarPs), a general-
ization of heritability to the diallel effects classes, are shown for three overall effects, five
rand m effects classes, and five corresponding sex-specific random effects classes (with
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Figure A10 Diall l effects on host infection response (weight change) at D4 post-
infection, using multiple imputation matched quartets. Effect estimates for additive, ma-
ternal, inbred, and epistatic effects, including sex-specific effects, are presented as highest
posterior density intervals (in percent starting weight) in 8-12 week old mice (n=513).
Parameters are labeled according to the methods, and intervals are presented as in Figure
2.5A. Symmetric epistatic, asymmetric epistatic, and sex-specific parameters are indicated
by “v:”, “w:”, and “f:”, respectively. The overall treatment effect θ is -8.849% (-9.920%,
-7.779%). (B) Model inclusion probabilities (MIPs) re given (posterior mean ± 1 s.d.) for
effect parameter classes. (C) Treatment response variance projections (TReVarPs), a gen-
eralization of heritability to the diallel effects classes, are shown for three overall effects,
five rando effects classes, and five corresponding sex-specific random effects classes (with
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Figure A11 Diall l effects on host infection response (weight change) at D1 post-
infection, using multiple imputation matched quartets and accounting for Mx1. Effect
estimates for additive, maternal, inbred, and epistatic effects, including sex-specific ef-
fects, are presented as highest posterior density intervals (in percent starting weight) in
8-12 week old mice (n=1,042) after including random effect u(Mx1 diplo). Parameters are
labeled according to the methods, and intervals are presented as in Figure 2.5A. Symmet-
ric epistatic, asymmetric epistatic, and sex-specific parameters are indicated by “v:”, “w:”,
and “f:”, respectively. The o erall t atm nt ffect θ is -0.193% (-1.128%, 0.707%). (B)
Model inclusion probabilities (MIPs) are given (posterior mean ± 1 s.d.) for effect param-
eter classes. (C) Treatment response variance projections (TReVarPs), a generalization
of heritability to the diallel effects classes, are shown for three overall effects, five random
effects classes, and five corresponding sex-specific random effects classes (with posterior
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Figure A12 Diall l effects on host infection response (weight change) at D2 post-
infection, using multiple imputation matched quartets and accounting for Mx1. Effect
estimates for additive, maternal, inbred, and epistatic effects, including sex-specific ef-
fects, are presented as highest posterior density intervals (in percent starting weight) in
8-12 week old mice (n=1,042) after including random effect u(Mx1 diplo). Parameters are
labeled according to the methods, and intervals are presented as in Figure 2.5A. Symmet-
ric epistatic, asymmetric epistatic, and sex-specific parameters are indicated by “v:”, “w:”,
and “f:”, respectively. The o erall t atm nt ffect θ is -0.925% (-1.991%, 0.113%). (B)
Model inclusion probabilities (MIPs) are given (posterior mean ± 1 s.d.) for effect param-
eter classes. (C) Treatment response variance projections (TReVarPs), a generalization
of heritability to the diallel effects classes, are shown for three overall effects, five random
effects classes, and five corresponding sex-specific random effects classes (with posterior
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Figure A13 Diall l effects on host infection response (weight change) at D3 post-
infection, using multiple imputation matched quartets and accounting for Mx1. Effect
estimates for additive, maternal, inbred, and epistatic effects, including sex-specific ef-
fects, are presented as highest posterior density intervals (in percent starting weight) in
8-12 week old mice (n=514) after including random effect u(Mx1 diplo). Parameters are la-
beled according to the methods, and intervals are presented as in Figure 2.5A. Symmetric
epistatic, asymmetric epistatic, and sex-specific parameters are indicated by “v:”, “w:”,
and “f:”, respectively. The overall treatment effect θ is -5.429% (-7.675%, -3.102%). (B)
Model inclusion probabilities (MIPs) are given (posterior mean ± 1 s.d.) for effect param-
eter classes. (C) Treatment response variance projections (TReVarPs), a generalization
of heritability to the diallel effects classes, are shown for three overall effects, five random
effects classes, and five corresponding sex-specific random effects classes (with posterior
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Figure A14 Diall l effects on host infection response (weight change) at D4 post-
infection, using multiple imputation matched quartets and accounting for Mx1. Effect
estimates for additive, maternal, inbred, and epistatic effects, including sex-specific ef-
fects, are presented as highest posterior density intervals (in percent starting weight) in
8-12 week old mice (n=513) after including random effect u(Mx1 diplo). Parameters are la-
beled according to the methods, and intervals are presented as in Figure 2.5A. Symmetric
epistatic, asymmetric epistatic, and sex-specific parameters are indicated by “v:”, “w:”,
and “f:”, respectively. The overall treatment effect θ is -7.986% (-11.202%, -4.147%). (B)
Model inclusion probabilities (MIPs) are given (posterior mean ± 1 s.d.) for effect param-
eter classes. (C) Treatment response variance projections (TReVarPs), a generalization
of heritability to the diallel effects classes, are shown for three overall effects, five random
effects classes, and five corresponding sex-specific random effects classes (with posterior
median and 95% HPDs).
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Figure A15 Timecourse of posterior predictive estimates of for Mx1 diplotype mean effects across four days post-infection. From left to
right, predictive estimates of IAV-induced weight change are provided for D1, D2, D3 and D4 p.i. The right-most plot is reproduced in
Figure 2.6.
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D4.weight ~ 1 + D0_weight_grams + locus(JAX00072951)
INLA samples: 100
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D4.weight ~ 1 + D0_weight_grams + locus(JAX00072951)
INLA samples: 100
Variance Explained
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Figure A16 Mx1 effects and proportion of variance explained on weight loss in the pre-
CC. [Top Left] Additive Mx1 haplotype effects in pre-CC mice (n=155) infected with IAV
(PR8) at day 4 post-infection. [Top Right] Bayesian credible intervals of the posterior
predictive distribution of mice with Mx1 diplotype. [Bottom Left] Dominance devia-
tion Mx1 effects in the pre-CC mice. Wide intervals are indicative of the low levels of
heterozygosity observed in the mostly inbred pre-CC mice. [Bottom Right] Bayesian cred-
ible intervals of the posterior predictive distribution of the proportion of the phenotypic
variance explained by the Mx1 additive effects, dominant effects and the combination
of both effects. Black intervals (VC) are based on the posterior samples of the variance
components. Red intervals (SS) are based on the posterior samples of sums of squares
estimators. SS estimators are (1) not dependent on variance component estimates, which
tend to be disperse, and (2) are based on the observed strains and crosses, rather than all
possible strains/crosses, with (1) and (2) resulting in much narrower confidence intervals.
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Figure A17 Mx1 allele effects and proportion of variance explained on weight loss in the
CC-RIX. [Top Left] Additive Mx1 haplotype effects in CC-RIX mice (n=1,402) infected
with IAV (CA04) at day 7 post-infection. [Top Right] Bayesian credible intervals of the
posterior predictive distribution of mice with Mx1 diplotype. [Bottom Left] Dominance
deviation Mx1 effects in the CC-RIX mice. Narrower intervals compared to observed in
pre-CC is indicative of the high levels of heterozygosity CC-RIX mice. [Bottom Right]
Bayesian credible intervals of the posterior predictive distribution of the proportion of the
phenotypic variance explained by the Mx1 additive effects, dominant effects, the combina-
tion of both Mx1 effects, and cumulative effects of other loci captured in the relationship
matrix. In the CC-RIX, the relationship matrix models the expected increased pheno-
typic correlation between CC-RIX mice that share a single CC parent. Black intervals
(VC) are based on the posterior samples of the variance components. Red intervals (SS)
are based on the posterior samples of sums of squares estimators. SS estimators are (1)
not dependent on variance component estimates, which tend to be disperse, and (2) are
based on the observed strains and crosses, rather than all possible strains/crosses, with
(1) and (2) resulting in much narrower confidence intervals.
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Table A1 Proportion of variance in IAV-induced weight loss attributable to diallel effect classes across 4 days post-
infection. Part C of Figure A7 through Figure A10 show Bayesian confidence interval plots of treatment response variance projection
(TReVarP) values presented here.
Effect Class 1 D1 0.025 0.975 D2 0.025 0.975 D3 0.025 0.975 D4 0.025 0.975
additive 0.0229 -0.0007 0.0565 0.0197 0.0002 0.0516 0.2163 0.0692 0.3612 0.3477 0.1896 0.4907
maternal 0.0192 0.0011 0.0474 0.0253 0.0030 0.0603 0.0381 0.0021 0.0965 0.0196 0.0000 0.0589
inbred (overall) 0.0306 0.0000 0.0723 0.0142 0.0000 0.0465 0.0025 0.0000 0.0211 0.0021 0.0000 0.0179
inbred 0.0082 -0.0021 0.0299 0.0064 -0.0017 0.0292 0.0031 -0.0136 0.0336 0.0023 -0.0134 0.0304
symmetric epistatic 0.0605 0.0137 0.1190 0.0433 0.0053 0.1008 0.0655 -0.0060 0.2239 0.0692 -0.0095 0.2117
asymmetric epistatic 0.0264 0.0043 0.0598 0.0233 0.0017 0.0608 0.0203 -0.0008 0.0698 0.0163 -0.0009 0.0667
female (overall) 0.0296 -0.0001 0.0669 0.0282 -0.0002 0.0664 0.0299 -0.0010 0.0786 0.0256 -0.0005 0.0692
sex-by-additive 0.0309 0.0038 0.0696 0.0169 0.0008 0.0468 0.0131 -0.0011 0.0506 0.0103 -0.0003 0.0455
sex-by-maternal 0.0143 -0.0002 0.0382 0.0224 0.0004 0.0602 0.0230 -0.0004 0.0751 0.0059 -0.0007 0.0259
female inbred (overall) 0.0024 -0.0025 0.0199 0.0027 -0.0027 0.0210 0.0047 -0.0030 0.0311 0.0027 -0.0028 0.0231
sex-by-inbred 0.0054 -0.0020 0.0278 0.0024 -0.0014 0.0156 0.0034 -0.0015 0.0382 0.0012 -0.0013 0.0194
sex-by-symm. epis. 0.0152 0.0006 0.0454 0.0100 -0.0001 0.0362 0.0089 -0.0008 0.0541 0.0052 -0.0010 0.0366
sex-by-asymm. epis. 0.0259 0.0018 0.0714 0.0218 -0.0006 0.0747 0.0119 -0.0031 0.0764 0.0059 -0.0009 0.0438
total explained 0.3276 0.2277 0.4260 0.2775 0.1845 0.3813 0.5164 0.3516 0.6866 0.5705 0.4176 0.7206
noise 0.6724 0.5740 0.7723 0.7225 0.6187 0.8155 0.4836 0.3134 0.6484 0.4295 0.2794 0.5824
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Table A2 Proportion of variance in IAV-induced weight loss attributable to diallel effect classes across 4 days post-
infection, after accounting for Mx1 diplotype. Part C of Figure A11 through Figure A14 show Bayesian confidence interval plots
of treatment response variance projection (TReVarP) values presented here.
Effect Class 2 D1 0.025 0.975 D2 0.025 0.975 D3 0.025 0.975 D4 0.025 0.975
additive 0.0292 -0.0007 0.0809 0.0233 -0.0011 0.0624 0.0631 0.0025 0.1802 0.0496 -0.0008 0.2343
maternal 0.0188 0.0002 0.0455 0.0250 0.0026 0.0601 0.0530 0.0047 0.1273 0.0309 0.0003 0.0916
inbred (overall) 0.0318 0.0000 0.0816 0.0183 0.0000 0.0587 0.0215 0.0000 0.0849 0.0062 0.0000 0.0467
inbred 0.0087 -0.0024 0.0328 0.0064 -0.0021 0.0298 0.0052 -0.0055 0.0381 0.0054 -0.0059 0.0425
symmetric epistatic 0.0639 0.0150 0.1276 0.0450 0.0050 0.1054 0.0286 -0.0025 0.1047 0.0333 -0.0024 0.1353
asymmetric epistatic 0.0260 0.0045 0.0596 0.0227 0.0014 0.0592 0.0272 -0.0014 0.0922 0.0268 -0.0012 0.1067
female (overall) 0.0288 -0.0003 0.0655 0.0280 -0.0001 0.0661 0.0395 -0.0005 0.1001 0.0393 -0.0008 0.1040
sex-by-additive 0.0308 0.0034 0.0696 0.0168 0.0009 0.0467 0.0167 -0.0010 0.0628 0.0152 -0.0010 0.0679
sex-by-maternal 0.0138 0.0000 0.0373 0.0219 0.0002 0.0585 0.0286 -0.0003 0.0931 0.0089 -0.0012 0.0385
female inbred (overall) 0.0023 -0.0026 0.0190 0.0026 -0.0028 0.0210 0.0056 -0.0042 0.0366 0.0040 -0.0043 0.0342
sex-by-inbred 0.0053 -0.0018 0.0269 0.0023 -0.0014 0.0154 0.0041 -0.0021 0.0462 0.0017 -0.0020 0.0241
sex-by-symm. epis. 0.0147 -0.0001 0.0447 0.0100 -0.0006 0.0354 0.0132 -0.0014 0.0811 0.0088 -0.0014 0.0666
sex-by-asymm. epis. 0.0257 0.0017 0.0713 0.0213 -0.0006 0.0734 0.0165 -0.0021 0.1099 0.0091 -0.0017 0.0669
total explained 0.3389 0.2373 0.4435 0.2866 0.1907 0.3939 0.4186 0.2488 0.6053 0.3381 0.1740 0.5365
noise 0.6611 0.5565 0.7627 0.7134 0.6061 0.8093 0.5814 0.3947 0.7512 0.6619 0.4635 0.8260
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Table A3 Model inclusion probabilities for diallel effects classes, (A) before and (B) after accounting for Mx1 diplotype.
We consider the following levels for strength of evidence for inclusion: positive {(0.05, 0.25] or [0.75, 0.95)}, strong {(0.01, 0.05] or [0.95,
0.99)} and very strong {[0, 0.01] or [0.99, 1]}, as described in the Statistical Methods. Part B of Figures A7 through A14 show bar plots
of posterior MIP values presented here.
(A) Effect Class D1 D2 D3 D4
theta 1.0000 1.0000 1.0000 1.0000
fixed: D0 0.0179 0.4630 0.6074 0.6699
random: batch 0.0772 0.8523 1.0000 0.9999
additive 0.0141 0.0494 0.9779 0.9980
maternal 0.0082 0.0713 0.7446 0.7400
inbred (overall) 0.3995 0.0164 0.9584 0.9992
inbred 0.1504 0.2024 0.3050 0.3504
symmetric epistatic 0.2309 0.3305 0.6674 0.9598
asymmetric epistatic 0.0366 0.1193 0.8197 0.9662
female (overall) 0.0904 0.1718 0.1719 0.3135
sex-by-additive 0.3140 0.1993 0.3174 0.6220
sex-by-maternal 0.0738 0.3212 0.5550 0.3697
female inbred (overall) 0.0237 0.0428 0.1012 0.0943
sex-by-inbred 0.2527 0.2325 0.4448 0.3981
sex-by-symmetric epistatic 0.1399 0.1694 0.3228 0.5873
sex-by-asymmetric epistatic 0.2016 0.3683 0.3682 0.4037
(B) Effect Class D1 D2 D3 D4
theta 1.0000 1.0000 1.0000 1.0000
fixed: D0 0.0180 0.4590 0.6319 0.5172
random: batch 0.0708 0.8332 0.9969 0.9979
random: Mx1 diplo 0.0345 0.5515 1.0000 1.0000
additive 0.0120 0.0558 0.3835 0.4305
maternal 0.0068 0.0671 0.6138 0.5272
inbred (overall) 0.3977 0.0238 0.6696 0.8789
inbred 0.1420 0.2068 0.2737 0.3334
symmetric epistatic 0.2195 0.3642 0.5561 0.7668
asymmetric epistatic 0.0318 0.1176 0.6825 0.8511
female (overall) 0.0876 0.1762 0.2294 0.3394
sex-by-additive 0.3051 0.1981 0.2859 0.4884
sex-by-maternal 0.0662 0.3194 0.4769 0.2939
female inbred (overall) 0.0237 0.0432 0.0913 0.0889
sex-by-inbred 0.2466 0.2345 0.3658 0.3345
sex-by-symmetric epistatic 0.1317 0.1692 0.3028 0.4359
sex-by-asymmetric epistatic 0.1924 0.3719 0.3387 0.3296
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Table A4 Details of populations analyzed for additive strain-specific effects in Figure
2.8.
POPULATION diallel pre-CC CC-RIX
Recombinant no yes yes
Inbreds yes (some) yes no
Heterozygotes yes (most) no yes
Sexes males & females females females
IAV used H1N1 (PR8) H1N1 (PR8) H1N1 (CA04)
Post-infection day analyzed day 4 day 4 day 7
Model Bayes Diallel Diploffect Diploffect
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Table A5 CC-RIX lines used in this experiment. A total of 1,402 mice from 105 CC-RIX
lines (about 13 mice per line), originating from a sparse diallel cross of 65 CC strains,














































































































Table A6 Summary of overall and additive effects from Figures 2.5A, A7A, A8A, A9A, and A10A. Posterior median and 95% HPD
intervals are provided for D1 through D4 p.i.
Diallel Effect D1 0.025 0.975 D2 0.025 0.975 D3 0.025 0.975 D4 0.025 0.975
treatment (overall) (θ) -0.131 -0.484 0.223 -0.833 -1.328 -0.318 -5.594 -6.470 -4.729 -8.849 -9.920 -7.779
inbred (overall) 1.258 0.407 2.100 1.212 -0.002 2.413 0.416 -1.641 2.477 -0.524 -3.122 2.018
female (overall) -0.895 -1.447 -0.362 -1.245 -2.037 -0.460 -1.655 -3.066 -0.220 -2.108 -3.868 -0.295
female inbred (overall) 1.221 -0.269 2.680 1.771 -0.375 3.940 -1.286 -5.052 2.438 -1.077 -5.872 3.559
fixed: D0 weight -0.135 -0.285 0.017 -0.306 -0.522 -0.093 -0.450 -0.928 0.025 -0.473 -1.061 0.123
additive: AJ -0.089 -0.641 0.445 -0.016 -0.689 0.647 -2.167 -3.721 -0.611 -2.767 -4.661 -0.864
additive: B6 -0.086 -0.642 0.450 -0.153 -0.845 0.524 -0.606 -2.010 0.801 -0.730 -2.638 1.181
additive: 129 0.270 -0.283 0.840 0.316 -0.379 1.031 0.002 -1.442 1.462 -0.997 -2.878 0.917
additive: NOD 0.115 -0.440 0.667 0.062 -0.608 0.771 -0.827 -2.249 0.601 -1.764 -3.703 0.116
additive: NZO 0.191 -0.363 0.747 0.276 -0.437 1.021 2.536 0.719 4.269 4.066 1.948 6.121
additive: CAST -0.184 -0.752 0.362 -0.120 -0.812 0.579 0.731 -0.674 2.157 1.235 -0.649 3.092
additive: PWK -0.149 -0.699 0.411 -0.258 -0.967 0.425 1.698 0.116 3.228 4.061 1.971 6.076
additive: WSB -0.067 -0.610 0.471 -0.108 -0.809 0.567 -1.350 -2.889 0.157 -3.088 -5.008 -1.176
σ2 3.808 2.923 4.786 8.188 6.284 10.182 12.199 6.881 17.899 19.679 12.024 28.777187
Table A7 Summary of overall, additive, and Mx1 effects from Figures A11A, A12A, A13A, and A14A. Posterior median and 95% HPD
intervals are provided for D1 through D4 p.i.
Diallel Effect D1 0.025 0.975 D2 0.025 0.975 D3 0.025 0.975 D4 0.025 0.975
treatment (overall) (θ) -0.193 -1.128 0.707 -0.925 -1.991 0.113 -5.464 -7.675 -3.102 -7.986 -11.202 -4.147
inbred (overall) 1.296 0.313 2.276 1.385 0.017 2.738 1.945 -0.417 4.282 1.046 -1.971 4.101
female (overall) -0.894 -1.435 -0.356 -1.251 -2.039 -0.468 -1.681 -3.061 -0.333 -2.105 -3.905 -0.339
female inbred (overall) 1.224 -0.231 2.705 1.765 -0.364 3.931 -1.221 -4.945 2.312 -1.018 -5.663 3.654
fixed: D0 weight -0.137 -0.289 0.012 -0.313 -0.528 -0.099 -0.548 -0.996 -0.096 -0.576 -1.155 -0.016
additive: AJ -0.094 -0.679 0.489 -0.015 -0.718 0.691 -1.147 -2.589 0.112 -0.854 -2.819 0.549
additive: B6 -0.086 -0.664 0.501 -0.145 -0.867 0.567 0.190 -0.980 1.352 0.401 -1.017 1.891
additive: 129 0.272 -0.327 0.873 0.323 -0.404 1.076 0.457 -0.695 1.663 0.174 -1.299 1.600
additive: NOD 0.113 -0.453 0.722 0.067 -0.639 0.799 -0.046 -1.221 1.130 -0.148 -1.769 1.266
additive: NZO 0.167 -0.510 0.859 0.232 -0.576 1.068 0.635 -0.737 2.279 0.447 -1.221 2.979
additive: CAST -0.137 -0.935 0.619 -0.048 -0.942 0.831 0.267 -1.225 1.866 0.230 -1.545 2.277
additive: PWK -0.162 -0.857 0.506 -0.303 -1.146 0.493 0.105 -1.273 1.578 0.523 -1.124 3.116
additive: WSB -0.072 -0.653 0.501 -0.111 -0.836 0.605 -0.514 -1.811 0.650 -0.909 -2.962 0.533
Mx1 : cast × cast -0.043 -1.555 1.470 -0.016 -1.712 1.652 0.511 -2.990 4.202 1.257 -3.773 6.904
Mx1 : cast × dom 0.057 -1.077 1.193 -0.089 -1.397 1.183 -0.311 -3.008 2.256 -1.287 -5.596 2.401
Mx1 : cast × mus -0.238 -1.572 1.028 0.036 -1.409 1.521 0.317 -2.619 3.433 0.451 -3.933 5.062
Mx1 : dom × dom 0.028 -1.076 1.217 0.015 -1.253 1.290 -2.831 -5.872 -0.131 -5.274 -9.857 -0.779
Mx1 : dom × mus 0.135 -0.897 1.213 0.290 -0.870 1.522 2.198 -0.207 4.743 2.624 -1.118 6.299
Mx1 : mus × mus 0.061 -1.251 1.445 -0.234 -1.817 1.213 0.016 -3.171 3.295 1.948 -2.574 7.167
σ2 3.797 2.913 4.769 8.190 6.328 10.268 11.270 6.644 16.627 19.296 12.210 27.397
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Table A8 Summary of dominance index for Mx1 from cast or mus, combined with Mx1 from dom in our diallel study. Posterior mode and
and 80% HPD intervals are provided from D1 through D4 p.i. The posterior mode is obtained from the value of D that has the maximum
posterior density within the range [−1, 2], via the density function from the stats package in R.
index D1 D2 D3 D4
D(cast; dom) 0.726 (-1.322, 2.676) 0.708 (-1.476, 2.833) 0.421 (-0.534, 0.907) 0.491 (-0.028, 0.836)
D(mus; dom) 0.650 (-1.181, 2.460) 0.832 (-1.410, 3.101) -0.278 (-2.547, 0.329) 0.068 (-0.568, 0.381)
D(cast; mus) 0.468 (-2.060, 3.042) 0.521 (-2.037, 2.966) 0.450 (-1.884, 2.794) 0.526 (-2.197, 3.135)
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APPENDIX B: Extending the Diallel Model
Appendix B.1: Analyzing the degree of dominance in a diallel
The following section I wrote as an appendix for a paper that has been published:
Turner et al., 2018, G3: Genes, Genomes, Genetics. 3
In Comstock and Robinson (1948), a method was described for obtaining a quantita-
tive estimate of the degree of dominance, a, from a simple linear model of phenotypes on
genotypes. The model is reproduced in summary below: p = y + e, where y is the pheno-
type, g is the genetic component, and e is the deviation or residual. The paper goes on
to describe a variance-component based method of determining the aggregate dominance
contribution to the phenotype. For the purpose of this manuscript, rather than compute
estimates of the average or aggregate dominance contribution based on the variance com-
ponents, which is captured to some extent in the Variance Projection analysis, we use
the posterior predictive estimates of phenotypes within the inbred and hybrid groups to
generate a posterior distribution of the degree of dominance parameter, a, for all pairings
of different inbred parents in the 6 × 6 diallel (n=15 categories).
Given a specific locus (in our case, we consider founder genome contributions rather
than loci), two alleles, B and b, can be combined as BB, Bb, or bb in a breeding popu-
lation, and the the phenotypic expectation for hybrids, in the absence of dominance, is
given by yBb = (yBB + ybb)/2, or equivalently, yBB − yBb = yBb − ybb. Elaborating the
notation to consider the case where dominance plays a role, we have:
yBB = z + 2u (B1)
yBb = z + u + au (B2)
ybb = z (B3)
3Turner SD, Maurizio PL, Valdar W, Yandell BS & Simon P. (2018). Dissecting the genetic architecture
of shoot growth in carrot (Daucus carota L.) using a diallel mating design. G3: Genes, Genomes, Genet-
ics, 8(2): 411-426. https://dx.doi.org/10.1534/g3.117.300235. PMID:29187419.
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Algorithm 1: Multiple Imputation Matched Quartets (MIMQ)
Data: Treatment diallel data frame (T)
Result: Posterior effect estimates for phenotypes in P
1 P ← phenotypes (e.g. pctD1, . . . , pctD4);
2 D ← diallel categories ({ j k, s, h});
3 R← total number of replicates (n = 1000);
4 C ← covariates;
5 for p ∈ P do
6 for d ∈ D do
7 Identify number of individuals to be deleted from this class (0-1); if > 0, add
class to set of classes to have deletions (Ddelete)
8 Identify number of individuals to be imputed from this class (0-3); if > 0 add
class to set of classes to have imputation (Dimpute)
9 end
10 for r ← 1 to R do
11 Make copy of T : T (r)
12 for d ∈ Ddelete do
13 Randomly delete row from class d in T (r);
14 end
15 for c ∈ C do
16 Obtain diallel effect (β̂c) and variance (σ̂2c) estimates by fitting covariate
data for c with BayesDiallel;
17 for d ∈ Dimpute do
18 Insert row(s) for class d into T (r), imputing cd according to the
following: c̃r
d
∼ N(dβ̂c, σ̂2c); based on counts from (8), multiple rows
with different cd values may be inserted;
19 end
20 end
21 Obtain diallel effect (β̂p) and variance (σ̂2p) estimates by fitting phenotype
data for p with BayesDiallel, conditional on imputed covariate(s);
22 for d ∈ Dimpute do





∼ N(dβ̂p, σ̂2p |c̃rd)
24 end
25 Run BayesDiallel on T (r);
26 end
27 Concatenate MCMC results from each of the T (r) runs and summarize;
28 end
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We can then rewrite the value of a according to the relationship between yBB, yBb,
and ybb in the following steps. First of all, regardless of the value of a, we know that
yBB − ybb = z + 2u − (z) = 2u. Also, we know that:
yBB − yBb = z + 2u − (z + u + au) = u − au = (1 − a) · u (B4)
(yBB − yBb)/u = 1 − a (B5)
a = 1 − (yBB − yBb)/u (B6)
We substitute the value of u in Eqn B4, using u = yBB−ybb2 , giving us the relation,





. We recognize that the quantity on the right, (yBB − yBb)/(yBB − ybb)
is equivalent to the definition of the dominance index, D, in Kacser and Burns (1981),
which is used in a diallel analysis of dominance in Maurizio et al. (2017).
The Comstock-Robinson parameter for dominance, aCR, was furthermore used in
Gardner and Lonnquist (1959) to quantify the degree of dominance in genetic crosses of
maize. We adapt the classification of degree of dominance in that paper, as follows, with
the corresponding values for the Kacser-Burns dominance index, DKB, given on the right:
category value (aCR) value (DKB)
(pseudo-)underrecessivity a << −1.0 D >> 1.0
recessivity a = −1.0 D = 1.0
no dominance (additivity) a = 0.0 D = 0.5
dominance a = 1.0 D = 0.0
pseudo-overdominance a >> 1.0 D << 0.0
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Appendix B.2: Modeling diallel count data using generalized linear mixed
models
This section is being prepared as supplementary material for a manuscript in prepa-
ration, to analyze litter size and sex ratio distortion in a diallel cross of the CC founder
mice. 4
Diallel Model for Litter Size
We collected data on litter size at weaning for 62 genetic crosses of inbred lines, across
four years of breeding. Our data is thus count-based, and follows a random process con-
strained to small positive integers. We choose to model our data using zero-truncated
Poisson (ZTP) regression.
This type of regression is explicit in its framework accounting for discrete observa-
tions, flexible in its ability to use linear mixed models on the latent scale, and allows for
parameterization of excess variance observed, in a way that standard Poisson regression
does not. We acknowledge zero depletion by using ZTP regression instead of standard
Poisson regression, since we exclude observations of birth cohorts where zero pups sur-
vived to weaning.
In Figure B1, the distribution of the observed data (litter size − 1) is displayed, along
with simulated data from a Poisson distribution, given the data mean as input, and from
the negative binomial distribution, which can also be used to model data of our type and
account for overdispersion.
To understand the genetic architecture of litter size in our population, we adapt a
previously published linear mixed model, BayesDiallel (Lenarcic et al. 2012), that has
been used to estimate heritable effects on the overall genetic architecture of quantitative
phenotypes. Whereas the original BayesDiallel software is able to accommodate continu-
ous data with Gaussian-distributed residuals, it has not yet been used to explicitly model
discrete data. We thus adapt the BayesDiallel model using a Gibbs sampler that can ac-
4Shorter JR, Maurizio PL, Bell TA, Shaw GD, Miller DR, Gooch TJ, Spence JS, McMillan L, Valdar W
and Pardo-Manuel de Villena F. A diallel of Collaborative Cross founder strains exploring heritability of
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Figure B1 Comparison of observed data and (pseudo-)randomly generated data. (A)
Distribution of the litter diallel data. (B) Distribution of pseudorandom data (n = 1× 108)
from a Poisson, using rpois(), with mean 4.57. (C) Distribution of pseudorandom data
(n = 1× 108) from a negative binomial, using rnbinom(), to approximate an overdispersed
Poisson, and with mean 4.57 and variance 6.41 (parameterized as size=375). The red
dotted lines indicate the mean values. The resulting variances in (A) and (C) are both
approximately 6.41, whereas the variance in (B) is approx. 4.57.
commodate discrete count data via a generalized linear mixed model using the R software
package MCMCglmm Hadfield (2010), using a ZTP distribution with a log-link.
The model is elaborated below:
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yi ∼ ZTPois (λi) [observed data] (B7)
λi = g
−1(`i) [expected data] (B8)
ηi = µ+ uorder[i] + ubatch[i] + dT{ jk}[i]β [latent] (B9)
`i = ηi + εi [+ overdisp.] (B10)
with the link function g(x) = log(x), and the inverse link function g−1(x) = ex. We
use log() to mean natural logarithm, ln(), throughout. For notational simplicity, we have
omitted implicit conditional statements in our formulas, e.g. yi | j k, order[i],batch[i] ∼
Pois (λi | . . .).
For the ZTP, the first two moments (mean and variance), for values yi > 0, are given
by:
E[yi] = λi1 − e−λi (B11)







The overdispersion error, ε, and random effects of litter order, uorder, and year-month,









corder · α, τ2order
)
(B14)
εi ∼ N(0,σ2) (B15)
The remaining part of the model, dT{ jk}β, is analagous to the ‘fullu’ (full, unsexed)
model as described in Bayes Diallel (Lenarcic et al. 2012), and is given below:
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dT{ jk}β = a j + ak︸  ︷︷  ︸
additive










vjk +S{ j<k} · w jk
)
︸                           ︷︷                           ︸
epistasis
(B16)
The effects for each of the five diallel random effects classes, {a, m, b, v,w} are drawn
from normal distributions, each with their own τ2 priors, similar to Eqn B13. We use the
following priors for fixed effects, fixed ∈ (µ, α, and βinbred), and for variances of random
effects, tau ∈ (σ2, τ2a , τ2m, τ2b , τ
2





0, 1 × 103

(B17)
tau ∼ IG (V = 1, ν = 0.002) (B18)
which is equivalent to
tau ∼ IG(α = 0.001, β = 0.001) (B19)
where α and β are the shape and scale parameters, respectively. The estimated pa-
rameter definitions appear in Table B1.
Dam and sire effects
In order to employ the posterior diallel effects estimates to specifically contrast dam-
specific (maternal) versus sire-specific (paternal) effects, we collapse the existing posterior
additive and posterior maternal-deviation effects into two distinct classes. Specifically, we
newly define maternal (dam) effects and paternal (sire) effects as simple linear combina-
tions of the following BayesDiallel parameters, for each of the eight strains, for example in
B6:
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dam:B6 = additive:B6 +maternal:B6
sire:B6 = additive:B6 −maternal:B6
Or more generally:
damj = a j +m j (B20)
sirej = a j −m j (B21)
where a j and m j are the additive and maternal deviation effects for strains j ∈ {AJ,
B6, 129S1, NOD, NZO, CAST, PWK, WSB}. This posterior re-parameterization, there-
fore, has the benefit of providing an interpretable directional parent-of-origin effects for
maternal and paternal strain contributions. Additionally, the re-parameterization has no
effect on the estimates for the other diallel categories, such as inbred deviation (βinbred,
bj), epistatic symmetric (vjk), or epistatic asymmetric (w jk) effects.
Diallel effect estimates
Diallel effect estimates are obtained using an MCMCglmm (Hadfield 2010) implemen-
tation of BayesDiallel (BayesDiallel-glmm, henceforth), with 1.515 × 106 iterations, 1.5 × 104
iterations of burn-in, and thinning by 500 (saving only every 1/500th iteration), to obtain
3000 independent samples with minimal autocorrelation, and plotted as highest posterior
densities (HPDs) in the results.
Conversion to the expected data scale
The effects estimated from the BayesDiallel-glmm model are transformed from the
latent scale to the (expected) data scale via the inverse link function, i.e. exp(aAJ ), for
interpretability of effects on the original data scale.
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Variance Explained Using Variance Components
We provide one estimate of the variance contribution to the phenotype, or propor-
tion of variance explained (PVE), using the estimated variance components from our
BayesDiallel-glmm model.6












for class ∈ {additive (a), maternal (m), inbred (b), epistatic.symmetric (v), epistatic.
asymmetric (w), ‘batch’, and ‘order’}.
Conversion to the expected data scale
For interpretation of the variance-component based estimates of PVE, we transform
the values to the (expected) data scale using the closed form calculation of additive ge-
netic variance contribution, in the presence of fixed effects, according to the QGglmm pack-
age described in de Villemereuil et al. (2016).
Variance Explained Using Variance Projection - Poisson model
In this case, we decompose the total sum of squares (SSTO) into the various compo-
nents, and then substitute the SS from the various classes in the place of the τ2 values
above.
In the case of the Poisson distributed variance contribution, we need to include addi-
tional variance in the calculation of the total.
6Jenkins et al. (2014) have used MCMCglmm to obtain variance component-based estimates of heritability.
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where log(·) represents the natural logarithm function, and subscripts are as defined
above.
Variance Explained Using Variance Projection - square-root transform
In order to account for heteroscedasticity (unequal variance) of the model residu-
als that arises from the approximately Poisson nature of the data, we used a variance-
stabilizing transformation (VST) (Yu 2009) and ran BayesDiallel again (Gaussian, LMM
version) to obtain Variance Projections on the modeled data. The VarPs that are calcu-
lated from these parameter estimates are an approximation of the VarPs that we obtain
from the GLMM model, and we provide a comparison of variance contribution estimates
from the two methods.
Diallel Models for Sex Ratio
We consider the counts of male and female pups in two ways. First, we perform a
stratified analysis of male and female weaned pup counts, and model them using standard
Poisson regression, similar to the approach with ZTP above. In this approach, we assume
that the diallel effects independently act on the male and female pup counts, and can look
at posterior HPDs to observe if there are substantial differences between estimated strain
and strain-specific effects for male vs. female weaned pup counts.
Second, we model the male pup counts and female pup counts jointly, using the Bayes-
Diallel linear model, formulated for binomial GLMM regression. This model directly
considers genetic effects on the imbalance in male vs. female pups by parameterizing the
number of males and number of total pups (or the total, and the fraction of males in the
total). The models are elaborated below.
199
Sex-Stratified Overdisperse Poisson Modelling of Diallel Effects on Pup Counts
female pups
0 5 10 15
rpois (female)
0 5 10 15
male pups
0 5 10 15
rpois (male)
0 5 10 15
Figure B2 Comparison of observed sex-stratified data and (pseudo-)randomly generated
data. [topleft] Distribution of the litter diallel data for males. [topright] Distribution of
pseudorandom data (n = 1 × 108) from a Poisson, using rpois(), with mean 2.761. [bot-
tomleft] Distribution of the litter diallel data for males. [bottomright] Distribution of
pseudorandom data (n = 1 × 108) from a Poisson, using rpois(), with mean 2.810. The red
dotted lines indicate the mean values. The resulting variances in [topright] and [bottom-
right] are 2.761 and 2.810, respectively, whereas the variance in [topleft] and [bottomleft]
are 3.030 and 3.069, respectively.
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Similar to the model used for total litter size, we independently model diallel effects
on male pup count and female pup count using an overdisperse Poisson model (without
truncation), elaborated below:
yi ∼ Pois (λi) [observed data] (B26)
λi = g
−1(`i) [expected data] (B27)
ηi = µ+ uorder[i] + ubatch[i] + dT{ jk}[i]β [latent] (B28)
`i = ηi + εi [+ overdisp.] (B29)
Binomial GLMM for Sex Distortion on Diallel Effects on Pup Counts
The mean and the variance of male ratio are 0.494 and 0.063, respectively. Simulated
binomial data (divided by n=16) are shown, with a resulting mean and variance of 0.494
and variance 0.250. 7
data
0.0 0.2 0.4 0.6 0.8 1.0
rbinom (n=16)
0.0 0.2 0.4 0.6 0.8 1.0
Figure B3 Comparison of observed data and (pseudo-)randomly generated data. (A)
Distribution of the litter diallel male ratio data. (B) Distribution of pseudorandom data
(n = 1 × 108) from a binomial, using rbinom(), with mean 0.494.
The proportion of weaned pups that are male, or equivalently, the proportion of
weaned pups that are female, is approximated by a binomial distribution.












































































































































































































Figure B4 Overview of litter data collected over time.
We implement a similar model as in our model for weaned litter size, elaborated be-
low:
yi ∼ Binom (ni, πi) [observed data] (B30)
πi = g
−1(`i) [expected data] (B31)
ηi = µ+ uorder[i] + ubatch[i] + dT{ jk}[i]β [latent] (B32)
`i = ηi + εi [+ overdisp.] (B33)
with the link function g(x) = logit(x) = log(x)/(1 − x), and the inverse link function
g−1(x) = logit−1(x) = expit(x) = ex/(1 + ex). The calculation of effect estimates, dam and
sire re-parameterization, and VarP calculation proceeds similarly to the process used in
the Poisson model shown above.
Binomial test, and boundary for male sex proportion
To generate the upper and lower 95% boundaries for the expected phenotype, under
the null hypothesis of male pup proportion = 0.5, we used the qbinom function in the





























variability in litter size
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Figure B8 Diallel effects on weaned litter size, female pups only. Diallel effects, includ-
ing (left) strain-specific additive, maternal, and inbred effects, and (right) epistatic effects
between each pairwise cross. For each parameter, thin and thick horizontal lines represent
95% and 50% highest posterior density (HPD) intervals, respectively, and vertical break
and dash give posterior median and mean, respectively. The gray vertical lines indicate
zero. Effects are shown as the log(·), or latent, scale effects on the mean litter size at-
tributable to each strain or strainpair and inheritance group, where values are centered at
0 for each random effect class. Intervals that exclude zero have non-negligible effects on
the mean litter size. Labels with “v” or “w” refer to symmetric or asymmetric epistatic
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Figure B9 Diallel effects on weaned litter size, male pups only. Diallel effects, including
(left) strain-specific additive, maternal, and inbred effects, and (right) epistatic effects
between each pairwise cross. For each parameter, thin and thick horizontal lines represent
95% and 50% highest posterior density (HPD) intervals, respectively, and vertical break
and dash give posterior median and mean, respectively. The gray vertical lines indicate
zero. Effects are shown as the log(·), or latent, scale effects on the mean litter size at-
tributable to each strain or strainpair and inheritance group, where values are centered at
0 for each random effect class. Intervals that exclude zero have non-negligible effects on
the mean litter size. Labels with “v” or “w” refer to symmetric or asymmetric epistatic
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Figure B10 Estimated maternal and paternal effects on weaned litter size, female pups
only. Highest posterior density (HPD) intervals for the maternal (“dam” strain) and
paternal (“sire” strain) effects on litter size, as calculated from the additive and maternal
parameters in the figure above, with HPD intervals defined correspondingly. The colored
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Figure B11 Estimated maternal and paternal effects on weaned litter size, male pups
only. Highest posterior density (HPD) intervals for the maternal (“dam” strain) and
paternal (“sire” strain) effects on litter size, as calculated from the additive and maternal
parameters in the figure above, with HPD intervals defined correspondingly. The colored
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Figure B15 Birth date and litter birth order effects on sex ratio distortion, quantified as
proportion of male pups to total pups weaned.
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Table B1 Model parameters, random and fixed (overall).
Parameter Key Description Type Levels
µ overall mean fixed 1
α litter order (overall) fixed 1
u(order) litter order random 6
u(batch) experimental batch random
a j strain-specific additive random 8
m j strain-specific maternal (parent-of-origin) random 8
βinbred overall inbred penalty fixed 1
bj strain-specific inbred penalty random 8
vjk strain pair-specific symm. epistasis random 28
w jk strain pair-specific asymm. epistasis (parent-of-origin) random 28
damj strain-specific maternal (a j +m j) 8
sirej strain-specific paternal (a j −m j) 8
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Table B2 Main effects estimates (latent scale).
Diallel Effect mean (0.025 0.975)
mean (overall) 1.698 1.610 1.809
inbred (overall) -0.190 -0.219 -0.158
fixed: litter number -0.046 -0.074 -0.022
additive:AJ -0.029 -0.075 0.015
additive:B6 0.130 0.084 0.177
additive:129S1 -0.005 -0.047 0.039
additive:NOD 0.186 0.142 0.229
additive:NZO 0.098 0.049 0.150
additive:CAST -0.132 -0.183 -0.074
additive:PWK -0.059 -0.102 -0.017
additive:WSB -0.176 -0.222 -0.131
maternal:AJ 0.021 -0.030 0.077
maternal:B6 0.138 0.084 0.187
maternal:129S1 0.013 -0.043 0.067
maternal:NOD 0.103 0.045 0.156
maternal:NZO 0.028 -0.035 0.092
maternal:CAST -0.044 -0.103 0.011
maternal:PWK -0.101 -0.157 -0.053
maternal:WSB -0.146 -0.196 -0.093
inbred:AJ 0.031 -0.058 0.130
inbred:B6 0.018 -0.078 0.117
inbred:129S1 -0.086 -0.182 0.012
inbred:NOD 0.132 0.012 0.256
inbred:NZO 0.027 -0.066 0.121
inbred:CAST -0.048 -0.160 0.063
inbred:PWK -0.001 -0.089 0.091
inbred:WSB -0.067 -0.182 0.022
σ2 (overdispersion) 0.012 0.003 0.022
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Table B3 Variance components using the Gaussian model.
Variance Class mean (0.025 0.975)
additive 0.061 0.013 0.137
maternal.dev 0.039 0.008 0.093
inbred 0.036 0.002 0.095
symmetric.epistatic 0.007 0.001 0.017
asymmetric.epistatic 0.020 0.004 0.041
total.explained 0.163 0.081 0.276
noise 0.837 0.724 0.919
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Table B4 Variance component estimates using the zero-truncated Poisson model.
Variance Class mean (0.025 0.975)
additive 0.085 0.019 0.185
maternal.dev 0.052 0.012 0.117
inbred 0.041 0.001 0.111
symmetric.epistatic 0.008 0.001 0.020
asymmetric.epistatic 0.021 0.006 0.042
total.explained 0.206 0.102 0.339
noise 0.794 0.661 0.898
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Table B5 Variance Projection (VarP) estimates using the Gaussian model.
Variance Projection mean (0.025 0.975)
additive 0.087 0.050 0.126
maternal.dev 0.057 0.028 0.087
inbred.overall 0.014 0.009 0.019
inbred -0.000 -0.007 0.008
symmetric.epistatic 0.024 -0.005 0.054
asymmetric.epistatic 0.025 0.000 0.051
total.explained 0.208 0.179 0.238
noise 0.792 0.762 0.821
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APPENDIX C: Availability of Software and Data
Software packages, code, and data used in this manuscript, where possible, have been
made publicly available online, under the MIT license, at the social coding site, GitHub:
https://github.com/mauriziopaul. Data for Chapter 2 has been deposited online at
the public archive, Zenodo: https://dx.doi.org/10.5281/zenodo.600609.
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